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 “Nerve paths are something fixed, ended, immutable. Everything may die; nothing may be 
regenerated.”  
Santiago Ramón y Cajal 
 
 
This citation from the founder of the “neuron theory” and probably one of the most important 
and popular scientist ever since in the field of neuroscience is escorting me since my Master 
studies. At that time, I worked on neuronal progenitor cells and their capacity to proliferate 
after spinal cord injury. As it is well described today, the mammalian nervous system is not a 
completely post-mitotic tissue but rather harbors certain pools of cells that are able to divide 
and to functionally integrate into pre-existing networks. Thus, the conclusion I draw after my 
Master studies was the following: as brilliant Mr. Cajal was, at least in his statement about the 
regenerative capacity of the nervous system he eventually was wrong. 
Now, after several additional years in neuroscience, working on a PhD project focusing on 
synaptic plasticity in the adult mouse brain, there is another statement of Santiago Ramón y 
Cajal that I have to reconsider: e.g. with focus on individual synapses or spines, the attributes 
“fixed, ended, immutable” do not fit any more into the current understanding of synaptic 
rearrangement, spine motility or very generally spoken to the theory of synaptic plasticity and 
learning and memory. 
With these notions, by no means I intend to subtract the remarkable and valuable contribution 
of Santiago Ramón y Cajal to modern neuroscience. Rather, they shall serve as an illustration 
of how convertible knowledge is. The driving force of science to constantly gain new insights 
into any kind of mechanism is ultimately followed by the consequence that pre-existing 
knowledge is dropped or modified. Due to this fact, as a scientist one constantly proceeds on 
a tightrope walk, trading well accepted knowledge off against the basic principle of science – 
that is constant questioning and discovering. Therefore, what the citation of Santiago Ramón 
y Cajal – or in other words studying the nervous system during my Master’s and PhD – taught 
me is that in general nothing may be fixed or ended or immutable… 
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1 SUMMARY 
mTOR is a serine/threonine protein kinase that appears in two functionally distinct multi-protein 
complexes. mTOR together with the scaffold protein raptor forms mTOR complex1 (mTORC1) that is 
inhibited in its function by rapamycin. In contrast, mTORC2 is dependent on the interaction with rictor 
and is considered to be rapamycin insensitive. mTORC1 controls a wide range of cellular processes, 
including protein synthesis, ribosome biogenesis, cell growth, gene transcription, autophagy and 
metabolism. In the developing CNS, mTORC1 was shown to be involved in axonal outgrowth and 
navigation, dendritic arborization as well as spine and filopodia formation. In the adult brain, the 
dysfunction of mTORC1 signaling has been linked to several neurodegenerative disorders like 
Parkinson’s, Alzheimer’s, or Huntington’s disease and to some mental disorders, such as 
schizophrenia or autism spectrum disorders. However, it is not known whether altered mTORC1 
signaling is cause or consequence of those pathologies. In addition, mTORC1 has also been 
suggested to be involved in synaptic plasticity and the process of learning and memory. To study the 
role of mTORC1 during development as well as in the adult stage of the brain, we deleted the 
mTORC1-defining component raptor by crossing floxed rptor mice with mice expressing the Cre-
recombinase under the control of the Nestin promoter (RAbKO mice) or under the control of the α-
CamKII promoter (RcKO mice), respectively. 
 
Analysis of the RAbKO mice revealed that several aspects of brain development are critically 
controlled by mTORC1. RAbKO mice showed a pronounced microcephaly which is evenly expressed 
in all brain structures and gets apparent at E17.5. The observed change in brain size is likely due to 
reduced cell size and cell number. The latter is potentially the result of two mechanisms that are 
altered in RAbKO mice. First, raptor-depletion results in an increased incidence of apoptosis at late 
embryonic stages. Secondly, RAbKO mice show reduced proliferation at E17.5 and prolonged cell 
cycle length earlier during development. Furthermore, RAbKO mice show deficits in glial 
differentiation, probably mediated by altered STAT3 signaling that is observed in those mice. 
Moreover, ablation of mTORC1 activity during brain development affects cortical and hippocampal 
layering. 
 
Due to the immediate postnatal lethality of RAbKO mice, there was need for the generation of a 
second knockout-mouse strain based on α-CamKII-Cre mediated recombination to further analyze the 
postnatal role of mTORC1 in the brain (RcKO mice). The data that were obtained from this mouse 
model indicate that mTORC1 is involved in cell size maintenance in adult neurons but does not affect 
apoptosis in the adult brain. Further, RcKO mice display a distinct deficit in learning and memory in the 
Morris water maze. Under long inter-training-interval conditions where consolidation takes place within 
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a time window that relies on de novo protein synthesis, the learning and memory performance of 
RcKO mice is reduced. This deficit can be overcome by an acquisition phase with short inter-training-
intervals. Additionally, RcKO mice do exhibit impairments in fear extinction learning whereas the 
learning as well as context- and cue-memory is not affected in the fear conditioning paradigm in RcKO 
mice compared to control. These behavioral phenotypes are resembled by impaired E-LTP and L-LTP 
maintenance in RcKO mice. In addition to these plasticity-related aspects, also basal synaptic function 
of CA1 hippocampal neurons is altered in RcKO mice. 
 
In summary, the data obtained from the two mouse models provide evidence that mTORC1 signaling 
controls several aspects of brain development and adult brain function. While during embryogenesis 
mainly cellular processes such as proliferation, differentiation and growth are affected by raptor 
deficiency, in the adult brain – besides the cell size control – primarily synaptic and plasticity-related 
functions depend on mTORC1 signaling. Further examination of mTORC1-related functions such as 
autophagy and mitochondrial regulation in RcKO mice potentially will provide new insights into 
mechanism of brain aging and neurodegenerative diseases, both of which are processes that are 
discussed to be dependent on mTORC1 signaling. 
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2 LIST OF ABBREVIATIONS 
TOR target of rapamycin 
mTORC1/mTORC2 mammalian TOR complex 1/2 
RAbKO raptor brain knockout 
RcKO rptor conditional knockout 
α-CamKII Calcium/calmodulin-dependent protein kinase type II subunit alpha 
CNS central nervous system 
E17.5 embryonic day 17.5 
STAT3 signal transducer and activator of transcription 3 
LTP long-term potentiation 
LTD long-term depression 
E-LTP early-LTP 
L-LTP late-LTP 
CA1/2/3 cornu ammonis region 1/2/3 
DG gyrus dentatus 
PIKK phosphatidylinositol kinase-related kinase 
HEAT  Hantignton, EF3, A subunit of PP2A, TOR1 
FRB FKBP12-rapamycin-binding 
FAT FRAP, ATM, and TRRAP 
FATC FAT C-terminus 
Raptor regulatory associated protein of mTOR 
GβL G-protein β-subunit-like protein 
mLST8 mammalian lethal with sec13 protein 8 
PRAS40 proline-rich Akt substrate 40 kDa  
deptor DEP domain containing mTOR-interactin protein 
rictor rapamycin-insensitive companion of mTOR 
mSin1 mammalian stress-activated MAP kinase-interacting protein 1 
protor protein observed with rictor 
Akt/PKB protein kinase B 
IRS insulin receptor substrate 
PI3K phosphoinositide-3-kinase 
PIP3 phosphatidylinositol-3,4,5-triphosphate 
TSC1/2 tuberous sclerosis complex 1/2 
Rheb Ras homolog enriched in brain 
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MAPK Mitogen-activated protein kinases 
GAP GTPase-activating protein 
AMP adenosine monophosphate 
AMPK 5’AMP-activated protein kinase 
ATP adenosine triphosphate 
LKB1 liver kinase b 1 
HIF1α hypoxia inducible factor 1α 
REDD1 regulated in development and DNA damage response 1 
p53 protein 53 
PTEN phosphatase and tensin homolog deleted on chromosome 10 
BAD Bcl-2-associated death promoter 
RSK1 ribosomal S6 kinase 1 
IKKβ inhibitor of nuclear factor-κB 
S6 ribosomal protein S6 
S6K S6 kinase 
4E-BPs elF4E-binding proteins 
UTR untranslated region 
UBF  upstream binding factor 
SREBP sterol regulatory element-binding protein 
PPARγ peroxisome proliferator-activated receptor-γ 
ULK1 unc-51-like kinase 1 
ATG13 autophagy-related protein 13 
TFEB transcription factor EB 
mRNA messenger ribonucleic acid 
eIF4A/B/C/D/E eukaryotic translation initiation factor 4A/B/C/D/E 
5’TOP mRNA 5’ oligo-pyrimidine tract containing mRNA 
5’UTR 5’ untranslated region 
SREBPs sterol regulatory element-binding proteins 
PPARγ peroxisome proliferator-activated receptor-γ 
DAP1 death-associated protein 1 
WIPI2 WD repeat domain phosphoinositide-interacting protein 2 
PGC1α PPARγ coactivator 1α 
PKC protein kinase C 
SGK1 serum-and glucocorticoid-induced protein kinase 1 
MEFs  mouse embryo fibroblasts 
AD Alzheimer’s disease 
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FMRP fragile X mental retardation protein 
Arc activity-regulated cytoskeleton-associated protein 
PSD95 post-synaptic density protein 95 
APP amyloid precursor protein 
Aβ amyloid beta 
PIKE PI3K enhancer 
Ras rat sarcoma 
AMPA-R α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
NMDA-R N-methyl-D-aspartate receptor 
mGluRs metabotropic glutamate receptors 
VDCCs voltage-dependent calcium channels  
RyR ryanodine receptor 
HFS high frequency stimulation 
PKA protein kinase A 
PKMζ protein kinase Mζ 
ERK extracellular-signal related kinase 
CamKK CamK kinase 
CPEs cytoplasmic polyadenylation elements 
CPSF cleavage and polyadenylation-specificity factor 
RISC RNA-induced silencing complex 
CREB cAMP-responding element binding protein 
Elk-1 E twenty-six (ETS)-like transcription factor 1 
BDNF brain-derived neurotrophic factor 
BrdU Bromodeoxyuridine 
Sox2  sex determining region Y box 2 
Tbr2  T-box brain protein 2 
PH3  phosphorylated histone 3 
VZ  ventricular zone 
SVZ  subventricular zone 
IZ  intermediate zone 
NeuN  neuronal nuclei 
Map2  microtubule-associated protein 2 
GFAP  glial fibrillary acidic protein 
BLBP  brain lipid binding protein  
Hsp90 heat-shock protein 90 
EGF epidermal growth factor 
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3 INTRODUCTION 
The history of TOR (target of rapamycin) started in the 1960’s with a Canadian expedition to Easter 
Island (in the native language named Rapa Nui) that aimed to collect plant and soil samples for 
subsequent analysis. One of such a soil sample contained the bacterium Streptomyces hygroscopicus 
that was found to produce a secondary metabolite, rapamycin, which displayed potent antifungal 
activity (Sehgal et al., 1975). After this first characterization of rapamycin as an antifungal agent and 
the finding of additional qualities such as immunosuppressive and cytostatic, the molecular targets of 
rapamycin were discovered in a yeast genetic screen by the group of M.N. Hall in Basel in 1991. 
These targets were named TOR1 and TOR2 (Heitman et al., 1991). Today, several years of 
investigation later, the field of knowledge about the target of rapamycin has grown exponentially. TOR 
is a large serine/threonine protein kinase that is conserved from yeast to human and is found in two 
distinct multi-protein complexes named TORC1 and TORC2 (Loewith et al., 2002). 
 In contrast to yeast, only one TOR ortholog has been identified in higher eukaryotes. The 
mammalian TOR (mTOR) forms two distinct protein complexes termed mTORC1 and mTORC2, 
respectively. mTORC1 and mTORC2 signaling are involved in a variety of cellular processes such as 
protein synthesis, autophagy, cell cycle progression, growth, metabolism, cytoskeletal organization 
and cell survival. As a consequence of this wide range of action, mTOR has been linked to cancer, 
metabolic disease such as obesity, fatty liver disease, insulin resistance and diabetes as well as 
several neurodegenerative diseases such as Parkinson’s, Alzheimer’s, or Huntington’s disease and to 
some mental disorders, such as schizophrenia or autism spectrum disorders (Laplante and Sabatini, 
2012). Proper basic neuronal function was recently intensively discussed to be dependent on 
balanced mTORC1 signaling. However, little is known about the mechanisms underlying altered 
mTORC1 signaling that was observed in a broad range of neuropathologies and brain disorders. 
 Given the fact that mTOR plays a central role in growing and dividing cells and additionally in 
post-mitotic adult tissues, it is still a challenge to therapeutically target and modulate this pathway 
specifically in respect to the above mentioned pathologies. Therefore, a better understanding of the 
mTOR signaling pathway in different organs and cell types in a healthy state as well as under disease 
conditions is crucial for future potential therapeutic targeting. The data presented here are the first that 
describe the genetically based depletion of mTORC1 signaling specifically in the developing brain and 
in adult excitatory neurons, respectively. In this study, we provide evidence for a crucial role of 
mTORC1 signaling during brain development and in adult forebrain neurons and describe the 
detrimental effects of the lack of mTORC1 activity during embryogenesis and the diminished synaptic 
efficiency accompanied by reduced cognitive abilities resulting from an inactivation of mTORC1 in the 
adult forebrain. 
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3.1 The mTORC1 pathway 
3.1.1 Domain structure of mTOR and assembly of mTORC1 and mTORC2 
The mammalian target of rapamycin (mTOR) is an atypical serine/threonine kinase of the 
phosphatidylinositol kinase-related kinase (PIKK) family. mTOR is a high molecular weight protein of 
approximately 290 kDa and contains 2549 amino acids (Figure 1). The C-terminal half of the protein is 
framed by two domains that are found in all PIKK family members, namely the FATC domain and the 
FAT domain. Between those two parts, the kinase domain and the FRB (FKBP12-rapamycin-binding) 
domain - the latter providing the docking-site for the binding of the FKBP12-rapamycin complex - are 
mapped. The N-terminus contains 20 tandem HEAT (Hantignton, EF3, A subunit of PP2A, TOR1) 
repeats (Fingar and Blenis, 2004). Such tandem HEAT repeats are found in many proteins and are 
associated with protein-protein interactions (Andrade and Bork, 1995). This HEAT repeat-rich N-
terminal part of mTOR is the region which is described to be important for the mTOR-raptor 
interaction. Raptor (regulatory associated protein of mTOR) was found by Kim et al. to form a 
stoichiometric complex with mTOR and thereby to positively regulate mTOR activity (Kim et al., 2002). 
Similarly, mLST8 (mammalian lethal with sec13 protein 8, identified as GβL), discovered originally by 
the group of Michael N. Hall (Loewith 
et al., 2002), was identified to be an 
additional binding partner of mTOR. 
Upon interaction of mLST8 with the 
mTOR kinase domain, the mTOR 
kinase activity is stimulated and the 
raptor-mTOR interaction gets 
stabilized (Kim et al., 2003). mTOR, 
raptor and mLST8 form a rapamycin-
sensitive complex that is termed 
mTORC1. After the initial identification 
of the above mentioned components 
of mTORC1, several additional 
proteins were described to interact 
with mTOR and the formation of two 
distinct multi-protein complexes was 
proposed. Currently, the following 
proteins are included in mTORC1: 
mTOR, raptor, PRAS40, deptor and 
Figure 1. Domain structure of TOR.  The NH2-terminal half of 
TOR is composed of tandem HEAT repeats. The COOH-
terminal half of the protein contains the central FAT domain, 
followed by the FRB, the kinase, and the FATC domains. mTOR 
is regulated by nutrients (amino acids and energy) and by 
growth factors to modulate rates of cell growth and cell cycle 
progression, which coordinately control cell proliferation. 
rapamycin, in complex with FKBP12, directly binds to the FRB 
domain to inhibit mTOR-dependent downstream signaling. 
(adapted from: Diane C Fingar and John Blenis Oncogene 
(2004) 23) 
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mLST8. The mTORC2 is defined as the assembly of: mTOR, rictor, mSin1, protor, deptor and mLST8 
(Laplante and Sabatini, 2012). The most striking difference between these two multi-protein 
complexes is their sensitivity to rapamycin. mTORC1 can be inhibited by short-term application of 
rapamycin, but only prolonged exposure is able to inhibit mTORC2 signaling in some cell types and an 
acute treatment does not affect the latter (Sarbassov et al., 2006). Thus, the general knowledge about 
mTORC2 is relatively limited. It still remains to be clarified what kind of inputs converge onto 
mTORC2. So far, only PI3K (phosphoinositide-3-kinase) and ribosomes were discussed to be 
upstream components of the mTORC2 pathway, but the signaling steps beyond PI3K are distinct from 
those upstream of mTORC1 and still unknown (Cybulski and Hall, 2009; Zinzalla et al., 2011). The 
downstream effectors of mTORC2 were identified just recently. The first direct substrate of mTORC2, 
Akt/PKB (protein kinase B), was found in 2005 by the group of David M. Sabatini (Sarbassov et al., 
2005). They demonstrated that mTORC2 specifically phosphorylates Akt/PKB at the residue Ser473. 
Akt/PKB belongs to the AGC subfamily of kinases that are implicated in the control of several 
important cellular processes as well as diseases such as cancer and diabetes (Pearce et al., 2010). In 
the course of further investigation, other AGC kinases such as different PKCs (protein kinase C) and 
SGK1 (serum-and glucocorticoid-induced protein kinase 1) were identified as direct substrates of 
mTORC2 (Facchinetti et al., 2008; Garcia-Martinez and Alessi, 2008; Sarbassov et al., 2004). 
Whereas the activity of SGK1 and several members of the PKC family are dependent on mTORC2, 
the phosphorylation of Akt/PKB by mTORC2 seems to be of minor importance for Akt/PKB activity 
(Laplante and Sabatini, 2012). Besides these AGC kinases also Rho GTPases belong to the targets of 
mTORC2 (Jacinto et al., 2004). Based on the characterized functions of those downstream targets of 
mTORC2 it is generally thought that mTORC2 signaling is involved in the regulation of cell survival, 
metabolism and cytoskeletal organization. 
 In contrast to the marginal knowledge about mTORC2, the characterization of mTORC1 has 
remarkably expanded over the past fifteen years. This is mainly due to the advantage of rapamycin as 
a specific mTORC1 inhibitor. Rapamycin forms a complex with FKBP12 (12 kDa FK506-binding 
protein), which subsequently interacts with mTORC1 and inhibits its activity (Brown et al., 1994; 
Sabatini et al., 1994). In the next two chapters, the up- and downstream components of the mTORC1 
pathway will be discussed in more detail. 
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3.1.2 Upstream control of mTORC1 
The mTORC1 pathway is a very complex and diverse signaling network that consists of several input-
branches that converge onto mTORC1 (Figure 2). The most commonly discussed intracellular and 
extracellular signals that are integrated by mTORC1 are the following: growth factors, energy status, 
amino acids, and stress. Additionally, other signaling pathways such as the Ras-ERK and TNFα can 
trigger the activation of mTORC1 (Laplante and Sabatini, 2012). In the next five sections, each of 
these upstream components of mTORC1 will briefly be described. The regulatory mechanisms that act 
specifically in the brain are described in the subsequent chapters 3.2-3.3. 
 
Growth factors   The general characteristic of mTORC1 as a controller of cell growth makes the 
link to upstream signaling molecules such as growth factors, mitogens and hormones conclusive. 
Insulin, as a prime example for this kind of upstream regulators, binds to its receptor and activates the 
PI3K-Akt/PKB pathway via IRS (insulin receptor substrate). Akt/PKB is recruited to the plasma 
membrane where it gets fully activated by PIP3 and subsequently directly phosphorylates TSC2 and 
Figure 2. The mTOR signaling pathway. Critical inputs regulating mTORC1 include growth factors, 
amino acids, stress, energy status, and oxygen. When active, mTORC1 promotes protein synthesis, 
lipogenesis, and energy metabolism and inhibits autophagy and lysosome biogenesis. (adapted from: 
Mathieu Laplante and David M. Sabatini Cell (2012) 149) 
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thereby causes an inactivation of the TSC1/2 complex that otherwise acts as a negative regulator of 
mTORC1 (Manning and Cantley, 2003). A second signaling branch emanating from mitogen-activated 
Ras/MAPK/ERK/RSK1 pathway converges on TSC2 (Roux et al., 2004). The phosphorylation events 
on TSC2 by the kinases of both branches result in an inhibition of the TSC1/2 complex and thus up-
regulate the mTORC1 activity. However, the link between TSC1/2 and mTORC1 is not direct but the 
signaling proceeds via the small GTPase Rheb (Ras homolog enriched in brain) towards which TSC2 
exhibits a selective GAP (GTPase-activating protein) activity (Garami et al., 2003). The GTPase-
activating protein domain of TSC2 stimulates the intrinsic GTPase activity of Rheb, thereby enhancing 
the conversion of Rheb to its GDP-bound, inactive state. Only in its GTP-bound form, Rheb is a potent 
activator of mTORC1. Thus, active TSC1/2 negatively regulates mTORC1 by converting Rheb to its 
inactive state towards mTOR (Inoki et al., 2003a). 
 
 Energy status   The coordination between cell growth and cellular energy levels is critical for the 
survival of any cell. In consideration of the fact that the best-known role of mTOR is growth control, it 
is not surprising that the energy status of a cell affects mTORC1 activity and its function on protein 
synthesis. However, there was a debate on how mTOR senses the cellular energy state – in a direct 
or indirect way. To date, there is evidence that AMPK (5’AMP-activated protein kinase) couples the 
information of limited amounts of ATP to the mTORC1 pathway (Kimura et al., 2003). AMPK is a 
master regulator of cellular energy metabolism. Activation of AMPK restores cellular energy levels by 
stimulating catabolic pathways, such as glucose uptake and/or glycolysis and fatty acid oxidation, as 
well as by inhibiting energy-consuming anabolic processes such as protein synthesis. A low cellular 
energy state is characterized by a shift in the intracellular AMP/ATP ratio that is sensed by AMPK 
(Hardie et al., 1998). Thus, when cellular energy levels are low, AMPK is activated and subsequently 
phosphorylates TSC2 at its activating residues Ser1345 and Thr1227 (Inoki et al., 2003b) and raptor 
at the residues Ser792 and Ser722 (Gwinn et al., 2008). Both phosphorylation events lead to the 
inhibition of mTORC1. In addition to the activation of AMPK through AMP/ATP levels, AMPK was 
found to be a substrate of the tumor suppressor LKB1 (liver kinase b 1), a protein that is associated 
with the autosomal dominant inherited cancer disorder Peutz-Jeghers syndrome (Woods et al., 2003). 
Under normal conditions, LKB1 is constitutively active and phosphorylates AMPK in order to prime it to 
further activation by AMP (Shaw et al., 2005). 
 
 Amino acids   In yeast, it was well described that TOR signaling is sensitive to nutrients such as 
amino acids (Crespo and Hall, 2002). In case of mammals, Hara et al. were the first to provide 
evidence for the sensitivity of mTORC1 to amino-acid deprivation (Hara et al., 1998). The mechanism 
responsible for amino acid sensing of the mTORC1 was disclosed just recently. Rag GTPases were 
identified by Kim et al. and Sancak et al. as activators of mTORC1 in response to amino acids signals. 
The four known mammalian Rag proteins (RagA, RagB, RagC, RagD) form the heterodimers RagA/B 
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and RagC/D. Effectual amino acids availability induces the formation of GTP-bound RagA/B complex 
which subsequently interacts with raptor. As a result of the Rag-raptor interaction, mTORC1 dislocates 
to the lysosome. In this cellular compartment, the main activator of mTORC1, namely Rheb, was 
found to preferentially be localized. Thus, amino acids might control the activity of the mTORC1 
pathway by regulating the movement of mTOR to the same intracellular compartment that contains the 
mTORC1 activator Rheb (Kim et al., 2008; Sancak et al., 2008). 
 
 Stress   Several cellular conditions can cause “stress-situations” that act as inhibitory on 
mTORC1. Among those, low energy levels, hypoxia and DNA damage are the best characterized. 
Down-regulation of mTORC1 activity in response to low energy levels is mediated by AMPK and 
TSC2 as described above. In the case of hypoxia, besides AMPK-mediated TSC2 activation, also HIF 
(hypoxia inducible factor) regulates mTORC1 inhibition via TSC2. Under low oxygen conditions HIF 
induces the expression of DNA damage response 1 (REDD1) that subsequently activates TSC2 
(Brugarolas et al., 2004). Furthermore, also genotoxic stresses such as radiation-induced DNA 
damage or oncogene activation interfere with the mTORC1 pathway via TSC2 by yet other initial 
components, namely p53 and PTEN. Feng et al. showed that p53 activation inhibits mTORC1 activity 
via AMPK and TSC2 (Feng et al., 2005). Additionally, p53 transcriptionally controls PTEN 
(phosphatase and tensin homolog deleted on chromosome 10) via a DNA-binding site directly 
upstream of the pten locus (Stambolic et al., 2001). PTEN is an upstream regulator of mTOR that acts 
as an inhibitor of PI3K and therefore negatively affects mTORC1 signaling (Vivanco and Sawyers, 
2002). 
 
 Ras-ERK and TNFα signaling   The Ras-ERK pathway is well described to control gene 
transcription and protein translation. Just recently, it has been shown that the Ras-ERK pathway also 
feeds into mTORC1 signaling by at least two mechanisms. First, ERK (extracellular-signal related 
kinase) can directly phosphorylate TSC2 and thereby reduce its inhibitory function on mTORC1. 
Secondly, the downstream target of ERK, RSK (ribosomal S6 kinase), exhibits phosphorylation-activity 
towards TSC2 and raptor, resulting in increased mTORC1 kinase activity (Ma and Blenis, 2009). 
Besides TSC2, also TSC1 is a described target for upstream mTORC1 regulation. The major effector 
of the TNFα signaling pathway, IKKβ (inhibitor of nuclear factor-κB), has recently been shown to 
phosphorylate TSC1, resulting in activation of mTORC1 (Lee et al., 2007). 
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3.1.3 Downstream targets of mTORC1 
The diversity of upstream regulatory mechanisms that merge onto mTORC1 – as discussed in the 
previous chapter – is reflected in the variety of cellular processes that are controlled by mTORC1 
signaling. The best characterized function of mTORC1 is growth control. Ultimately, controlling growth 
means nothing else than regulating protein synthesis, lipid synthesis and proliferation. However, these 
processes need to be in balance with the energy levels that are disposable for a given cell at a given 
time. Therefore, in a low-energy state the cell switches from the “synthesis-program” to a “recycling-
program”. The latter provides a backup source of metabolites in order to keep up with the basic 
functions for cell survival. mTORC1 plays a central role within these processes by regulating protein 
synthesis through S6K and 4E-BPs, lipid synthesis through SREBP and PPARγ, autophagy through 
ULK1 and ATG13, and lysosome biogenesis through TFEB (Figure 3). Moreover, mTORC1 
contributes to cell survival via S6K-mediated inhibition of the pro-apoptotic protein BAD (Bcl-2 
associated death promoter). Most of these downstream effectors and the molecular consequences of 
their regulation by mTORC1 will be described in the subsequent sections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Downstream signaling of mTORC1 and mTORC2. (adapted from: Mathieu Laplante 
and David M. Sabatini Cell (2012) 149) 
Introduction  Regula M. Lustenberger 
 
 
Page | 18  
 Protein synthesis   The best described downstream targets of mTORC1 – S6K and 4E-BPs – 
are control-components of the mRNA translation machinery. The initial step of protein synthesis (once 
the mRNA is produced) is the recruitment of a ribosome to the 5’ end of the mRNA (Hershey, 1991). 
The 5’ end of most mRNAs is characterized by a so-called cap, a structure that is specifically 
recognized by the eukaryotic translation initiation factor 4E (eIF4E) (Altmann et al., 1989). The binding 
of eIF4E to the cap is the first event in the assembly of the ribosome initiation complex at the 5’ end of 
a given mRNA (Gingras et al., 1999). As the name already suggests, the mTORC1 downstream 
targets 4E-BPs (elF4E-binding proteins) interfere with this critical step of translation initiation. 4E-BPs 
compete for the binding site on eIF4E with other proteins that belong to the ribosome initiation 
complex and consequently 4E-BP-bound eIF4E locks translation initiation (Mader et al., 1995). The 
phosphorylation of 4E-BPs by mTORC1 prevents the binding of 4E-BPs to eIF4E and therefore allows 
the formation of the ribosome initiation complex at the mRNA and the subsequent accomplishment of 
the protein synthesis procedure (Heesom and Denton, 1999). Processes involved in translation 
initiation are schematically summarized in Figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Regulation of cap-dependent translation innitiation. a The recruitment of the 40S ribosomal 
subunit to the 5' end of mRNA is a crucial and rate-limiting step during cap-dependent translation. A 
number of translation initiation factors, including the 5' cap-binding protein eukaryotic translation initiation 
factor 4E (eIF4E), have essential roles in this process. Phosphorylated 4E-binding proteins (4E-BPs) 
bind tightly to eIF4E, thereby preventing its interaction with eIF4G and thus inhibiting translation. 
mTORC1-mediated phosphorylation of 4E-BPs releases the 4E-BP from eIF4E, resulting in the 
recruitment of eIF4G to the 5' cap, and thereby allowing translation initiation to proceed. b Another well-
studied initiation factor that is targeted by signal transduction pathways is eIF4B. Following 40S 
ribosomal protein S6 kinase (S6K)- or ribosomal S6 kinase (RSK)-mediated phosphorylation, eIF4B is 
recruited to the translation pre-initiation complex and enhances the RNA helicase activity of eIF4A. This 
is particularly important for translating mRNAs that contain long and structured 5' untranslated region 
sequences, because the unwinding of these RNA structures is required for efficient 40S ribosomal 
subunit scanning towards the initiation codon. (adapted from: Xiaoju M. Ma and John Blenis Nature 
Reviews Molecular Cell Biology (2009) 10) 
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Besides the 4E-BPs also S6K is involved in protein synthesis by promoting increased mRNA 
translation. S6K is an intensively studied effector of mTORC1 but in contrast to 4E-BPs, which 
contribute to overall cap-dependent translation, it was thought that S6K is triggering only a specific 
subset of mRNA that is characterized by an oligo-pyrimidine tract at the 5’ end (Jefferies et al., 1994). 
This subclass of mRNA is called 5’TOP mRNA and encodes primarily ribosomal proteins and certain 
other components of the translation machinery. For a long time it was hypothesized that S6K triggers 
protein synthesis of these mRNAs mainly via phosphorylation of its substrate S6 (ribosomal protein 
S6) (Thomas, 2002). Several recent studies, however, are inconsistent with this hypothesis as e.g. 
genetic inactivation of S6K1 has no effect on TOP mRNA translation, rapamycin only partially blocks 
translational activation of these mRNAs and no deficiency in TOP translation could be observed in a 
phospho-mutant of S6 (Ma and Blenis, 2009). Therefore, it is suggested, that mTOR regulates TOP 
mRNA translation independently of mTORC1 and S6K. A more established mechanism by which S6K 
controls mRNA translation is via phosphorylation of eIF4B (eukaryotic translation initiation factor 4B) 
and thereby stimulating the helicase activity of elF4A (Raught et al., 2004). This helicase activity is 
particularly required for the linearization of long hairpin structures that are often found in the 5’ UTR 
(untranslated region) of a specific subset of mRNAs that code for proteins involved in cell growth and 
proliferation as reviewed by Nissim Hay and Nahum Sonenberg (Hay and Sonenberg, 2004). By 
unwinding these stable hairpin structures, eIF4A provides the structural prerequisites for the ribosome 
to bind and scan these mRNAs (Figure 4b). Additionally, mTORC1 mediated S6K activation promotes 
ribosome biogenesis via phosphorylation of the transcription factor UBF (upstream binding factor) that 
subsequently induces 45S ribosomal gene transcription (Hannan et al., 2003). Therefore, mTORC1 
contributes dually to overall mRNA translation by phosphorylating both 4E-BPs and S6K that 
synergistically promote protein synthesis. 
 
Lipid synthesis   While the link between mTORC1 to cell growth and underlying protein synthesis 
has been accepted for many years, the regulation of lipid biosynthesis by mTORC1 just more recently 
attracted notice. The known ability of mTORC1 to sense the energy status of a cell and the 
observation that mTORC1 is highly activated in adipose tissue of obese mice led to the hypothesis 
that mTORC1 may play a role in lipogenesis and adipogenesis (Um et al., 2004). As soon as the 
balance of energy intake versus energy expenditure is shifted towards more intake than consumption, 
the spared carbohydrates will be converted to adipose tissue by lipogenesis (Kersten, 2001). Key 
regulators of de novo lipogenesis are the transcription factors SREBPs (sterol regulatory element-
binding proteins). SREBPs control lipid homeostasis by controlling gene expression of various genes 
that are involved in the synthesis of cholesterol, fatty acid, triglyceride and phospholipids (Foretz et al., 
1999; Kersten, 2001). SREBPs are activated by the IRS-Akt/PKB pathway in an mTORC1-dependent 
manner (Porstmann et al., 2008) and fatty acid metabolism was shown to be rapamycin sensitive 
(Brown et al., 2007). 
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The term adipogenesis refers to the differentiation of pre-adipocytes into mature fat cells. This process 
is controlled by a highly specific geneprogram that finally results in the activation of PPARγ 
(peroxisome proliferator-activated receptor-γ) as described by Evan D. Rosen and Ormond A. 
MacDougald (Rosen and MacDougald, 2006). mTORC1 is hypothesized to be involved in this process 
by regulating the expression and activation of PPARγ (Kim and Chen, 2004). Especially the 
phosphorylation of 4E-BPs by mTORC1 was shown to be a critical step in the translational regulation 
of PPARγ and other proteins involved in adipogenesis (El-Chaar et al., 2004). 
 
 Autophagy   In contrast to protein and lipid synthesis, both of which are process occurring under 
high energy availability, autophagy is initiated during conditions of insufficient nutrient and energy 
supply. Once autophagy is activated, cellular components are embedded into autophagosomes, which 
then are further fused with lysosomes where the enclosed cellular components are degraded. This 
process ultimately provides a nutrient source to maintain vital cellular activities. The first evidence for a 
contribution of mTORC1 in the regulation of autophagy comes from studies in yeast, where Noda et al. 
showed that treatment of yeast cells with rapamycin induced autophagy even in cells growing in 
nutrient-rich medium (Noda and Ohsumi, 1998). The mechanism by which mTORC1 negatively 
controls autophagy is mainly through phosphorylation of ATG13 (autophagy-related gene 13) and 
ULK1 (unc-51-like kinase 1). These phosphorylation events are regulated in a nutrient-dependent 
manner and result in the suppression of the ULK1/ATG13/FIP200 protein-complex, a complex 
required for the initiation of autophagy (Ganley et al., 2009; Hosokawa et al., 2009). Additionally, other 
autophagy-related proteins, such as DAP1 (death-associated protein 1) and WIPI2 (WD repeat 
domain phosphoinositide-interacting protein 2) were reported to be targets of mTORC1 (Hsu et al., 
2011; Koren et al., 2010). Thus, low mTORC1 activity inhibits growth and induces autophagy. 
Therefore, mTORC1 has a key role not only in nutrient response, but also in cellular energy 
homeostasis. 
 
 Energy metabolism   An important component of the mTORC1 up- and downstream signaling is 
HIF1α. Under hypoxic conditions, HIF acts upstream of mTOR and activates TSC2, thereby inhibiting 
mTORC1 (see 3.1.2). On the other hand, mTORC1 was shown to promote the transcription and 
translation of HIF1α and thereby to activate several metabolic genes (Duvel et al., 2010). Therefore, 
mTORC1 activates specific energetic and anabolic cellular processes. Furthermore, mTORC1 is 
correlated with mitochondrial metabolism (Schieke et al., 2006). The ability of mTORC1 to modulate 
the oxygen consumption and oxidative capacity appears to be independent of S6K and 4E-BPs. Thus, 
yet another downstream target of mTORC1, namely PGC1α (PPARγ coactivator 1α), is supposed to 
link mTORC1 signaling to the control of mitochondrial biogenesis and oxidative function (Cunningham 
et al., 2007). PGC1α acts as a co-activator of the transcription factor PPARγ. Thereby, PGC1α 
triggers the expression of genes that encode mitochondrial respiratory chain proteins and 5-
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aminolevulinate synthase, as well as mitochondrial transcription factor A, a regulator of mitochondrial 
DNA transcription and replication (Wu and Boss, 2007). 
 
3.1.4 Feedback inhibition within mTORC1 signaling 
An important feature of the mTORC1 pathway regulation is the negative feedback loop that S6K 
exhibits on IRS – in terms of both transcriptional suppression and phosphorylation-dependent activity, 
respectively (Harrington et al., 2004). The initial observation of such a potential feedback loop was 
made in MEFs (mouse embryo fibroblasts) lacking either TSC1 or TSC2. In such cells, the stimulation 
with different growth factors, in particular insulin, failed to induce an activation of the PI3K-Akt/PKB 
pathway (Harrington et al., 2004; Zhang et al., 2003). The underlying mechanism is mainly based on 
the phosphorylation of IRS1 at Ser302 by S6K. Phosphorylation of this site prevents IRS1 to interact 
with the insulin receptor and thus the insulin-PI3K-Akt/PKB pathway is attenuated. As a consequence 
of long-term mTORC1 activation, also the transcription level of IRS1 was found to be reduced (Shah 
et al., 2004). Upon application of rapamycin or upon other approaches that lead to inactivation of 
mTORC1 signaling the feedback inhibition is absent (Bentzinger et al., 2008; Chen et al., 2010). This 
in turn can result in an increased PI3K-Akt/PKB activity that has to be taken into consideration 
whenever manipulating the mTORC1 signaling pathway. This negative feedback inhibition has 
important implications in several diseases such as diabetes and tumor syndromes (Manning, 2004; 
Um et al., 2004). 
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3.2 mTORC1 in the developmental and adult brain 
During the last decades the interest of neurobiologists in the mTORC1 signaling pathway has grown 
extensively. A main reason why mTORC1 became more and more attractive in the field of 
neuroscience is based on the hypothesis that abnormal mTORC1 signaling during brain development 
is the cause of many brain malformations and pathologies. Additionally, new methodological 
possibilities for in vivo genetic modifications of specific subsets of neurons or glia cells in parallel with 
an increased basic knowledge about a bunch of neurodegenerative diseases and psychiatric disorders 
further pushed the intention to investigate the role of mTORC1 in the brain. The following chapters will 
give an overview of what is known about mTORC1 in brain development and brain pathologies. 
 
3.2.1 mTORC1 in neuronal development 
The major feature of mTORC1 is the control of growth and proliferation. During development, these 
processes are of particular importance. However, the role of mTORC1 in neuronal development goes 
beyond the simple control of cell size and number. Initial experiments in cell culture systems revealed 
that mTORC1 is involved in axonal outgrowth and pathfinding, dendritic arborization as well as control 
of spine number and morphology. For example, treatment of cultured neurons with rapamycin alters 
the responsiveness of growth cones mediated by Semaphorine3A and Netrin most likely in a protein 
synthesis-dependent manner (Campbell and Holt, 2001; Piper et al., 2006). Since directional axonal 
growth is a crucial early step during brain development, this and similar other observations propose 
that mTORC1 signaling is important already at very early steps during brain development. 
Furthermore, mTORC1 was shown to promote the growth and branching of dendrites (Jaworski et al., 
2005). Jaworski et al. showed that the complexity of the dendritic tree was reduced in the presence of 
rapamycin and the opposite phenotype was observed in neuron cultures lacking the mTORC1 
negative regulator PTEN. The synergistic signaling between PI3K-Akt/PKB-mTORC1 and the Ras 
pathway was shown for dendritic tree expansion (Kumar et al., 2005). Additionally, Kumar et al. and 
others (Tavazoie et al., 2005) reviewed that also the very small morphological units of a neuron, 
namely the spines, are controlled by mTORC1 in terms of number and shape. Finally, not only 
morphological features but also the regulation of differentiation into glial/neuronal cells is dependent 
on mTORC1 activity as shown by several groups. However, whether the glial or neuronal linage is 
induced by mTORC1 signaling is still not conclusive (Han et al., 2008; Uhlmann et al., 2002). 
Unfortunately, most of the studies on the involvement of mTORC1 in neuronal development were 
carried out in cell culture systems due to the early embryonic lethality of several knockout mouse 
models such as mTOR -/-, rptor -/- or mLST8-/- (Gangloff et al., 2004; Guertin et al., 2006). Thus, for 
future directions the use of cell type specific knockout mouse models eventually will provide more 
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detailed insight into the function of mTORC1 in the developing nervous system. A first step towards a 
better understanding of mTORC1 signaling during brain development was done in our study where we 
deleted the mTORC1-defining protein raptor in all neuronal cells by the use of the Cre-LoxP system 
(see chapter 4.2). 
 
3.2.2 mTORC1 in brain physiology and pathologies 
As shown for other tissues, the balanced activity of mTORC1 is also crucial for the maintenance of 
physiological functions in the brain. However, other than most of the organs in the body, the brain is 
composed of a big number of diverse specialized structures that all contain a selective pool of 
excitatory and inhibitory neurons and therefore is even more susceptible to failures in pivotal signaling 
cascades. In recent years, the mTOR pathway was linked to cancer and to the pathogenesis of a 
variety of diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Tuberous 
sclerosis complex, neurofibromatosis, Fragile X syndrome and epilepsy. Furthermore, also mental 
disorders such as schizophrenia, depression and autism spectrum disorders have been related to 
unbalanced mTORC1 activity (Chong et al., 2010). In the subsequent paragraphs, most of these 
diseases will be discussed with regard to mTORC1 dysfunction. The main findings on the contribution 
of mTORC1 signaling to these different diseases are summarized in Table 1. 
 
 Alzheimer’s disease (AD)   Alzheimer’s disease is characterized by brain atrophy, the formation 
of senile plaques – mainly consisting of amyloid beta (Aβ) – and the accumulation of neurofibrillary 
tangles made of Tau aggregates. The main physiological function of the protein Tau is to promote the 
assembly and stabilization of the microtubule structure in neurons. Tau is a protein with multiple 
phosphorylation sites. Phosphorylation is essential for its function and Tau protein is susceptible to 
hyperphosphorylation, which commutes it into an inactive state in which it preferentially forms 
aggregates, which is a hallmark of Alzheimer’s disease. Several kinases and phosphatases have been 
identified to regulate the phosphorylation of Tau (Pei and Hugon, 2008). The role of mTORC1 in 
Alzheimer’s disease is controversially discussed. Currently, two hypotheses are debated: 1) It is 
suggested that mTORC1 activity is reduced in AD. This hypothesis is supported by the findings of Ma 
et al. where they published an impaired mTORC1 activity in a mouse model of Alzheimer’s disease. 
This study reports a compromised LTP in their mouse model of Alzheimer’s disease that could be 
prevented by pharmacological and genetic upregulation of mTOR signaling (Ma et al., 2010). 
Furthermore, inhibition of mTORC1 activity was observed in cultured neurons that were exposed to 
the major component of the senile plaques, Aβ (Lafay-Chebassier et al., 2005). Accordingly, a 
decrease in the level of protein synthesis has been described in the brain of AD patients (Langstrom et 
al., 1989). 2) On the other hand, several groups reported an increase in mTORC1 activity and other 
pathway components in samples of AD patients (An et al., 2003; Griffin et al., 2005; Lafay-Chebassier 
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et al., 2005). In line with these observations, the expression and phosphorylation level of Tau was 
observed to nicely correlate with the activity of mTORC1 (Pei et al., 2008). Studies in Drosophila 
further indicate that Tau-induced neurodegeneration is triggered by mTORC1 and can be suppressed 
by rapamycin (Khurana et al., 2006). Therefore, upon these studies it is hypothesized that mTORC1 
activity is increased in Alzheimer’s disease and subsequently results in elevated translation levels of 
toxic proteins. Further studies are necessary to more specifically disclose the role of mTORC1 for 
Alzheimer’s disease – in both, the development and progression of the disease – in order to eventually 
approach the mTORC1 pathway as a therapeutic target for AD. 
 
 Parkinson’s disease   Besides Alzheimer’s Disease, Parkinson’s disease is the second most 
common degenerative disorder of the central nervous system. The disease is progressive and results 
from loss of dopaminergic neurons in the substantia nigra pars compacta (Parkinson, 2002). The link 
between mTORC1 and Parkinson’s disease arises from the stress response protein REDD1 (also 
known in this context as RTP801). As described in chapter 3.1.2, REDD1 is a negative regulator of 
mTORC1 signaling, acting upstream of TSC1/2 but downstream of Akt/PKB (Corradetti et al., 2005). 
REDD1 is highly induced in cellular models as well as in mouse models of Parkinson’s disease and 
was also found to be elevated in dopaminergic neurons of patients (Chong et al., 2010). Furthermore, 
the expression of a major pro-survival factor in dopaminergic neurons, Engrailed 1, was shown to be 
induced by mTORC1 (Di Nardo et al., 2007). Together, these data suggest that due to a cellular stress 
response the mTORC1 signaling is inhibited through REDD1 and results in down-regulation of specific 
pro-survival factors in dopaminergic neurons of individuals suffering from Parkinson’s disease. 
Interestingly, however, it is not conclusive why treatment with rapamycin in a mouse model of 
Parkinson’s disease was shown to protect against neuronal death (Malagelada et al., 2010). The 
authors of this study hypothesize that the observed neuroprotective effect of rapamycin arises from its 
selective suppression of some (e.g. blocking of protein synthesis, in particular of REDD1) but not all 
actions of mTOR. Further investigations have to be done to more clearly determine the role of 
mTORC1 in the genesis and progression of Parkinson’s disease.  
 
 Huntington’s disease   The autosomal dominant neurodegenerative Huntington’s disease is 
caused by a mutation in the gene encoding the protein huntingtin. This mutation causes an abnormal 
translation of the mRNA encoding huntingtin resulting in huntingtin proteins with long polyglutamine 
tracts that form intraneuronal aggregates which are detrimental for neurons (Rubinsztein, 2002). The 
current understanding of how mTORC1 is involved in the progression of Huntington’s disease is via its 
inhibitory control of autophagy. The clearance of the polyglutamine aggregates by induction of 
autophagy is a potential therapeutic strategy in Huntington’s disease. In line with this, rapamycin 
treatment attenuates the progression of the disease and protects against neurotoxicity (Berger et al., 
2006). 
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 Tuberous sclerosis complex   Also TSC is an autosomal dominant genetic disease caused by 
either mutation of the gene encoding TSC1 or TSC2. As TSC1/2 functions as a negative regulator of 
mTORC1, a mutation in either gene results in an exaggerated activation of the mTORC1 pathway and 
therefore excessive protein synthesis. Patients frequently display intellectual disabilities, autistic 
characteristics, epileptic seizures and show the formation of tubers consisting of giant neurons and 
astrocytes (Tomasoni and Mondino, 2011). Mice that carry heterozygous mutations in the genes 
encoding TSC1 or TSC2, respectively, show impaired learning and memory, impaired social behavior 
and abnormalities in contextual fear conditioning (Goorden et al., 2007). Furthermore, also oxidative 
stress is observed in TSC and contributes to neuronal dysfunction. Therefore, it is not surprising that 
treatment of TSC with rapamycin is promising and showed improvement of distinct characteristics in 
different animal models (Ehninger et al., 2008). 
 
 Fragile X syndrome   Like in TSC, also in Fragile X syndrome the origin of the disease is found 
in a genetic mutation that leads to exaggerated protein synthesis. The disease is based on a massive 
trinucleotide repeat expansion within the gene encoding the fragile X mental retardation protein 
(FMRP) located on the X chromosome. These trinucleotide repeat accumulations result in 
transcriptional silencing and loss of the FMRP (Kremer et al., 1991). FMRP is a RNA-binding protein 
that binds several mRNAs of neuron-specific proteins (including its own), such as Arc, αCamKII, 
PSD95, APP, PIKE and thereby regulates transcription of those in dendrites and spines in response to 
neuronal activity (Berry-Kravis et al., 2011; Weiler et al., 1997). In the absence of FMRP the synthesis 
of many proteins is dysregulated and results in altered LTP and LTD. Additionally, also learning and 
memory impairments in different paradigms were reported in the mouse model of Fragile X syndrome 
(Berry-Kravis et al., 2011). It has been proposed that the up-regulation of mTORC1 activity observed 
in mouse models of Fragile X syndrome is the consequence of the increased expression of PIKE 
(PI3K enhancer), that activates PI3K and subsequently Akt/PKB, mTOR, S6K and 4E-BP (Sharma et 
al., 2010). 
 
 Schizophrenia   Deregulated gene expression is a characteristic of schizophrenic patients. 
Especially the reduced expression and activity of the PI3K-Akt/PKB-mTOR signaling components was 
observed (Kalkman, 2006). Mutations in the gene encoding Akt/PKB are associated with the genetic 
form of schizophrenia and reduced Akt/PKB phosphorylation as well as diminished kinase activity 
have been found in post-mortem brains of schizophrenic patiens (Santini and Klann, 2011). In line with 
this correlation, several therapeutic strategies for schizophrenia treatment results in an increased 
activity of the PI3K- and mTORC1 pathway as reviewed by Kalkman. However, whether the mTORC1 
is directly involved in schizophrenia has not been clearly shown to date. Recently, an alternative 
hypothesis was discussed which suggests that dysregulation of mTORC2 causes reduced Akt/PKB 
activity (Siuta et al., 2010). However, data that are supportive of this hypothesis are still lacking. 
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Summarizing this extensive body of work on mTORC1 signaling in brain diseases and disorders, it can 
generally be concluded that adjusted mTORC1 activity is crucial for proper neuronal function. An 
imbalance towards either an increased or decreased mTORC1 activity may be detrimental for normal 
function of the brain, cell survival and cognition. However, to date it is not at all clear whether the 
observed changes in mTORC1 activity and its pathway components in either animal models, cell 
culture systems or in human tissue samples are cause or consequence of the according diseases and 
disorders. In this regard, it is of high importance to unravel the role of mTORC1 signaling in the 
development and progression of those diseases. Especially the analysis of different cell types, 
individual stages of a disease and the physiological consequences of altered mTORC1 activity will be 
crucial for prospective pharmacological therapies. 
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Table 1. Summary of altered mTORC1 signaling in brain disorders. (adapted from: Emanuela Santini and Eric 
Klann Frontiers in behavioral neuroscience (2011) 5) 
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3.3 mTORC1 in synaptic plasticity and learning and memory 
The human brain consists of around 100 billion neurons and each neuron possesses around 1000 – 
10’000 synapses which allows one cell to connect and to communicate with up to 30’000 other cells. 
Just by considering these three numeric facts one can anticipate the complexity of the total network 
that finally forms the brain. The basic principle of how information is processed and stored within this 
gigantic number of interconnected cells is the plastic modulation of neuronal circuits – and further 
down in the scale to the level of individual synapses – to a given environmental stimulus. Since the 
time of Santiago Ramón y Cajal it was hypothesized that the mechanism of informational storage in 
the brain is based on activity dependent changes in synaptic efficiency. This concept was later refined 
by Donald O. Hebb in 1949 when he published his paper “The Organization of Behavior: A 
Neuropsychological Theory”. The Hebbian theory states that an increase in synaptic efficacy arises 
from a repeated and persistent stimulation from the presynaptic cell on the postsynaptic neuron 
(Brown, 2006). While at the time of Hebb’s publication this concept was only a theory, the first 
“Hebbian synapse” was described in 1973 by Terje Lomo and Timothy V.P. Bliss who electrically 
stimulated the perforant path of rabbit brains and reported a sustained increase of the efficiency of 
synaptic transmission to the granule cells of the hippocampus (Bliss and Lomo, 1973). Today, this 
phenomenon is called long-term potentiation (LTP) and is generally thought to be the cellular 
mechanism underlying synaptic plasticity and learning and memory. 
 
3.3.1 Mechanisms of synaptic plasticity 
When talking about synaptic plasticity, one basically has to separate two distinct forms: 1) functional 
plasticity that refers to the change in synaptic strength and efficiency, and 2) structural plasticity that 
involves changes in synapse number, dendritic branching and synaptic connectivity (Wiegert and 
Bading, 2011). Both forms depend on protein synthesis and gene expression and eventually together 
add up to what is generally called learning and memory. Within the scope of this manuscript, only 
functional plasticity will be discussed. 
 The molecular mechanisms that underlie synaptic plasticity were discovered and still are mainly 
studied in the hippocampus due to its well described function for learning and memory in humans and 
the suitable anatomical architecture for electrophysiological approaches. In terms of LTP, two 
temporally and functionally different forms have been described. E-LTP (early-LTP) lasts for 1-2 hours 
and is independent of transcription and translation but rather relies on the autonomous kinase 
activation of several postsynaptic proteins (Roberson et al., 1996). In contrast, L-LTP (late-LTP) lasts 
several hours and requires new protein synthesis and at later stages also transcription (Reymann and 
Frey, 2007). Using the example of a “classical” LTP at the CA3-CA1 synapse in the murine 
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hippocampus, the following section will describe the main steps that are involved in the induction and 
progression of E-LTP and L-LTP.  
Upon neurotransmitter release (typically glutamate) and binding of the transmitter to corresponding 
postsynaptic receptors (typically AMPA-R) the postsynaptic membrane is depolarized (mainly by Na+ 
influx through AMPA-Rs), which subsequently results in the release of the Mg2+ block of the NMDA-
Rs. The removal of the Mg2+ block is a critical step in the induction of LTP and results in a substantial 
influx of Ca2+ through NMDA-Rs into the spine. This event causes a further depolarization of the 
membrane and activates multiple signaling cascades and triggers subsequent steps (Herron et al., 
1986; Reymann et al., 1989). Along with the NMDA-R activation, additional receptors (depending on 
the induction protocol) such as mGluRs (metabotropic glutamate receptors), VDCCs (voltage-
dependent calcium channels) or RyRs (ryanodine receptors, located in the endoplasmatic reticulum) 
may contribute to the Ca2+ influx into the postsynaptic cell (Reymann and Frey, 2007). As a result of 
the increase in Ca2+ in the postsynaptic compartment, different mechanisms are induced (eventually 
depending on the type of receptors that were involved in the Ca2+ influx) that account for distinct types 
of LTP (E-LTP or L-LTP). These different mechanisms can be roughly classified as follows: post-
translational modification, dendritic protein synthesis and nuclear gene regulation. 
 
 Post-translational modification   Upon weak stimulation, such as 1 HFS (high frequency 
stimulation), the potentiation of the postsynaptic response is temporally restricted to 1-2 h and typically 
independent of local protein synthesis. This type of synaptic plasticity is called E-LTP and mainly 
involves immediate (within 1 min) activation of CamKII by Ca2+ and its subsequent 
autophosphorylation that keeps the kinase in a constitutively activated state up to 1 h post initial 
activation (Fukunaga et al., 1993). Autophosphorylation of CamKII leads to its association with the 
PSD where it phosphorylates the GluR1 subunit of the AMPA-Rs (Lisman et al., 2002). It is suggested 
that the phosphorylation of GluR1 increases the AMPA-R mediated current across the membrane due 
to an increased conductance of the channel and additionally also by modulation of the receptor 
trafficking within the synaptic membrane (Soderling and Derkach, 2000). This mechanism is further 
enhanced by the contribution of other kinases such as PKA and PKC. PKA is activated by cyclic-AMP 
(cAMP) and inhibits the process of protein phosphatase-mediated dephosphorylation of GluR1 and 
CamKII and secondly, PKA can directly phosphorylate GluR1 which apparently results in an increased 
AMPA-R current (Roberson and Sweatt, 1996; Soderling and Derkach, 2000). The involvement of 
PKC is linked to synaptic mGluR (metabotropic glutamate receptor) activation that leads to the 
production of diacylglycerol. It was reported that as a consequence of diacylglycerol-mediated 
activation of PKC, the latter can phosphorylate NMDA-Rs,  resulting in an increased Ca2+ influx into 
the postsynapse (Fitzjohn et al., 1996). However, a more important role is assigned to PKC for the 
control of protein synthesis-dependent mechanisms during L-LTP. A schematic illustration of the 
mechanisms involved in E-LTP is depicted in Figure 5. 
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Dendritic protein synthesis   As it is the case for all long-lasting cell biological phenomena, the 
late-phase of LTP requires new protein synthesis. The hypothesis of the dependence of the later 
phase of LTP on protein synthesis is consistent with the early findings that 1) multiple inhibitors of 
protein synthesis, with varying modes of action, can affect L-LTP maintenance and 2) that 
polyribosomes move into activated spines after L-LTP induction (Abraham and Williams, 2008). A L-
LTP is typically induced by several HFS pulses that are applied in an inter-stimulus-interval of 1 to 5 
min. The signaling components that are thought to link the initial activity in the dendritic spine upon 
such an intensive stimulation regime to a sustained enhancement of the synaptic efficiency include 
kinases such as CamKII, PKC, ERK and mTOR (Raymond, 2007). As discussed above, the activation 
of CamKII is triggered by Ca2+ and is required for the induction of an E-LTP and L-LTP. A similar 
crucial function for the induction of LTP is attributed to PKC (Malinow et al., 1989). Unlike CamKII and 
PKC, the catalytic fragment of the atypical isoform PKCζ, namely PKMζ, is constitutively active and 
does not require Ca2+ or diacylglycerol for its activation. PKCζ is transcribed independently of PKCζ 
and its mRNA is transported specifically to dendrites where it is preferentially translated upon LTP 
induction and subsequently the PKMζ protein contributes to the maintenance of the late, protein 
Figure 5.  Postsynaptic protein phosphorylation mechanisms during LTP in the CA1 region of hippocampus. 
Left: Basal synaptic transmission via glutamate (triangles) is mediated largely by low-conductance state 
(∼10pS) AMPA receptors that give rise to an EPSC. NMDA receptors are inactive because of voltage-
dependent block of their channels by Mg2+. Little of the Ca2+/calmodulin-dependent protein kinase II 
(CaMKII) is in the activated, phosphorylated state (*), owing to low basal concentrations of Ca2+–calmodulin 
(Ca2+–CaM) and high activity of protein phosphatase 1 (PP1). Right: Early-phase LTP (E-LTP) expression is 
due, in part, to CaMKII-mediated phosphorylation of the AMPA receptor GluR1 subunit (*), which converts it 
largely to higher conductance states (∼25 pS). The CaMKII is maintained in its autophosphorylated, 
constitutively active form, owing to protein kinase A-mediated phosphorylation of inhibitor 1 (I1), which 
blocks the ability of PP1 to dephosphorylate CaMKII and perhaps GluR1. (adapted from: T.R. Soderling and 
V.A. Derkach Trends Neuroscience (2000) 23) 
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synthesis-dependent phase of LTP by mediating an increased number of AMPA-Rs at the synapse 
(Ling et al., 2006; Yao et al., 2008). The function of ERK and mTOR is to control local protein 
synthesis upon L-LTP induction. It was shown recently that besides PKC also the NMDA-R-dependent 
activation of CamKI by CamKK can trigger the activation of ERK that subsequently regulates mRNA 
translation via phosphorylation of S6K as well as eIF4E and 4E-BP1 (Schmitt et al., 2005). Similarly, 
mTORC1 is known to be activated upon neuronal activity via various pathways (see chapter 3.3.2) 
and mTORC1 triggers both cap-dependent protein synthesis and translation of 5’TOP mRNA by 
regulating 4E-BPs, S6K and potentially other substrates (Swiech et al., 2008). Proteins encoded by 
mRNAs containing 5′TOPs have been observed in dendrites (Asaki et al., 2003). However, whether 
mTORC1-mediated S6K activation is critical for the translation of this specific subset of dendritic 
mRNA is still controversially discussed (Stolovich et al., 2002). Irrespective of the ongoing discussion 
on 5’TOP mRNA translation, it is generally thought that ERK and mTORC1 activation results in 
increased translation initiation of specific mRNAs that code for proteins that are required for the 
maintenance of L-LTP, such as CamKII or AMPA-R subunits. However, several observations indicate 
that the global amount of protein synthesis is reduced upon increased neuronal activity. Thus, it is 
hypothesized that global protein synthesis eventually is differently regulated during LTP than the 
translation of a specific mRNA pool that encodes for plasticity related proteins (Sutton and Schuman, 
2005). In line with this hypothesis, the translational regulation of a subset of mRNAs (including CamKII 
mRNA) is known to be mediated by cytoplasmic polyadenylation of the 3’ end upon neuronal activity. 
These mRNAs contain short sequences known as cytoplasmic polyadenylation elements (CPEs; 
UUUUAU or similar) and an AAUAAA sequence (Figure 6). The CPEs are recognized by the CPE-
binding protein (CPEB) that functions as a translational repressor when bound to Maskin – an eIF4E 
binding protein – and as a polyadenylation stimulator and translational activator when phosphorylated. 
CPEB is phosphorylated by the protein kinase Aurora (also known as Eg2), which induces CPEB to 
interact with cleavage and polyadenylation-specificity factor (CPSF) on the AAUAAA sequence 
Figure 6. Messenger RNAs containing a cytoplasmic polyadenylation element (CPE) are translationally 
dormant (masked) and reside in a complex containing the CPE-binding protein (CPEB), maskin and eIF4E. 
Newly phosphorylated CPEB (by the kinase Eg2) recruits the cleavage and polyadenylation specificity factor 
(CPSF) and poly(A) polymerase (PAP), which elongates the poly(A) tail. At a time coincident with this 
elongation, maskin dissociates from eIF4E. One possible cause of this maskin–eIF4E dissociation is the 
formation of a stable poly(A)-binding protein (PABP)–eIF4G complex, which outcompetes maskin for binding to 
eIF4E and thereby assembles the 48S complex. (adapted from: R. Mendez and J.D. Richter Nature Reviews 
Molecular Cell Biology (2001) 2) 
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(Huang et al., 2002; Mendez et al., 2000). Upon CPSF recruitment, the poly(A) tail of the mRNA is 
lengthened by the poly(A) polymerase. Polyadenylation subsequently causes Maskin to dissociate 
from eIF4E, permitting the binding of eIF4E to eIF4G, and the subsequent recruitment of ribosomes in 
order to increase translation (Mendez and Richter, 2001). The inhibition or knockout of CPEB results 
in impaired synaptic plasticity and deficits in learning and memory (Zearfoss et al., 2008). Similarly, 
also FMRP – as introduced in chapter 3.2.2 – is an RNA-binding protein that has a well-described 
function in the transport and translational control of certain mRNAs. FMRP is highly expressed in the 
brain and preferentially found in the dendritic compartment of neurons where it is associated with 
ribosomes. In a phosphorylated state, FMRP represses the translation of its target mRNAs (such as 
PSD95) via the RNA-induced silencing complex (RISC). Upon neuronal activity, FMRP is 
dephosphorylated by protein phosphatase-2A that leads to a release of RISC from the target mRNAs 
and enables translation (Mercaldo et al., 2009). Besides these putative mechanisms of selective 
mRNA-translation control, it was reported that upon L-LTP induction the number of polyribosomes is 
increased in activated spines (Bourne et al., 2007). Therefore, the current theory of plasticity-related 
protein synthesis suggests that only about 10 % of the abundant mRNA is capable of undergoing an 
activity-induced transition from a rather translationally inactive to a preferentially active state. 
However, there is still not much known about which exact mRNAs belong to the privileged ones that 
are translated, or what the exact mechanisms are that are involved in the specific mRNA processing, 
and finally what the initial trigger for the specific mRNA translation is. An overview of the main 
mechanisms that are known to date to be involved in protein synthesis-dependent L-LTP is depicted in 
Figure 7. 
 
 
Figure 7. Stimulation of synaptic NMDARs (for 
example, long-term potentiation (LTP) induction) 
promotes Ca2+ influx that activates calcium/calmodulin-
dependent protein kinases (CaMKs) and extracellular 
signal-related kinases (ERKs) in dendritic spines. 
These kinases phosphorylate and activate translation 
factors (for example, eIF4E, 4E-BP1 and CPEB) that 
are required for the stabilization of local mRNAs 
through their polyadenylation, and to initiate translation 
of mRNAs that have been selectively transported into 
the dendrites and/or spines. This local protein 
synthesis provides a feedforward mechanism to 
increase receptor numbers, receptor trafficking, levels 
of scaffolding and cytoskeleton proteins that promote 
surface expression, and lateral diffusion and 
stabilization of AMPARs at potentiated synapses. E-
LTP, early phase LTP; PSD, postsynaptic density; 
TARPs, transmembrane AMPAR regulatory proteins 
(adapted from: Victor A. Derkach et al Nature Reviews 
Neuroscience (2007) 8) 
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 Gene regulation   In contrast to the described mechanisms above, gene transcription is spatially 
separated from the initial site of activity. Therefore, to trigger gene transcription in the soma, changes 
in Ca2+ concentration at the level of the synapse are in most cases not sufficient but generally rather 
require additional involvement of VDCCs (Raymond, 2007). The main transcription factors that 
regulate LTP-specific gene transcription are CREB (cAMP-responding element binding protein) and 
Elk-1 (E twenty-six (ETS)-like transcription factor 1) and the main immediate early genes involved in L-
LTP are cfos, cjun, zif268, arc and homer. Upon initial elevation of the Ca2+ concentration in the spine, 
several signaling pathways can be triggered which result in CREB or Elk-1 activation: 
Ca2+/cAMP/PKA/CREB; Ca2+/CamKII/CREB; Ca2+/Ras/ERK/CREB; Ca2+/cAMP/ERK/Elk-1 (Davis et 
al., 2003). Subsequently, CREB and ElK-1 induce the transcription of the above mentioned 
immediately early genes that further induce activation of late response genes that encode for proteins 
such as receptors and structural cell components (Walton et al., 1999). 
 
3.3.2 The role of mTORC1 in synaptic plasticity 
In neurons, mTORC1 activity can be triggered by various stimuli, including neurotrophic factors (e.g. 
BDNF, brain-derived neurotrophic factor), cytokines (e.g. leptin), Ca2+ and neurotransmitter activation 
via G protein-coupled receptors or ionotropic receptors (Swiech et al., 2008). With regard to synaptic 
plasticity, especially the response of mTORC1 to ionotropic receptor activation, elevated Ca2+ levels 
and BDNF are of interest. Different signaling cascades that converge onto mTORC1 upon neuronal 
activity are depicted in Figure 8. mTORC1 is considered to be a regulator of local protein synthesis 
during L-LTP. This assumption is based on several observations. 1) Rapamycin application prevents 
CA1 L-LTP maintenance in rat hippocampal slices (Tang et al., 2002). 2) Tang et al. also showed that 
mTOR, the translation initiation component eIF4E and the mTORC1 substrate 4E-BP co-localize with 
post-synaptic markers. These observations strongly suggest that mTOR inhibition with rapamycin 
targets the postsynaptic translation machinery. 3) It was show that L-LTP is sensitive to application of 
rapamycin only during the induction paradigm, whereas inhibition of mTORC1 after the establishment 
of L-LTP was ineffective. 4) Phosphorylation of S6K by mTORC1 has been shown to be induced in an 
NMDA-R- and PI3K-dependent manner throughout the dendrites but not in the cell bodies of CA1 
neurons in hippocampal slices after L-LTP induction. Thus, it is generally hypothesized that the 
NMDA-R/PI3K-dependent dendritic activation of the mTORC1 pathway is necessary for the induction 
of protein synthesis-dependent synaptic plasticity (Cammalleri et al., 2003). Several mRNAs of 
plasticity-related proteins are reported to be translated in response to mTORC1 activity, such as NR1, 
αCamKII, PSD95, Arc or PKMζ (Garelick and Kennedy, 2011). Furthermore, the relevance of 
mTORC1 signaling for synaptic plasticity was additionally confirmed in several learning and memory 
tasks. For instance, rapamycin injections into the amygdala impaired the memory performance in the  
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cued fear conditioning paradigm. Similarly, rapamycin disrupted memory consolidation in 
hippocampus-dependent spatial tasks, auditory cortex-dependent memory paradigms and prefrontal 
cortex-dependent trace fear memory tests (Garelick and Kennedy, 2011). Upon these first descriptions 
of mTORC1 contribution in L-LTP progression – all of which were mainly based on rapamycin 
application – several studies aimed to analyze different knockout mouse models in which up- or 
downstream components of the mTORC1 signaling pathway were depleted. A summary of the 
findings from such knockout mouse models is depicted in Table 2. Striking with regard to these 
Figure 8. Schematic model of neuronal mTOR signaling pathways. Activation of neuronal receptors and 
channels (mGluRs, NMDARs, TrkB, D1Rs, and D2Rs) leads to activation of mTORC1 and mTORC2. 
mTORC1 activation increases some neuronal processes (protein synthesis) while inhibiting others 
(autophagy). mTORC1 regulates the activity of downstream effectors involved in translation (S6K1, 4E-BP2), 
some of which are also directly phosphorylated via convergent activation of the MAPK signaling pathway 
(S6K1, MnK, S6). mTORC1-dependent phosphorylation of 4E-BP2 results in the association of eIF4E with 
eIF4G and the formation of the active eIF4F (eIF4E–eIF4A–eIF4G) complex. eIF4F recruits eIF4B and MnK 
and promotes the binding of mRNAs to the 43S pre-initiation complex to form the 48S initiation complex. The 
eIF4F complex and the poly(A) tail act synergistically together with MnK-dependent phosphorylation of eIF4E 
to stimulate cap-dependent translation initiation. Black solid arrows indicate direct phosphorylation/activation, 
pink double arrows represent molecular association/dissociation and blue lines indicate inhibition. (adapted 
from: Emanuela Santini and Eric Klann Frontiers in Behavioral Neuroscience (2011)) 
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genetic studies is the variety of phenotypes that were reported at both the level of behavior and the 
level of electrophysiology. One explanation for this diversity in phenotypes could be that different 
genetic approaches were used, such as global knockout, cell type-specific knockout, virus-induced 
knockout, or heterozygous knockout. Second, the complexity of the mTORC1 signaling pathway, and 
in particular the negative feedback loop onto IRS, has to be taken into account when the results of a 
particular knockout animal model are discussed. Depending on whether a particular protein of interest 
lies up- or downstream of mTORC1 and depending on how expansively the potentially altered 
feedback inhibition influences the components and activity of the total signaling network, the knockout 
phenotypes of two closely related proteins can eventually vary quite extensively. Therefore, in future it 
will be important to carefully analyze the role of mTORC1 at the level of individual cell types and in the 
bigger context of mTORC1 as an integrator of various signals ranging from neuronal activity, growth 
factors, survival cues or stress. An attempt towards this goal was carried out by the studies on which 
is reported in this manuscript. 
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3.4 The aim of the study 
The goal of this study was to analyze the specific contribution of mTORC1 in 1) brain development 
and 2) adult neuronal functions such as synaptic efficiency, synaptic plasticity and learning and 
memory. Due to the fact that null mutants of mTOR, rptor and mLST8 are early embryonically lethal, a 
detailed analysis of mTORC1 in the brain was precluded so far. In regard to brain development, most 
of the knowledge about mTORC1 signaling that was obtained to date is based on rapamycin 
application in primary neuron cultures. Similarly, also the role of mTORC1 in adult synaptic plasticity 
was preferentially studied by treatment of hippocampal slices with rapamycin. The major drawback of 
pharmacological inhibition lies in the fact that both the compound specificity and the effect specificity 
are not guaranteed. 
 To circumvent premature death of whole body knockout mice and certain unpredictable side 
effects or non-cellautonomous effects by the use of pharmacological inhibiton, two conditional 
knockout mouse models were generated on the basis of the Cre-LoxP system. As a consequence of 
the existence of two functionally different multi-protein complexes – mTORC1 and mTORC2 – that 
both include mTOR as the catalytic component of the respective complex, the genetic targeting of 
mTOR would not result in a specific mTORC1 deficiency. Thus, we generated mice with floxed rptor 
alleles in our lab. Raptor is the regulatory associated protein of mTOR necessary for mTORC1 
function. 
 For the analysis of the role of mTORC1 during brain development, Cre-mediated knockout of rptor 
was achieved by crossing floxed mice with mice expressing the Cre recombinase under the Nestin 
promoter that gets activated as early as E10.5 in neuronal tissue. The characterization of these mice 
was primarily performed by Dimitri Cloëtta and Venus Thomanetz. 
In order to study the involvement of mTORC1 in postnatal excitatory neuronal function, the same 
floxed mice were used in combination with an α-CamKII-Cre mouse line. The α-CamKII promoter 
starts to be active about P18 and reaches full activity by P29. Therefore, the embryonic development 
and postnatal maturation should not be compromised in these mice. Such a conditional knockout 
mouse model serves as an ideal tool to study basic neuronal functions, synaptic plasticity and learning 
and memory. 
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4 RESULTS 
4.1 Paper 1 (in preparation) 
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ABSTRACT 
The mammalian target of rapamycin complex 1 (mTORC1) regulates many processes, including cell 
growth, survival and proliferation. In the central nervous system, deregulation of mTORC1 has further 
been implicated in neurodegenerative diseases, autism spectrum disorders and plasticity. Here we 
investigated the role of the mTORC1-defining component raptor in adult forebrain neurons by 
postnatal, tissue-specific deletion of the rptor gene (RcKO mice). Biochemical analysis showed 
successful inhibition of the mTORC1 downstream substrates S6 and 4E-BP1 and hyperactivation of 
the IRS-Akt/PKB-TSC axis due to relief of S6K-mediated feedback inhibition. Electrophysiological 
recordings revealed reduced synaptic efficiency and impairment in both early and late forms of LTP. 
Behaviorally, RcKO mice showed learning and memory deficits in the Morris water maze and impaired 
fear extinction. Interestingly, the deficits in the water maze paradigm could be occluded by short 
training-intervals during the acquisition phase. Furthermore, the targeted brain-regions showed a 
reduction in size. In summary, our data show that in the adult brain mTORC1 activity is crucial to 
maintain neuron function and synaptic plasticity. These results thus indicate that prolonged treatment 
with mTORC1 inhibitors might be detrimental for brain function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results – Paper 1  Regula M. Lustenberger 
 
 
Page | 40  
INTRODUCTION 
In the adult brain, information processing takes place within neuronal networks down in the scale to 
the level of individual synapses. One of the most studied forms of information processing, synaptic 
modification and its underlying molecular features is hippocampus-dependent learning and memory. 
Synaptic strength can bidirectionally be modified upon a previously received input depending on the 
temporal pattern and intensity of the received stimulus. This ability of synapses to undergo long-lasting 
changes on the functional, structural as well as biochemical level in response to certain activation is 
termed synaptic plasticity. It is reflected in the electrophysiological concept of long-term potentiation or 
depression (LTP or LTD), respectively. Temporal forms of LTP are characterized by an early phase of 
LTP (E-LTP) lasting 1-2 hours, which is transcription and translation independent, and a late phase of 
LTP (L-LTP) lasting several hours, which is dependent on new protein synthesis and transcription 
(Bartsch et al., 1998; Frey et al., 1988; Frey and Morris, 1997; Kelleher et al., 2004). The ability of 
isolated CA1-dendrites to undergo L-LTP provides evidence that local mRNA translation plays a 
critical role in protein synthesis-dependent forms of plasticity (Kang and Schuman, 1996; Tsokas et 
al., 2005). Multiple components of the translational machinery were shown to be localized within 
dendrites or even spines, which corroborates the importance of de novo protein synthesis within these 
structures (Steward and Schuman, 2003). Several protein kinases have been implicated in the 
initiation or maintenance of translation-dependent LTP. Among these, CamKII, mitogen-activated 
protein kinase (MAPK), extracellular signal-related protein kinase (ERK), protein kinase C (PKC) and 
the mammalian target of rapamycin (mTOR) have been associated to plasticity-related processes 
(Kelleher et al., 2004; Klann et al., 1991, 1993; Malinow et al., 1989; Tsokas et al., 2007). 
 mTOR is a serine/threonine protein kinase that associates with two biochemically and functionally 
distinct multiprotein complexes. mTOR together with the scaffold protein raptor forms the mTOR 
complex1 (mTORC1) that is inhibited by the immunosuppressant rapamycin. mTORC2, with rictor as 
the complex-defining protein, is largely rapamycin insensitive (Kim et al., 2002; Sarbassov et al., 
2004). The mTORC1 signaling pathway is activated by various growth factors and the insulin receptor 
substrate (IRS) that activates PI3K, which in turn phosphorylates Akt/PKB. Activated Akt/PKB causes 
the phosphorylation of TSC2 and subsequent activation of Rheb (Ras enriched in brain). Rheb, in turn, 
activates mTORC1 that controls a wide range of cellular processes, including protein synthesis, 
ribosome biogenesis, cell growth, gene transcription, autophagy and metabolism (Wang and Proud, 
2011). In the CNS, mTORC1 has been shown to be involved in axonal outgrowth and navigation, 
dendritic arborization as well as spine and filopodia formation (Campbell and Holt, 2001; Jaworski et 
al., 2005; Kumar et al., 2005; Piper et al., 2006; Tavazoie et al., 2005). Recently, several 
neurodegenerative disorders like Parkinson’s-, Alzheimer’s- and Huntington’s disease and mental 
disorders, such as schizophrenia or autism have been linked to mTORC1 dysfunction (Santini and 
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Klann, 2011; Swiech et al., 2008). However, whether altered mTORC1 signaling is cause or 
consequence of these pathologies remains to be elucidated. 
 Besides this wide range of diseases, the role of mTORC1 in synaptic plasticity and learning and 
memory has been discussed. The induction of LTP was shown to activate mTORC1 that subsequently 
phosphorylates its downstream targets ribosomal S6 kinase (S6K) and the translation regulator 4E-
BP. These phosphorylation events are suggested to positively regulate 5’TOP mRNA and cap-
dependent translation (Gelinas et al., 2007; Tsokas et al., 2007). Thus, mTORC1 is a prominent 
candidate to trigger protein synthesis-dependent processes locally at the synapse. Yet, there is still 
debate about the role of the mTORC1-S6K axis in 5’TOP mRNA translation during LTP. Rapamycin 
only partially blocks TOP mRNA translation and mice lacking S6K do not show a defect in TOP mRNA 
translation (Shima et al., 1998; Stolovich et al., 2002). Further, neither S6K1 nor S6K2 knockout mice 
show deficits in L-LTP progression (Antion et al., 2008). On the other hand, increased activity of the 
mTOR pathway was shown to substantially affect synaptic plasticity. Both, the ablation of upstream 
negative regulators of mTORC1, such as PTEN, TSC and FKBP12 (Hoeffer et al., 2008; Sperow et 
al., 2012; von der Brelie et al., 2006) and the knockout of the mTORC1 downstream target 4E-BP 
(Banko et al., 2005), alter L-LTP. Thus, the question arises, whether mTORC1 signaling only affects 
synaptic plasticity when hyperactivated but does not prevent LTP when inactivated. No direct genetic 
targeting of mTORC1 has so far been applied to clarify this open question. Furthermore, data from 
long-term inactivation of mTORC1 in the postnatal brain are currently lacking. 
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RESULTS 
Reduced brain size in mice lacking mTORC1 signaling in forebrain neurons 
To analyze the in vivo neuronal function of mTORC1 in the adult brain and more specifically its role in 
processes involved in synaptic plasticity and learning and memory we generated mice lacking the 
mTORC1-defining protein raptor in forebrain excitatory neurons. We therefore crossed rptorfl/fl 
(Bentzinger et al., 2008) mice with mice expressing Cre-recombinase under the control of the α-
CaMKII-promoter (Tsien et al., 1996), hereafter called RcKO mice (Fig. 1A). The successful 
recombination of the floxed rptor-alleles was shown by PCR and revealed the removal of exon 6 in the 
cortex (CX), the CA1 and CA3 area of the hippocampus as well as the dentate gyrus (DG). No 
recombination was detected in the cerebellum and in non-CNS parts of the body, such as the tail, 
indicative of the specificity of the recombination process (Fig. 1B). On the protein level, raptor was 
reduced in lysates of the CA1-region as well as in the CX of RcKO mice. The phosphorylation of 
mTOR at serine 2448, a site reflecting mTORC1 activity, as well as phosphorylation of the well-known 
mTORC1 downstream targets S6(Ser235/236) and 4E-BP1(Ser37/46) were found to be reduced in 
RcKO brains compared to controls (Fig 1C; Supplementary Table S1). In addition, 
immunohistochemical staining of pS6 revealed a significant reduction in the CA1 region of RcKO mice 
as well as a partially reduced signal in the CA3 region and the DG (Fig. 1Fd). Besides the reduction of 
raptor and the phosphorylation levels of mTORC1 downstream targets, we additionally observed a 
significant reduction of mTOR protein (Fig. 1C; Supplementary Table S1). The mTORC1 signaling 
cascade has a well described feedback inhibition that is exhibited from S6K to IRS1. To address 
whether the reduced phosphorylation of S6 is also reflected in a lack of this feedback loop, we 
analyzed mTORC1 upstream targets. As shown in Figure 1D, the phosphorylation levels of 
IRS1(Ser636/639), Akt/PKB(Thr308), Akt/PKB(Ser473) and TSC2(Ser1432) were increased in RcKO 
lysates. Since Akt/PKB(Ser473) is also phsophorlyated by mTORC2 (Wullschleger et al., 2006), we 
tested the activity of mTORC2 by quantifying mTOR-phosphorylation at the complex2-specific residue 
Ser2481, by quantifying the protein rictor and the phosphorylation of the mTORC2 downstream targets 
PKCα and PKCγ (Fig. 1E; Supplementary Table S1). No difference in these phosphorylation sites or in 
the amount of rictor between control and RcKO mice could be detected. These data indicate that 
deletion of rptor by α-CaMKII-driven recombination specifically inactivates mTORC1 signaling and 
does not affect mTORC2. This inactivation of mTORC1, in turn causes increased phosphorylation of 
the IRS-Akt/PKB-TSC axis due to the lack of the negative feedback-loop that S6K normally exhibits on 
IRS. In addition, we could not detect any change in mTORC2-signaling. 
 To address whether the absence of mTORC1 signaling in forebrain neurons affects the general 
appearance of RcKO mice, we tested for several brain-specific and general physiological parameters 
(Fig. 1F and 1G). The overall brain size of RcKO mice was reduced without altering the basic 
structural architecture of the brain. The hippocampus was formed correctly in RcKO brains but was 
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significantly reduced in its weight. Measurements of dendritic length and soma size of RcKO CA1 
hippocampal neurons revealed a significant decrease in both parameters compared to control mice 
(Supplementary Figure S1). Additionally, a reduction in the weight of the cortical tissue fraction was 
observed. To exclude that the reduction in brain weight was the result of apoptosis, we also examined 
cleaved caspase3 and ubiquitinylation in tissue sections and protein lysates, respectively 
(Supplementary Figure S2). No signs of increased degradation or cell death were observed in RcKO 
brains. Furthermore, no change in the weight of the cerebellum was detected, indicative for a specific 
weight reduction only in those brain structures that also showed recombination of the floxed rptor 
alleles. This observation is in line with the well-described function of mTORC1 in cell size control (for 
review see: (Wullschleger et al., 2006)). Despite the smaller size, the spine density seemed not 
changed in raptor-deficient CA1 neurons as determined by Golgi staining, suggesting that postnatal 
synaptogenesis and formation of the overall neuronal networks were not altered in RcKO mice. The 
lifespan of RcKO mice and control littermates did not differ and no difference in the body weight could 
be detected (data not shown). Furthermore, no abnormalities in motor function could be detected (data 
not shown). Proper motor control is essential for several behavioral tasks. Taken together, our data 
show that mTORC1 is not active in excitatory neurons of the forebrain in RcKO mice, which led us to 
conclude that they are ideally suited to study the role of mTORC1 signaling electrophysiologically and 
behaviorally. 
 
Raptor depletion causes task-specific impairment in learning and memory 
Synaptic plasticity on a long-term scale is known to depend on local de novo protein synthesis and 
based on experiments using rapamycin, mTORC1 has been suggested to contribute to such synaptic 
translational events (Gafford et al., 2011; Stoica et al., 2011; Tsokas et al., 2005). To test this 
hypothesis more directly, we tested whether the lack of mTORC1 signaling in RcKO mice caused 
alterations in spatial and associative learning and memory in the Morris water maze (MWM) and fear 
conditioning (FC) paradigm, respectively. 
 First, the MWM experiment consisted of two training sessions per day over 14 days with a probe 
trial at day 10 as well as two probe trials after training (24 h and 14 days post training). During the 
acquisition phase, the RcKO mice performed clearly worse than littermate controls. While control mice 
showed a constant and significant reduction of the escape latency and the swim path, the learning-
curve of RcKO mice differed significantly from that of control mice in both the swim path and escape 
latency (Fig. 2A). These data indicate that the knockout mice exhibit a pronounced spatial learning 
impairment. To assess memory performance, the mice were tested in 3 individual probe trials. The 
first probe trial on day 10 within the acquisition phase revealed a significant preference of both 
genotypes for the target zone, yet the time that the RcKO spent in the target zone was significantly 
lower compared to controls (Fig 2A). On probe trial 2 (24 hours after training), both genotypes showed 
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a significant preference for the area where the platform formerly was located without any difference 
between genotypes. In contrast, RcKO mice performed clearly worse than controls in the last probe 
trial (14 days after training). While the preference for the target zone remained high in coltrol mice, 
RcKO mice completely lost their formerly acquired preference for the target zone and performed 
significantly worse compared to control mice (Fig 2A). These data identify mTORC1 as an important 
component for the acquisition and maintenance of spatial long-term memory. 
 To test whether the remarkable deficits of RcKO mice in learning and memory were modifiable by 
an efficient within-day-training, we used a second configuration of the MWM. This consisted of a 
similar total number of trials arranged in 6 training sessions per day over a total of 4 days followed by 
two probe trials. This version of the MWM is characterized by an intensive acquisition phase with short 
time intervals between individual training sessions. The RcKO mice showed an initial learning deficit 
during the very first day (Fig. 2B). However, this deficit disappeared over the total acquisition phase 
and both control and mutant mice showed a significant reduction in escape latency and swim path 
over the total training phase. This indicates that the learning impairment in RcKO mice can be largely 
occluded by short training intervals. Subsequently, the memory performance was tested in two 
separate probe trials. Surprisingly, both genotypes displayed in probe trial 1 (24 h post training) and 
probe trial 2 (14 days post training) a clear preference for the target zone (Fig. 2B). These data 
indicate that both the learning and the long-term memory deficit of RcKO mice can be overcome in 
paradigms with a temporal arrangement of the training sessions that does not involve extensive 
overnight consolidation. 
 To determine whether mTORC1 would also be involved in other forms of learning and memory, 
we tested the mice with a conditioned fear paradigm. The mice were trained with 3 shocks paired with 
a tone and freezing upon conditioning was analyzed. Both genotypes showed very low and similar 
levels of freezing prior to the training and displayed an increased freezing in response to the training. 
The training effect was even higher in RcKO mice compared to controls (Fig 2C). Associative memory 
was tested 24 h and 14 days after the conditioning and we found no significant differences at both 
time points in either the cue or the context test between control and KO mice (Fig 2C). Control as well 
as RcKO mice demonstrated similar freezing levels at 24 h and 14-21 days post training, indicating 
that the formation of a context and cue associative long-term memory under these particular training 
conditions is mTORC1 independent. Following the testing of long-term memory in the cue and context 
test, we performed an extinction test. Extinction of fear refers to the reduction in the measured level of 
freezing to a cue previously paired with an aversive event when that cue is presented repeatedly in the 
absence of the aversive event. This process is thought to represent not an erasure of the original fear 
memory but instead an active form of learning (Davis, 2011). The performance of RcKO mice in the 
extinction test disclosed a clear deficit compared to control mice. Both control and mutant mice 
showed decreased freezing in response to the extinction training; however, the learning curve in raptor 
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deficient mice was significantly slower compared to controls (Fig 2D). This observation indicates that 
besides spatial learning and memory, the mTORC1 signaling pathway is also critically involved in the 
distinct process underlying extinction learning. 
 
Loss of raptor affects aspects of basal synaptic activity 
Based on the learning and memory deficits of the RcKO mice, we next investigated whether the lack 
of raptor also affected synaptic function and plasticity. To asses synptic propoerties, we first analyzed 
miniature excitatory postsynaptic currents (mEPSC) in CA1 neurons by patch-clamp recording. While 
no difference in the mean frequency was observed, the mean amplitude of the mEPSCs in RcKO mice 
was significantly smaller than in controls (Fig. 3A). In addition, the input-output relationship in field 
recordings from RcKO mice was shifted towards a smaller ratio of fEPSP slope and fibervolley (Fv) 
amplitude (Fig. 3C). Consistent with these observations, protein levels of GluR2 were reduced in 
lysates of the CA1 region from RcKO mice (Fig. 3D). Together, these results indicate that the 
efficiency of the postsynapse in raptor-deficient neurons is impaired. 
 To investigate whether mTORC1 was also involved in presynaptic short-term plasticity, we 
analyzed paired-pulse facilitation (PPF) in field recordings at the Schaffer collateral-CA1 synapse. No 
difference between control and RcKO mice could be observed in an inter-pulse-interval in the range 
from 20 - 200 ms (Fig. 3B). These data suggest that presynaptic properties are not affected in RcKO 
mice. 
 
Impaired E-LTP and L-LTP in RcKO mice 
To determine whether the observed deficits in learning and memory of RcKO mice in the MWM and 
the FC-extinction test was also reflected in altered LTP, we examined the expression of both L-LTP 
and E-LTP. Previous work based on the application of rapamycin suggested that protein synthesis 
dependent L-LTP requires mTORC1 signaling, whereas the translation-independent E-LTP did not 
(Cammalleri et al., 2003; Tang et al., 2002; Tsokas et al., 2005). However, genetic ablation of 
S6K1/S6K2, the main downstream targets of mTORC1, did not interfere with the maintenance of L-
LTP but rather compromised E-LTP (Antion et al., 2008). Therefore, it is still controversial what role 
mTORC1 plays in different forms of LTP. To address this open question, we first measured L-LTP in 
hippocampal slices of RcKO and control mice by applying three trains of high frequency stimulation 
(HFS) to the Schaffer collaterals. In control mice, such stimulation induced an increase of the field 
excitatory postsynaptic potential (fEPSP) that lasted for the entire duration of recording of 4 hours. In 
contrast, the potentiation of the RcKO fEPSPs constantly decreased over time and reached baseline 
level after 3-4 hours (Fig. 4A). This observation indicates that the maintenance of the protein 
synthesis-dependent form of LTP induced by HFS requires mTORC1 signaling in the hippocampus. 
To test whether rapamycin would have a similar effect on L-LTP maintenance when added to control 
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slices and to test whether LTP progression of RcKO slices was further changed by rapamycin, we 
performed L-LTP recordings in the presence of 1 µM rapamycin. Such treatment did not further alter 
the course of the L-LTP in RcKO slices (Fig. 4B), whereas the maintenance of the potentiation in 
control slices was abolished (Fig. 4C). This is the first time that direct genetic interference with 
mTORC1 is shown to resemble the pharmacological inhibition of mTORC1 by the use of rapamycin 
regarding the L-LTP phenotype (summarized in Fig. 4D). Further, the L-LTP progression of RcKO and 
control slices in the presence of the ERK-inhibitor PD98059 were indistinguishable from each other 
(Supplementary Figure S3). Thus, potential compensatory mechanisms by increased ERK signanling 
(Chen et al., 2010) are unlikely in RcKO mice. 
 To address whether E-LTP was also affected by the raptor deficiency, we used a single HFS 
applied to the Schaffer collaterals to induce an early-LTP response in the CA1 neurons. Surprisingly, 
this de novo protein synthesis-independent form of plasticity was also altered in the RcKO mice. The 
decline of the fEPSP slope after HFS stimulation was more pronounced in knockout slices and 
significantly differed from control 1 h post LTP induction (Fig. 4E, F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results – Paper 1  Regula M. Lustenberger 
 
 
Page | 47  
DISCUSSION 
mTORC1 signaling is activated by diverse neuronal signals such as glutamate or BDNF and mTORC1 
dysfunction has been linked to several neurodegenerative and mental disorders (Swiech et al., 2008). 
Therefore, this pathway is thought to critically regulate neuronal function and plasticity in the adult 
brain. However, data supporting this notion originate from retrospective observations in mice modeling 
neurodegenerative disorders or from interference with mTORC1 signaling using either rapamycin or 
genetic approaches that target up- or downstream targets of mTORC1. In most of those mouse 
models mTORC1 activity is increased. Furthermore, results from these genetic approaches are 
controversial, e.g. for LTP and memory performance in mice with conditional or constitutive deletion of 
the genes coding for TSC2, 4E-BP2 or FKBP12 mice (Banko et al., 2005; Hoeffer et al., 2008; von der 
Brelie et al., 2006). The only mouse model in which mTORC1 signaling was diminished are mice with 
a deletion of the genes encoding S6K1 and S6K2 (Antion et al., 2008). These mice, however, did not 
show a deficit in L-LTP but in E-LTP. The impairment of the early form is not consistent with studies 
using rapamycin where only forms of L-LTP were altered (Cammalleri et al., 2003; Tang et al., 2002). 
Finally, the data using pharmacological inhibitors of mTORC1 are controversial. There, the effect 
depends on the brain structure, the application scheme and the species (mice, rats, humans). In some 
studies, treatment with rapamycin had a very restrictive or even an enhancing effect on LTP or 
memory (Lang et al., 2009; Panja et al., 2009; Tsokas et al., 2007). Thus, despite the several studies 
published, the function of mTORC1 in adult neurons remained unclear as its role was so far not 
directly studied. 
 We therefore aimed to study the impact of a temporally and spatially restricted inhibition of 
mTORC1 signaling on a genetic based mouse model. Due to the fact, that mTOR can be found in at 
least two distinct multi-protein complexes, depletion of mTOR itself does not allow an analysis of the 
specific function of mTORC1. To overcome this problem, we choose the mTORC1-defining protein 
raptor as target for our genetic approach. We took advantage of the Cre-LoxP system and found that 
α-CamKII-Cre mediated depletion of exon 6 of the gene encoding raptor resulted in specific 
recombination of the targeted allele in the cortex, the hippocampus but not in the cerebellum or non-
CNS parts of the body. Further, we could show that the presence of raptor is critical for mTORC1 
signaling in the brain since ablation of raptor led to decreased phosphorylation of the two well-known 
downstream targets S6 and 4E-BP. In other tissues, it is described that S6K exhibits a negative 
feedback loop onto IRS to prevent exaggerated mTORC1 signaling (Bentzinger et al., 2008). We 
could clearly show that this feedback inhibition also exists in the brain. Especially the pronounced 
increase in Akt/PKB phosphorylation on both residues Thr308 and Ser473 indicates how sensitively 
mTORC1 regulates Akt/PKB in the CNS. Since we could not detect any significant change in 
mTORC2 signaling, the activation of Akt/PKB(Ser473) is very likely mTORC2 independent, as it has 
been also shown previously in our lab on muscle tissue (Bentzinger et al., 2008). Akt/PKB signaling is 
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involved in the control of apoptosis and ubiquitin-related aging (Low, 2011). Previous studies on 
enhanced Akt/PKB signaling in the brain reported an increased susceptibility to seizures and 
increased neuronal cell size (Tokuda et al., 2011). So far, we could not detect any detrimental effects 
of the remarkably increased Akt/PKB activity in RcKO brains. No signs of tumorgenesis, deregulated 
ubiquitinylation or apoptosis could be detected and neuron size was not increased but reduced in 
RcKO mice. Thus, we have evidence that constitutively activated Akt/PKB in combination with 
repressed mTORC1 signaling does not detrimentally affect cell survival in the adult brain. Further, we 
hypothesize that at least the increase in cell size induced by increased Akt/PKB-activity that has been 
reported by Tokuda et al. is likely dependent on mTORC1-activity. Despite the downstream and 
feedback loop targets of mTORC1 we surprisingly found, that the amount of mTOR protein was also 
reduced in KO tissue, indicative for the importance of raptor for the abundance of mTOR in the brain. 
The same observation was done in the study of Kim et al. where they showed that reduced levels of 
raptor negatively regulates mTOR abundance without affecting its mRNA levels (Kim et al., 2002). 
However, this was not observed in in other tissue-specific rptor knockout mice so far. 
 A key finding of our study is that mTORC1 has a distinctive role in learning and memory. We 
show that in learning tasks which rely on consolidation over a long time window (several hours), a 
process that strongly depends on new protein synthesis, mTORC1 is crucial for acquisition and 
retrieval of the learned task. We observed specific learning and memory impairments in the MWM 
upon long inter-training-interval conditions. Interestingly, upon intensive training, the deficits in learning 
and memory in the water maze could be decreased in KO mice. These data indicate that mTORC1 
very likely is a regulator of processes involved in protein synthesis-dependent neuronal plasticity and 
that the lack of mTORC1 signaling can be overcome under circumstances where the consolidation 
phase is within a short time window that presumably does not completely rely on de novo protein 
synthesis. These findings resemble the phenotype of CREB-mutant mice (Gass et al., 1998). 
Interestingly, the RcKO mice exhibit a specific fear-extinction learning deficit without showing 
alterations in the other fear conditioning parameters. This observation points towards a role of 
mTORC1 in this specific type of NMDA-R-dependent form of plasticity. Further investigations will be 
carried out to clarify the underlying mechanism of this interesting phenotype. 
 Further, our results together with the data from Antion et al. provide evidence that mTORC1 
mainly contributes to long-term plasticity via its regulation of 4E-BP and that activation of S6K is 
probably not involved in L-LTP but rather in E-LTP. While S6K1 knockout mice show impaired E-LTP 
but do not display a L-LTP deficit in electrophysiological experiments, rptor deletion results in reduced 
S6 and 4E-BP activity and RcKO mice exhibit an impairment in both forms of LTP. Thus, our data for 
the first time provide electrophysiological and behavioral evidence that mTORC1 signaling is critical 
for learning and memory performance. 
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 In addition to deficits in neuronal plasticity and learning and memory, we found a reduction in 
synaptic efficiency in RcKO mice that is potentially due to a reduced availability of GluR2 in raptor 
deficient neurons. In line with this observation, the overexpression of PTEN (a mTORC1 suppressor) 
in hippocampal slices results in depressed synaptic transmission (Jurado et al., 2010). The opposite 
phenotype is observed in 4E-BP2-/- mice, in which Bidinosti et al. showed an increase in mEPSC 
amplitude (Bidinosti et al., 2010). Together with our data, this indicates that the regulation of mTORC1 
signaling in neurons is critical for both specific protein synthesis-dependent plasticity processes (such 
as L-LTP) and for the maintenance of basal synaptic functions. To date, this aspect of the mTORC1 
signaling has not been intensively discussed. It could well be that mTORC1 activity is regulating the 
basal synthesis-level of AMPA receptors and other synaptic proteins and upon further stimulation of 
mTORC1 by increased synaptic activity mTORC1 additionally contributes to the L-LTP-specific de 
novo protein synthesis. In line with this hypothesis, the study by Auerbach et al. provides evidence 
that diseases such as fragile X syndrome or TSC, both of which are associated with increased 
mTORC1 activity, are potentially based on alterations in the control of basal protein synthesis 
(Auerbach et al., 2011). Furthermore, several studies report a conversion of E-LTP to L-LTP under 
conditions of constant mTORC1 hyperactivity (Banko et al., 2005; Ehninger et al., 2008). In 
combination with our observations, these data point towards an important role of mTORC1 in protein 
synthesis homeostasis in adult neurons and indicate that unbalanced mTORC1 signaling can have 
detrimental effects on brain functioning and the coordination of plasticity-related processes. 
To date, we cannot explicitly assign the plasticity-related phenotypes we observed in the RcKO mice 
to one (control of basal protein synthesis-level) or the other (de novo protein synthesis) role of 
mTORC1 only. It is very likely, though, that both mechanisms are displayed synergistically in the 
observed LTP characteristics of RcKO mice. It remains to be further analyzed whether the repression 
of mTORC1 in postnatal brain structures affects other aspects of neuronal function and processes 
associated with neurodegenerative diseases. 
 Our data so far indicate that basal mTORC1 activity is crucial for the regulation of postnatal 
neuron size, synaptic function and plasticity and thus ultimately for learning and memory. Therefore, in 
the view of the fact that rapamycin is prescribed to patients as an immunosuppressive drug for a 
prolonged time period, our results also shed new light onto potential side effects of this drug in the 
central nervous system.  
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Figure 1. Selective depletion of raptor in the forebrain results in diminished mTORC1 activity 
and reduced brain size. 
(A) Schematic presentation of the localization of the LoxP sites in the rptor gene in the wild-type allele 
(WT) and the targeted allele (floxed) before and after (KO) recombination. Positioning of the primers 
P1-P3 used in (B) are indicated. 
(B) PCR identification of rptor floxed alleles, alleles from recombined LoxP sites and Cre in DNA 
extracts from cortex (CX), CA1, CA3, dentate gyrus (DG), cerebellum (Cereb) and the tail from control 
(Ctr) and RcKO (KO) mice. P1, P2 and P3 represent primers indicated in (A). 
(C-E) Western blot analysis showing protein and phosphorylation levels of the indicated targets in 
lysates from cortex (CX) and CA1 tissue. For quantification see Supplementary Table 1. 
(F) Representative photographs of whole brain, cresyl violet stained cross-sections, Golgi-stained 
cross-sections and immunohistochemical pS6-staining of cross-sections from adult control (left) and 
RcKO (right) mice. Total brain size, hippocampal size, length of basal dendrites (BD) and apical 
dendrites (AD) are reduced in RcKO. pS6 staining in CA1 neurons (yellow asterisk) of RcKO mice is 
strongly reduced. No difference in pS6 staining in CA2 area (white asterisk) is observed. 
(G) Quantification of specific tissue weight from total brain, cortex (CX), hippocampus, cerebellum and 
whole body weight of control (white) and RcKO (black) mice. RcKO mice show reduced weight of total 
brain, CX and hippocampus (Ctr: n = >3; KO: n = >6). 
Data represent mean ± SEM. Statistics: ** p<0.01, two-tailed t-test. Scale bars: 4 mm (F,a), 0.5 mm 
(F,b), 0.1 mm (F,b`), 5 µm (F,c), 0.2 mm (F,d). 
 
 
 
 
 
 
 
Results – Paper 1  Regula M. Lustenberger 
 
 
Page | 52  
 
 
Figure 2. Task-specific impairment of learning and memory in RcKO mice. 
(A) Left: escape latency and swim path during the training phase of 14 days in the MWM. Each point 
represents average across 4 sessions of 2 days. KO took on average significantly longer to reach the 
platform. Right: time spent in the target zone versus average of control zones in the other quadrants 
(probe 1: at day 10 of training; probe 2: 24 h post training; probe 3: 14 days post training). KO showed 
a weaker preference for the target zone during probe trial 1 and no preference for the target zone at 
probe trial 3 while no difference could be detected in probe trial 2 (Ctr: n = 17; KO: n = 17). 
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(B) Left: escape latency and swim path during the training phase of 4 days in the MWM. Each point 
represents average across the 6 sessions per day. Both genotypes show overall robust learning. 
Right: time spent in the target zone versus average of control zones in the other quadrants (probe 1: 
24 h post training) or time in target zone of probe 1 versus time spent in target zone during probe 2 
(probe 2: 14 days post training). Independent of genotype mice showed strong preference for the 
target zone (Ctr: n = 18; KO: n = 17). 
(C) Cued and contextual fear conditioning. Left: freezing in the training chamber before and 
immediately after training. KO froze more after training. Middle: context test shows freezing in the 
training chamber before training, 24 h and 15-21 days after training. Independently of genotype, mice 
showed significant retention. Right: cued test shows freezing in a new context before and during 
representation of the tone (24 h and 15-21 days after conditioning). Both genotypes showed robust 
freezing to the tone. 
(D) Freezing during 1 min baseline and 15 min of extinction. Blocks 1-5 represent average across 5 
consecutive tone presentations (25 s each). Both groups reduced freezing in response to extinction 
training but reduction was less in RcKO mice (Ctr: n = 35; KO: n = 35). 
Data points of control mice are shown in white, data points of RcKO are shown in black. Data 
represents mean ± SEM. Statistics: follow-up one-sample t-test versus chance: ### p<0.001, ## 
p<0.01, # p<0.05, ~ p<0.1. Follow-up unpaired t-test KO versus Ctr: ** p<0.01, * p<0.05. 
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Figure 3. Reduced synaptic efficiency in RcKO mice. 
(A) Quantification of mEPSC recordings in CA1 neurons of 3 months old control (Ctr) and RcKO (KO) 
mice. Bars represent mean amplitude and mean frequency of mEPSCs. Amplitude of mEPSCs in 
RcKO mice was significantly reduced (Ctr: n = 9; KO: n = 11). 
(B) PPF measured in CA1 field recordings from adult control and RcKO mice. The percentage of 
facilitation, determined by the ratio of the second fEPSP to the first fEPSP, is shown at interpulse 
intervals from 20 to 200 ms. RcKO mice show normal PPF (Ctr: n = 10; KO: n = 9). 
(C) Input (fibervolley (Fv) amplitude) versus output (fEPSP slope) plot (left) and cumulative frequency 
plot of Fv/slope ratios (right) are depicted. A shifted input-output relationship towards smaller Fv/slope 
ratios is observed in KO (Ctr: n = 13; KO: n = 17). 
(D) Representative western blot of GluR2 of CA1 lysates from control (Ctr) and RcKO (KO) mice and 
quantification of grey values normalized to β-Actin. The abundance of GluR2 is reduced in RcKO 
lysates (Ctr: n = 7; KO: n = 7). 
Data represents mean ± SEM. Statistics: two-tailed t-test, * p<0.05; Kolmogorov-Smirnov-test, * 
p<0.05. 
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Figure 4. Impaired E-LTP and L-LTP in RcKO mice. 
(A) Three trains of HFS (100 Hz, 1 s, 4 min inter-train-interval) induced L-LTP in control (Ctr) and 
RcKO (KO) slices. Graph shows fEPSP slope as percentage of mean baseline values. Each data 
point represents average of recordings during a time interval of 3 min. L-LTP maintenance is reduced 
in KO slices (Ctr: n = 9; KO: n = 9). (B) L-LTP recording in RcKO mice as described in (A) compared 
to measurements of KO slices treated with 1 µM rapamycin (KO Rapa) during baseline measurements 
and for 1 h post induction. No difference between the two groups is observable (KO Rapa: n = 6). (C) 
L-LTP recording in control mice as described in (A) compared to measurements of control slices 
treated with 1 µM rapamycin (Ctr Rapa) during baseline measurements and for 1 h post induction. 
rapamycin treatment impaired L-LTP maintenance in Ctr slices (Ctr Rapa: n = 3). (D) Quantified levels 
of potentiation during the first 15 min (filled bars) and after 4 h (striped bars) post L-LTP induction. 
RcKO slices, control and RcKO slices treated with rapamycin showed significantly reduced 
potentiation levels after 4 h recording (color code is as follows: Ctr: white; KO: black; Ctr Rapa: blue; 
Results – Paper 1  Regula M. Lustenberger 
 
 
Page | 56  
KO Rapa: red). (E) One train of HFS (100 Hz, 1 s) was applied to Ctr and KO slices and E-LTP 
progression was measured for 1 h. Graph shows fEPSP slope as percent of mean baseline values. 
Each data point represents average of recordings during a time interval of 3 min. LTP progression in 
KO slices was affected compared to Ctr (Ctr: n = 7; KO: n = 6). (F) Graph shows level of potentiation 
during the first 12 min (filled bars) and after 1 h (striped bars) post E-LTP induction for Ctr (white) and 
KO (black). The level of potentiation in KO slices 1 h post LTP induction was significantly reduced 
compared Ctr. Data represents mean ± SEM. Statistics: two-tailed t-test, ** p<0.01, * p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results – Paper 1  Regula M. Lustenberger 
 
 
Page | 57  
 
 
Supplementary Figure S1. Reduced dendritic length and soma size of CA1 neurons in RcKO 
mice. 
(A) Analysis of dendritic length based on cresyl violet stained tissue sections from control (Ctr) and 
RcKO (KO) mice. Graphs on the left show quantification of apical dendritic length and basal dendritic 
length in the CA1 region of Ctr (white bars) and RcKO (black bars) mice. Representative photographs 
of the CA1 region of cresyl violet stained coronal cross sections from KO and Ctr mice are depicted on 
the right. Both dendritic areas showed reduced length in KO sections (Ctr: n = 5; KO: n = 5). 
(B) Analysis of the soma size of CA1 and CA2 neurons based on tissue sections from control (Ctr) and 
RcKO (KO) mice that were stained for S6. Graphs on the left show quantification of soma size of Ctr 
(white bars) and KO (black bars) from CA1 neurons and CA2 neurons, respectively. Representative 
photographs of CA1 and CA2 neurons from cross sections stained against S6 (red) are depicted on 
the right. Soma size of CA1 neurons in KO sections is reduced, whereas no difference was observed 
in soma size of CA1 neurons (Ctr: n = 5; KO: n = 5). 
Data represents mean ± SEM. Statistics: two-tailed t-test, ** p<0.01, * p<0.05. Scale bars: 200 µm (A); 
50 µm (B). 
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Supplementary Figure 2. No pronounced apoptosis and autophagy alterations in RcKO mice. 
(A) Western blot analysis showing LC3B I and LC3B II protein levels in cortex (CX) and CA1 lysates 
from 3 months and 18 months old mice. No significant difference in LC3B I and LC3B II was detected 
neither in CX lysates nor in CA1. Probing against cleaved caspase3 did not reveal any signal in 
control (Ctr) and RcKO (KO) mice (Ctr: n<5; KO: n<5). As positive control for the probing against 
cleaved caspase3 a protein sample of apoptotic primary mouse neurospheres was used. 
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Representative microscope pictures showing cleaved caspase3 staining (red) and DAPI (blue) are 
depicted on the right. No positive staining for cleaved caspase3 could be detected in sections from 3-
18 month old mice. 
(B) Western blot analysis of lysates from cortex (CX) and CA1 region from Ctr and KO mice of 
different ages probing against ubiquitinylated proteins (Ctr: n<5; KO: n<5). No difference in signal 
intensity could be detected between Ctr and KO. 
Data represents mean ± SEM. Statistics: two-tailed t-test, * p<0.05. Scale bar: 0.2 mm (A). 
 
 
 
 
 
Supplementary Figure 3. Control and RcKO mice show similar LTP progression in response to 
PD98059. 
Three trains of HFS (100 Hz, 1 s, 4 min inter-train-interval) induced L-LTP in control (Ctr) and RcKO 
(KO) slices. Graph shows fEPSP slope as percentage of mean baseline values. Each data point 
represents average of recordings during a time interval of 3 min. L-LTP maintenance is impaired in Ctr 
(white) and KO (black) slices  (Ctr: n = 5; KO: n = 5). 
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Supplementary Table 1. Quantification of Western blot analysis. 
Table shows quantified grey values of representative Western blots from Figure 1. All values were 
normalized to the β-Actin signal of the corresponding sample. The mean intensity for each individual 
target of interest from control lysates was set as 100%. The mean values from RcKO are indicated as 
percentage of control. In the right column, the targets and phosphorylation sites which were probed for 
are indicated. In the middle column, the results from Western blot analysis of CA1 lysates from control 
(Ctr) and RcKO (KO) are depicted. The right column shows the results from Western blot analysis of 
cortex (CX) lysates. Number of samples used for each target are indicated as n (Ctr) / n (KO). Data 
represent mean ± SEM. Statistics: two-tailed t-test, *** p<0.001, ** p<0.01, * p<0.05, ~ p<0.075. 
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MATERIAL AND METHODS 
Raptor cKO Mice: RcKO 
Mice were maintained in a conventional facility with a fixed day-night cycle. Studies were carried out 
according to criteria outlined for the care and use of laboratory animals and with approval of the Swiss 
authorities. Mice with floxed rptor alleles (Rfl/fl) were generated as described previously (Bentzinger et 
al., 2008). For the generation of forebrain-specific rptor knockout, mice homozygously floxed for the 
rptor allel were crossed to T29-1 α-CamKII-Cre mice (from The Jackson Laboratory). All mice were 
bread in a clean C57BL/6J background. For genotyping, tail lysates were analyzed with Cre specific 
primers and primers identifying the floxed rptor allel (P1, P2). Cre fw: 5’-TGT GGC TGA TGA TCC 
GAA TA; Cre bw: 5’-GCT TGC ATG ATC TCC GGT AT; P1: 5'-ATG GTA GCA GGC ACA CTC TTC 
ATG; P2: 5'-GCT AAA CAT TCA GTC CCT AAT C. Successful recombination of the LoxP sites in 
knockout mice was tested using P1 and an additional primer P3: 5'-CAG ATT CAA GCA TGT CCT 
AAG C. Control mice used in this study carried the genotype α-CamKII-Cre-/Rfl/fl and RcKO mice 
carried the genotype α-CamKII-Cre+/Rfl/fl. Only female α-CamKII-Cre+ mice were used for the RcKO 
breedings. If not specifically indicated, adult mice (2-12 month) were used for all the experiments. 
 
Protein lysate preparation and immunoblotting 
Mice were deeply sedated with Isoflurane (AttaneTM) and decapitated. After removal of the brain, the 
hippocampus as well as the frontal cortex was rapidly dissected. Cortices were immediately frozen in 
liquid nitrogen. The hippocampi were further cut into 400 µm thick slices with the tissue chopper 
(McIlwain). Microdissection of the CA1, CA3 and DG was performed in ice cold PBS and tissue 
fragments were subsequently frozen in liquid nitrogen. Tissue samples were homogenized in protein 
lysis buffer (50 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA, 1% Triton-X100, protease inhibitor cocktail 
(Roche), phosphatase inhibitor cocktail (Roche)) using a 1 ml syringe. Homogenates were centrifuged 
at 13’600 rpm for 20 min at 4 °C and the supernatant was harvested. Total protein concentration was 
measured using BCA protein assay kit (Pierce). Protein sample buffer was added and samples were 
cooked at 95 °C for 15 min. The positive control for the cleaved caspase3 was kindly provided by Dr. 
M. Tome, Group of Prof. B. Bettler, Pharmazentrum, University of Basel, and contained lysed primary 
mouse neurospheres treated with 20 µM Etoposide for 6 h before lysis. For western blot analysis, 
equal amount of protein was loaded on SDS gels and subsequently transferred onto nitrocellulose 
membranes and subsequently probed for the specific proteins and phosphorylation sites indicated. All 
primary antibodies were diluted in PBST (PBS, 5 % BSA (Sigma), 0.1 % Tween (Sigma)) and 
incubated over night at 4 °C. The following primary antibodies were used: rabbit anti: Raptor, Rictor, p-
mTOR(2448), p-mTOR(2481), mTOR, p-S6(235/236), S6, p-4E-BP(37/46), p-Akt/PKB(308), p-
Akt/PKB(473), Akt/PKB, p-IRS1(636/639), IRS1, p-TSC2(1462), TSC2, PKCα, PKCε, LC3B, cleaved 
Caspase3 and β-Actin from Cell Signaling; rabbit anti p-PKCα(657) from Santa Cruz; rabbit anti p-
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PKCε(729) from Abcam; mouse anti ubiquitinylated proteins from Millipore; mouse anti GluR2 from BD 
Biosciences. Secondary antibodies were as follows: goat anti-mouse HRP and goat anti-rabbit HRP 
from Nordic Immunology. 
 
Immunohistochemistry 
Adult mice were deeply anesthetized with Esconarkon (Streuli Pharma) and transcardially perfused 
with 4 % PFA. Brains were removed and either embedded in Paraffin (Merck) and subsequently cut 
with a microtome (Microm) or froze in Tissue-Tek® (Sakura) and cut with a cryostat (Leica), 
respectively. Before starting the staining procedure, paraffin sections were deparaffinated by backing 
the slides for 20 min at 60 °C, followed by dehydration steps (xylol, 100 % EtOH, 98 % EtOH, 96 % 
EtOH, 70 % EtOH, H2O). For cresyl violet staining, the sections were incubated for 15 min in cresyl 
violet and afterwards dehydrated (70 % EtOH, 96 % EtOH, 100 % EtOH, xylol) and mounted with 
toluol-based medium. For antibody stainings, the sections were washed in PBS, cooked in citrate 
buffer (0.1 M sodium-citrate, pH 6) and blocked for 30 min in blocking buffer (PBS, 5 % BSA, 0.1 % 
TritonX). Primary antibodies were diluted in blocking buffer or PBS (cleaved caspase 3) and incubated 
over night at 4 °C. Secondary antibodies combined with Dapi were applied for 1 h at room 
temperature. After washing with PBS, sections were mounted with Kaisers glycerol gelatin (MERCK). 
The following antibodies were used: rabbit anti-pS6 (Cell Signaling, 1:200), rabbit anti-S6 (Cell 
Signaling, 1:250), rabbit anti-cleaved caspase 3 (Cell Signaling, 1:200), DAPI (1:1000), goat anti-rabbit 
Cy3 (Jackson Immunoresearch, 1:500). For microscopic analysis, a Leica microscope (Leica DM 5000 
B) and the Analysis software (analySIS Pro 3.2) were used. 
 
Morris Water Maze 
Spatial learning and memory performance was tested in the  Morris water maze (MWM) according to 
previous publication (Morris, 1984). In brief, a round white poly-propylene swim tank with a diameter of 
150 cm, was filled with water (temperature 24-26 ° C, depth 15 cm) and made opaque by addition of 1 
l of milk. The white quadratic goal platform (14x14 cm) was hidden 0.5 cm below the water surface. 
Salient distant cues were available in the indirectly illuminated room (4 40W bulbs, 12 lux). Animals 
were video-tracked at 4.2 Hz and 576x768 pixel spatial resolution using a Noldus EthoVision 3.00 
system (Noldus Information Technology, Wageningen NL). Raw data were then transferred to public 
domain software Wintrack 2.4 (www.dpwolfer.ch/wintrack) for further analysis. The short version of the 
MWM consisted of 6 trainings per day over 4 consecutive days and a probe trial (removal of the 
platform) at 1 day or 14 days after training, respectively. The long version of the MWM consisted of 2 
trainings per day over 14 consecutive days with one probe trial at day 10 as well as at day 1 and day 
14 after the training session, respectively.  
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Fear Conditioning 
Four mice were tested in parallel in an Actimetrics FreezeFrame video-based Conditioned Fear 
System (www.actimetrics.com). The conditioning chambers (175 mm deep x 180 mm wide x 280 mm 
high) were enclosed in ventilated and sound-attenuated cabinets and had a floor consisting of 
stainless steel rods permitting the application of current. The conditional stimulus (CS) was a 2500 Hz 
85 dB tone lasting 30 s, co-terminating with a 2 s 0.25 A foot shock (US). Freezing (absence of 
movement aside from respiration) was quantified automatically by the FreezeFrame software 
subtracting subsequent images recorded by the ceiling-mounted IR video cameras in the conditioning 
chambers. Bouts of 1.0 s were used to define % freezing and movement thresholds were set at 20 
(training and context test) or 8 units (tone test). The conditioning consisted of 1min baseline 
measurement followed by three CS with 30 sec of CS-CS interval. The cue-test was performed in 
modified cabinets for 2 min (1min baseline followed by 1 min CS representation). The context-test was 
performed in the same cabinets as during the training session for 2 min. For both, cue- and context-
test, a short-term and long-term testing was executed at day 1 and day 14 after the training, 
respectively. For the extinction test, mice were placed in a modified cabinet and after 1 min of baseline 
recording, the CS was represented 25 times for 30 s with a 5s CS-CS interval. The delayed extinction 
test was performed 1 day after. 
 
Golgi staining 
Adult mice were deeply deeply anesthetized with Esconarkon (Streuli Pharma) and transcardially 
perfused with 4 % PFA. Further procedure was according to the manual of the FD Rapid GlogiSatinTM 
Kit (FD Neuro Technologies, Inc.). 
 
Electrophysiology 
For patch clamp recordings, mice at the age of 8 to 12 weeks were deeply sedated with isofluran 
(AttaneTM). After decapitation, the brain was rapidly removed and immediately transferred into ice cold 
oxygenated (95 % O2, 5 % CO2) low-calcium artificial cerebrospinal fluid (low-Ca2+-ACSF) containing: 
119 mM NaCl, 1 mM NaH2PO4, 2.5 mM KCl, 0.125 mM CaCl2, 3.3 mM MgCl2, 11 mM D-glucose and 
26.2 mM NaHCO3. Brains were cut with a vibratome (Leica) into 300 µm coronal sections and retained 
at least for 1 h at room temperature in oxygenated ACSF (119 mM NaCl, 1 mM NaH2PO4, 2.5 mM 
KCl, 2.5 mM CaCl2, 1.3 mM MgCl2, 11 mM D-glucose and 26.2 mM NaHCO3) before recording. 
Miniature events were recorded using an Axonpatch Multiclamp 700B amplifier and borosilicate glass 
pipettes (4-8 mΩ) filled with intracellular solution (135 mM CsMeSO4, 8 mM NaCl, 10 mM HEPES, 0.5 
mM EGTA, 4 mM Mg-ATP, 0.3 mM Na-GTP, 5 mM Lidocaine-N-ethylbromid). For mEPSC recording, 
the holding potential was set to -70 mV. The postsynaptic current was recorded for 10 min in the 
presence of 0.5 µM TTX. Traces were further analyzed with Mini Analysis Program v6 (Synaptosoft). 
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For field recordings, brain slices of 400 µm thickness were obtained as described and transferred into 
oxygenated ACSF at 30 °C for 30 min before placing them in an interface chamber (house made) 
perfused with oxygenated ACSF at least 1 h prior to recording. For all recordings, a Pt-Ir electrode (25 
µm in diameter) was used to stimulate the Schaffer collaterals and field responses of CA1 neurons 
were measured with a glass pipette (1-6 MΩ) filled with ACSF. Extracellular postsynaptic field 
potentials (fEPSP) were evoked by test stimuli applied at 0.33 Hz with an intensity to induce 40-50 % 
of maximal fEPSP. After 30 min of baseline recording, E-LTP (1x HFS: 100Hz, 1 s duration) or L-LTP 
(3x HFS: 100 Hz, 1 s, 4 min inter-train-interval) was induced. Stimulus intensity of the HFS was 
matched the intensity during baseline recording. When indicated, slices were perfused with ACSF 
containing 1 µM rapamycin (LC Laboratories) or 40 µM PD98059 (Tocris), respectively. Signals were 
averaged over 3 min and normalized to baseline recordings. Paired-pulse facilitation was analyzed in 
the range of inter-pulse-intervals from 20 ms to 200 ms and the slope response of the second stimuli 
was calculated relatively to the first response. For input-output relationship assessment, slices were 
stimulated in the range of 20 µA - 9 mA and fibervolley amplitude and fEPSP slope were analyzed. 
 
Quantifications and statistics 
Quantification of Western blots was performed using the ImageJ software. Background-corrected grey 
values were normalized to β-Actin levels and the mean value of Ctr was set to 100 %. For 
quantification of soma size as well as apical and basal dendritic length of CA1 neurons the software 
Analysis (analySIS Pro 3.2) was used. For soma size quantification, the area of positive S6 staining 
surrounding CA1 nuclei was measured. The length of apical and basal dendritic area was measured 
based on cresyl violet stainings.  If not otherwise indicated, data are expressed as mean ± SEM. For 
statistical analysis of the MWM and FC data, mixed ANOVA models were used with follow-up one-
sample t-test versus chance and follow-up unpaired t-test Ctr versus RcKO. The cumulative frequency 
of Fv/slope ratio was analyzed using Kolmogorov-Smirnov test. For all other statistical comparisons of 
two genotypes or conditions, the Student’s t-test was used. Levels of significance are as indicated in 
the figure legends.  
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SUMMARY 
The mammalian target of rapamycin (mTOR) regulates cell growth in response to various intracellular 
and extracellular signals. It assembles into two multiprotein complexes, the rapamycin-sensitive 
mTOR complex 1 (mTORC1) and the rapamycin-insensitive mTORC2. In this study, we inactivated 
mTORC1 in mice by deleting the gene encoding raptor in the progenitors of the developing central 
nervous system. Mice are born but never feed and die within a few hours because of respiratory 
difficulties. The brains deficient for mTORC1 show a strong microcephaly which becomes visible at 
E17.5, and is the consequence of reduced cell number and cell size. The reduced cell number is due, 
at least in part, to specific changes in cell cycle phases during late cortical development and increased 
cell death. Depletion of raptor in vitro inhibits differentiation of neural progenitors into glia but not 
neurons. The differentiation defect is paralleled by decreased Stat3 signaling, which is a target of 
mTORC1 and has been implicated in gliogenesis. Taken together, our results show that postnatal 
survival, overall brain growth and specific aspects of brain development critically depend on mTORC1 
function. 
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INTRODUCTION 
In eukaryotes, cell growth is regulated by the TOR pathway (Hay and Sonenberg, 2004; Laplante and 
Sabatin, 2012; Wullschleger et al., 2006). The mammalian ortholog mTOR assembles into two distinct 
multiprotein complexes referred to as mTORC1 and mTORC2 (Jacinto et al., 2004; Sarbassov et al., 
2004). mTORC1 consists of mTOR, raptor (gene abbreviated as rptor), mLST8 and PRAS40 and is 
sensitive to acute treatment with the immunosuppressant rapamycin (Wullschleger et al., 2006). 
mTORC1 has been implicated in the control of metabolism, protein translation, ribosome biogenesis, 
autophagy and transcription (Wullschleger et al., 2006). However, analysis of the physiological 
function of mTORC1 in vivo was for a long time restricted to early embryonic development, due to the 
lethality of mTOR-, raptor- and mLST8-deficient embryos. mTOR-/- and rptor-/- embryos die shortly 
after implantation due to proliferation defects (Gangloff et al., 2004; Guertin et al., 2006; Murakami et 
al., 2004). Because of this early lethality of the constitutive mutants, none of these studies have 
addressed the role of mTOR in brain development. 
 The role of mTOR in the brain has so far mainly been studied using cultured cells. A few studies 
addressed differentiation of neural stem cells and came to the seemingly conflicting conclusions that 
mTORC1 is either crucial for commitment into the neuronal (Han et al., 2008) or into the glial lineage 
(Rajan et al., 2003; Wang et al., 2008). Different conditions may explain these alterations, thus posing 
the question to which extent the chosen conditions reflect the physiological situation. A large set of 
studies addressed consequences of mTOR inhibition or knockdown for growth of postmitotic neurons 
(Swiech et al., 2008). Based on those studies, mTOR has been postulated to be important for 
polarization, dendrite development and axonal growth and guidance. Moreover, it has been shown 
that the complexity of the dendritic tree is reduced upon mTORC1 inhibition (Jaworski et al., 2005; 
Kumar et al., 2005). For axons, some studies have shown that local translation in growth cones that 
mediates axon guidance or regrowth after axotomy, is rapamycin-sensitive (Campbell and Holt, 2001; 
Park et al., 2008; Verma et al., 2005). Other studies have shown that axon specification and 
elongation is mTORC1-dependent (Li et al., 2008). In summary, in vitro data have resulted in a 
panoply of potential functions of mTORC1. However, the role of mTORC1 in vivo has not been 
addressed. 
 The only study that has addressed the role of mTOR in brain development has characterized the 
flat-top mutant (Hentges et al., 1999) caused by a mutation in the mTOR gene that results in a splicing 
defect (Hentges et al., 2001). Mutant embryos lack telencephaly and die at midgestation. Interestingly, 
this effect is phenocopied by prolonged application of rapamycin to pregnant mice (Hentges et al., 
2001). Interpretation of these results is difficult because mTOR null embryos die in a much earlier 
developmental stage (Gangloff et al., 2004; Murakami et al., 2004) and because the prolonged 
treatment with rapamycin is likely to inhibit both mTORC1 and mTORC2. The generation of floxed 
alleles for rptor and rictor (Bentzinger et al., 2008; Cybulski et al., 2009; Polak et al., 2008) has 
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allowed to study the specific role of mTORC1 and mTORC2 in the developing brain. Here, we 
addressed the physiological function of mTORC1 in brain development by mating rptor-floxed mice 
with mice expressing Cre under the control of the nestin promoter (Tronche et al., 1999). We find that 
raptor-deficient brains are uniformly smaller than control brains due to decreased cell size and 
reduced cell number. Moreover, we show that differentiation into the glial but not the neuronal lineage 
is impaired and that the development of the hippocampal layering is affected. 
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RESULTS 
mTORC1 controls embryonic brain size and is required for postnatal survival 
To address the role of mTORC1 in brain development, we conditionally inactivated rptor in nestin-
expressing neural progenitors using rptor floxed mice (Bentzinger et al., 2008) and the well-described 
nestin-Cre mice (Graus-Porta et al., 2001; Tronche et al., 1999). In those rptorfl/fl;nestin-Cre (RAbKO) 
mice (Fig. S1A), rptor was successfully deleted as verified by the elimination of exon 6 in genomic 
DNA from brain but not from tails (Fig. S1B). Deletion of exon 6 resulted in the almost complete loss of 
raptor protein (Fig. 1A).  Consistent with a complete loss of mTORC1 activity, phosphorylation of the 
mTORC1-dependent site serine 2448 in mTOR (Copp et al., 2009; Jastrzebski et al., 2007) and of the 
downstream substrate S6 was strongly decreased in the brains of RAbKO mice (Fig. 1A, Table S1 for 
quantification). In contrast, abrogation of mTORC1 did not affect the function of mTORC2 as the 
protein level of rictor and phosphorylation of mTOR at the mTORC2-specific phosphorylation site at 
serine 2481 (Copp et al., 2009), and of Akt/PKB at serine 473 (Sarbassov et al., 2005) was not 
abrogated. To the contrary, phosphorylation at both sites was rather increased in RAbKO mice (Fig. 
1A, right), consistent with previous results from mice in which raptor was conditionally deleted in other 
tissues (Bentzinger et al., 2008; Godel et al., 2011; Inoki et al., 2011; Polak et al., 2008; Shende et al., 
2011). These data are strong evidence that mTORC1 activity had been eliminated by loss of raptor 
and that mTORC2 activity was not impaired. Although RAbKO mice were born at the expected 
Mendelian ratio (Table 1) and their body weight was normal (Fig. 1B), they became cyanotic and died 
within a few hours after birth (data not shown). Their stomachs never contained milk and their 
breathing was often irregular (gasping), suggesting that the mice died of respiratory failure. The 
respiratory difficulties seemed not to be due to malformations of the neuromuscular junctions as 
revealed by the staining of presynaptic motor nerves with antibodies to neurofilament and postsynaptic 
acetylcholine receptors with α-bungarotoxin in the diaphragm (Fig. S2). Rather, higher brain centers 
involved in respiratory control might be affected.  
 The brains of RAbKO mice appeared smaller and their brain weight was reduced to 54% of that in 
control animals (Fig. 1C) even though the body weight was not changed (Fig. 1B). The difference in 
brain size could be caused by a decrease in cell number or cell size, both processes that have been 
reported to be influenced by mTOR (Laplante and Sabatini, 2012; Wullschleger et al., 2006). 
Comparative analysis of cell number by quantification of the DNA content indicated a more than 30% 
reduction in the number of cells in the brains of E19.5 RAbKO mice (Fig. 1D, upper part). Together 
with the reduced brain weight, these data suggest that the DNA amount/g brain tissue (reflecting cell 
density) was increased to more than 120% in the brains of RAbKO mice compared to controls (Fig. 
1D, lower part). Moreover, the ratio of protein to DNA amount was decreased to 71 ± 10% (mean ± 
SEM; N ≥ 3) (data not shown) consistent with the concept that the cells in RAbKO brains are smaller. 
Together, these results indicate that a decrease in cell number and a decrease in cell size (resulting in 
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higher cell density) contribute to the microcephaly observed in newborn RAbKO mice. Although brain 
size was reduced, the overall structure was normal at birth (Fig. 1E). The difference in brain size 
became obvious at E17.5 (Fig. 1F, lower part) but could not be detected earlier (Fig. 1F, upper part). 
Although there was a trend in E17.5 RAbKO mice for an increased cell density compared to control 
mice, this difference did not reach significance (Fig. 1G), indicating that the smaller size of RAbKO 
brains at this developmental period was mainly due to changes in cell number. In summary, these 
data indicate that the size difference becomes manifest between E15.5 and E17.5 and increases 
progressively until birth.  
 
Raptor deficiency increases apoptosis and affects cell cycle duration 
To address the mechanism involved in the loss of cells in RAbKO mice, the presence of apoptotic 
cells was assessed by staining brain sections with antibodies to cleaved Caspase 3. Apoptotic, 
cleaved Caspase 3-positive cells were not increased in E15.5 or E17.5 RAbKO mice compared to 
controls (Fig. 2A,C). However, the appearance of apoptotic cells was strongly increased in RAbKO 
mice at E19.5 (Fig. 2A,C) and the vast majority of the dying cells were NeuN-positive neurons (Fig. 
2B). Apoptotic cells were not unique to cortical regions but could also be found at E19.5 in other brain 
regions, such as the hippocampus (Fig. 7C) or the thalamus (data not shown). This suggests that the 
reduced brain size and the decreased cell number at E17.5 is not a consequence of cell death. 
However, neuronal cell death contributes to the reduced cell number in the brain of RAbKO mice at 
late developmental stages.  
 To search for the mechanism involved in the earlier brain size reduction, we next assessed cell 
cycle kinetics and cell differentiation. As mTORC1 has been implicated in controlling G2/M phase 
transition during the cell cycle (Ramirez-Valle et al., 2010) we analyzed proliferation in embryonic 
RAbKO mice by BrdU labeling in utero. Radial glial cells in the ventricular zone of the developing 
cortex display phase-related interkinetic nuclear migration during cell cycle progression (Gotz and 
Huttner, 2005; Sargeant et al., 2008). DNA replication takes place in the basal and mitosis in the 
apical region of the ventricular zone.  In order to determine nuclear position, we divided the developing 
cortex into three progenitor regions R1 to R3, based on Sox2 and Tbr2 staining. R1 covered the apical 
VZ, R2 the basal VZ and the subventricular zone and R3 the intermediate zone (Fig. S3). E15.5 
RAbKO embryos labeled with BrdU 3 hours prior to sacrifice did not show differences in the 
distribution of BrdU-labeled cells in the developing cortex compared to controls (Fig. 3A,B). When 
RAbKO mice were pulsed with BrdU at E15 and analyzed 12 hours later, a significantly larger 
proportion of the BrdU-labeled cells was detected in R1 and this was at the expense of labeled cells in 
R2 (Fig. 3C,D). Following one pulse of BrdU at E14.5 and analysis 24 hours later showed that roughly 
a quarter of the BrdU-positive nuclei in control mice were located in R1 whereas in RAbKO mice, only 
very few BrdU-positive cells were found in R1 (Fig. 3E,F). In contrast, significantly more BrdU-positive 
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cells were present in R2 in the RAbKO mutants (Fig. 3E,F). This nuclear localization phenotype was 
also observed when BrdU was injected at E16.5 and mice were analyzed at E17.5 (Fig. 3G).  
 Moreover, the total number of BrdU-positive cells per ventricular surface length was reduced in 
RAbKO mice at E17.5 but was not changed at E15.5 and E19.5 (Fig. 3H). Thus, labeling of cells in S-
phase by one pulse of BrdU at E16.5 results in fewer BrdU-positive cells 24 hours later. To address 
the proportion of cortical cells within the cell cycle, we also performed cumulative labeling of cells by 
repetitive administration of BrdU for up to 12 hours (Fig. S4). Analysis of mice at E15.5 showed that 
more than 50% of the cortical cells were BrdU-positive after 8 hours of cumulative labeling (Fig. S4) 
and there was no significant difference in the labeling index (number of BrdU-positive cells/total cell 
number) between control and RAbKO mice (Fig. 3I; Fig. S4). When the same cumulative labeling 
studies were performed at E17.5, only approximately 8% of the cells incorporated BrdU after 8 hours, 
consistent with the view that peak neurogenesis occurs at E15.5 and decreases thereafter. Also at 
E17.5, the relative labeling index of BrdU-positive cells was the same in RAbKO and control mice (Fig. 
3I). Since after a 24 hour BrdU pulse, E17.5 RAbKO mice have approximately 15% fewer BrdU-
positive cells, it is possible that labeling during one cell cycle is not sufficient to obtain a detectable 
difference in the number of cumulatively labeled cells. The finding that fewer cells entered the S-phase 
at E16.5 in the RAbKO mice (Fig. 3H) indicates that the cell number reduction occurs in a narrow time 
window between E15.5 and E17.5 and is due, at least in part, to defects in proliferation. 
 
Loss of Raptor affects neurosphere formation and growth 
Neurosphere formation and maintenance is a surrogate assay for neural stem cells (Reynolds and 
Weiss, 1996). Thus, we isolated and cultured spherogenic neural stem/progenitor cells from the 
telencephalon of P0 mice. The number of secondary neurospheres generated from RAbKO and 
control animals was similar (control: 10.9 ± 3.04; RAbKO: 12.7 ± 5.29; N ≥ 15; p > 0.05), whereas the 
size of RAbKO-derived neurospheres was strongly reduced (Fig. 3J,K). Compared to control cultures, 
the size distribution in RAbKO spheres was shifted towards smaller diameters (p < 1.384 x 10-12; 
Wilcoxon two sample test). Thus, spherogenic stem cells seemed not to be affected by loss of raptor 
but the proliferative capacity of cells within the neurospheres was decreased. Interestingly, a similar 
proliferation defect was reported for embryonic stem cells deficient for raptor or mTOR (Gangloff et al., 
2004; Guertin et al., 2006; Murakami et al., 2004).  
 
Cell cycle exit and proliferation are reduced in raptor-deficient neural progenitor cells 
The changes in tempospatial distribution of progenitor cells and the reduction of cells in S-phase 
indicated potential defects in specific periods of the cell cycle. Therefore, we addressed whether loss 
of raptor affected cell cycle exit of progenitors. We administered BrdU to pregnant mice at E14.5, 
E16.5 or E18.5 of gestation and examined progenitor cell cycle exit by co-staining for BrdU and Ki67 
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24 hours later (Fig. 4A,B). The proportion of BrdU-positive progenitors that exited the cell cycle (i.e. 
became Ki67 negative) was not affected at E15.5 but was reduced by approximately 50% in E17.5 
and E19.5 RAbKO cortices (Fig. 4A,B). Hence, precursor cells in the cortex of RAbKO mice in late 
embryonic development remain longer in the cell cycle. We also examined cells in mitosis by 
immunostaining for phosphorylated histone 3 (PH3). The number of PH3-positive cells was not 
changed in the cortex of E15.5 RAbKO mice (Fig. 4D) but there was a significant reduction at E17.5 
(Fig. 4C,D). These data suggested that a prolongation of the cell cycle time and delayed cell cycle exit 
affect brain size in RAbKO mice.  
 Because the above data can also be interpreted as a sign for changes in the differentiation of 
neural precursors, we then determined the number of Sox2-positive neural progenitors and Tbr2-
positive basal progenitors in the cortex of control and RAbKO mice. Both, the number of Sox2-positive 
cells and the number of Tbr2-positive cells when determined above a specific ventricular surface area 
were reduced in RAbKO mice at E17.5 but were not changed at E15.5 (Fig. 4E-G). Consistent with 
our finding that the total cell number is already reduced at E17.5 (Fig. 1G), we calculated the number 
of Sox2- and Tbr2-positive cells relative to the total cell number and found a significant reduction of 
Sox2 progenitors but only a trend to reduced Tbr2 cell numbers (Fig. 4H). Therefore, these findings 
together support a reduced expansion of the Sox2 progenitor pool due to a prolonged cell cycle and 
exclude a precocious differentiation to Tbr2-positive, committed basal progenitors in RAbKO mice. 
 During cortical development, radial glial cells are highly polarized and possess specialized apical 
endfeet that form the lining of the ventricle and basal processes stretching to the pial surface. The 
apical cell surface of the radial glial cells contains important fate determinants. Loss of cell polarity or 
detachment from the apical membrane following mitosis results in proliferation defects (Loulier et al., 
2009). We therefore examined the structure of radial glial cells in the cortex of RAbKO embryos. Like 
in control embryos, radial glia in the ventricular zone of RAbKO mutants showed a continuous and 
apical staining for the adhesion complex protein β-catenin (Fig. 4I) and for F-actin at E15.5 and E17.5 
(Fig. S5). Moreover, the radial glia morphology appeared normal following immunostaining for nestin 
(Fig. S5). Thus, a disturbed radial glial morphology and polarity cannot explain the observed changes 
in progenitor proliferation and differentiation in the cortex of RAbKO brains. 
 
Effect of raptor deficiency on cortical layering  
Cortical precursor proliferation, differentiation and migration of neurons are intimately linked (Gotz and 
Huttner, 2005). We examined the production of differentiated cells in the cortical plate from E12.5 and 
E14.5 progenitors by BrdU label and chase experiments. When progenitors were labeled at E12.5, no 
differences in BrdU-labeled progeny in the cortical plate at E19.5 could be observed and BrdU-labeled 
cells were distributed throughout all cortical layers in both genotypes (Fig. 5A). However, when labeled 
at E14.5, cortical progenitor derived cells showed a different cellular distribution in RAbKO mice 
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compared to controls at E19.5. Whereas in control mice most BrdU-positive cells populated the upper 
cortical plate (Fig. 5B), the labeled cells in RAbKO mice remained concentrated in the ventricular 
zone/subventricular zone/intermediate zone (VZ/SVZ/IZ) and fewer cells reached the cortical plate 
(Fig. 5B). As a consequence, the ratio between BrdU-positive cells in the cortical plate and in the 
VZ/SVZ/IZ was significantly reduced in RAbKO mice (Fig. 5C). Therefore, fewer cells generated after 
E14.5 reached the cortical plate in RAbKO mice but were in a location more reminiscent of less 
mature cells. These data are in agreement with a previous study showing that rapamycin does not 
interfere with preplate splitting and early cortical plate formation (Jossin and Goffinet, 2007).  
 Despite the change in size and proliferation, the gross organization of cells within the cortex of 
RAbKO mice seemed normal at E19.5 (Fig. 5D). In addition, NeuN-positive neurons were present in 
the cortex and the subplate appeared to have been normally formed (Fig. 5E). However, Map2 
staining (a dendritic marker) revealed that although preplate splitting and subplate formation was 
normal in RAbKO mice (Fig. 5F), expression was weak compared to controls indicative of a reduction 
of neuropil or a decrease in the number of neurons in the cortical plate of raptor-deficient mice. To test 
whether the low Map2 signal in RAbKO cortex was the consequence of a reduced dendritic 
complexity, we also examined neurite outgrowth in raptor-deficient neurons in vitro. We deleted rptor 
from E16.5 primary hippocampal neurons of floxed raptor mice after 4 days in vitro by transfection with 
a Cre-expression vector. Transfected neurons were visualized by co-transfection with a GFP-
expressing vector (Fig. 5G). Sholl blot analysis 10 days post transfection showed a significant 
decrease in the complexity of the neurites compared to control-transfected neurons (Fig. 5G,H). These 
results are also in agreement with previous work using rapamycin or RNAi against mTOR (Jaworski et 
al., 2005; Kumar et al., 2005). Thus, the decreased Map2 staining in cortical sections of RAbKO mice 
could have been due to a reduction in the neuronal complexity. 
 
Effect of raptor deficiency on hippocampal layering  
In contrast to the normal layering of the cortex, layering of the hippocampus was altered in RAbKO 
mice. At E19.5, the CA regions and the dentate gyrus were less structured in RAbKO mice (Fig. 6A, 
1st row). Map2 staining was reduced in the cortical plate and in the hippocampus of E19.5 RAbKO 
mice (Fig. 6A, 2nd row, left) and this difference was already obvious at E15.5 (Fig. 6A, 2nd row, right). 
Because cell density is not changed in E15.5 RAbKO cortices this indicates a defect in neurite 
elaboration. Examination of neuronal layer formation revealed that NeuN-positive neurons in the CA 
regions of the hippocampus did not form a proper pyramidal layer in RAbKO mice (Fig. 6A, 3rd row, 
open arrowhead).  In the dentate gyrus, which contains a secondary proliferation zone distinct from 
the VZ, neurons did not form the C-shaped structure in the hilus (Fig. 6A, arrow) and did not show the 
initial signs of a granule cell layer (Fig. 6A, asterisk). These changes were not observed in E15.5 
RAbKO brains. We also analyzed the formation of hippocampal layering by BrdU label and chase 
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experiments of E14.5 progenitors. At E19.5, BrdU-labeled progenitors were still near or within the VZ 
in RAbKO mice (Fig. 6C) whereas in control mice those progenitors were integrated into the pyramidal 
cell layer. These results show that mTORC1 strongly contributes to the formation of a pyramidal layer 
in the CA regions and to a defined granule cell layer in the dentate gyrus. 
 
Glial differentiation is impaired in raptor-deficient brains 
mTORC1 is important for neural stem/progenitor cell differentiation into neurons and glia (Han et al., 
2008; Rajan et al., 2003; Wang et al., 2008). Thus, we analyzed the expression of neuronal and glial 
proteins in the brains of E19.5 control and RAbKO mice by Western blot analysis. We did not detect 
significant changes in the expression of the neuron-specific isoform β-tubulinIII, or GAD65/67, a 
marker for a subpopulation of inhibitory interneurons (Zhu et al., 1999), or brain lipid-binding protein 
(BLBP), a radial glia marker reflecting the number of neuronal precursors (Hartfuss et al., 2001) (Fig. 
7A). In contrast, the astrocytic marker glial fibrillary acidic protein (GFAP) was strongly reduced in 
RAbKO brain lysates (Fig. 7A; Table S1). In newborn mice, when GFAP+ cells start to populate the 
brain (Sancho-Tello et al., 1995; Shu et al., 2003), GFAP immunostaining in RAbKO brains was 
weaker compared to controls in the granule cell layer of the dentate gyrus and in the midline glial 
stuctures: the indusium griseum glia, the midline zipper glia and the glial wedge (Fig. 7B). Although 
apoptosis was increased in the hippocampus of RAbKO mice at E19.5, the cells positive for Caspase 
3 were not GFAP-positive (Fig. 7C). We also examined expression of S100β, a marker of postmitotic 
astrocytes. RAbKO mice showed a trend to have fewer S100β-positive cells but this was not 
significant (Fig. S6). In summary, these results indicate that mTORC1 is also important for the 
generation of glial cells. 
 mTOR signaling has been linked to glial differentiation via its ability to phosphorylate Stat3 (Rajan 
et al., 2003; Yokogami et al., 2000), which regulates astrocyte development (Bonni et al., 1997; Johe 
et al., 1996). Hence, Stat3 could provide a potential explanation on how glial differentiation is 
regulated by mTORC1. Thus, we studied the expression and phosphorylation state of Stat3 in brain 
lysates of newborn RAbKO mice. Indeed, the level of Stat3 protein as well as its phosphorylation was 
decreased in RAbKO compared to control mice (Fig. 7D; Table S1). This result suggests that failure of 
mTORC1-mediated activation of Stat3 may be the cause for the decrease in GFAP-positive cells. 
 We addressed whether the reduction in GFAP expression in RAbKO mice was due to a reduced 
ability for RAbKO progenitors to differentiate into the astroglial lineage. Thus, we induced 
differentiation in dissociated neurosphere cultures from RAbKO and control mice. Whereas the 
number of β-tubulinIII neurons was not changed, the number of GFAP-positive cells was much lower 
in 5 day old cultures of RAbKO mice (Fig. 7E,F). In addition, Western blot analysis confirmed that 
GFAP levels were lower in RAbKO-derived cell cultures (Fig. 7G). 
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To examine whether the changes in glial differentiation were due to inherent differences in the stem 
cell pool of RAbKO mice, we ablated raptor from neural stem cells, derived from heterozygously or 
homozygously floxed rptor mice in culture by using a Cre-expressing adenovirus. This acute removal 
of raptor also resulted in fewer GFAP-positive cells (Fig. S7A,B). In addition, an increase in the 
number of β-tubulinIII-positive immature neurons was observed (Fig. S7A,B). Western blot analysis of 
such cultures showed that the state of phosphorylation of Stat3 was lower in RAbKO-derived neural 
progenitors (Fig. S7D) as was also observed in brain lysates. In conclusion, these results indicate that 
mTORC1 is important for the proper differentiation of neural progenitor cells into the glial lineage and 
that this function is mediated by activation of the Stat3 pathway.  
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DISCUSSION 
Raptor is required for CNS development 
We addressed the role of raptor in brain development by conditional inactivation of rptor in nestin-
expressing progenitor cells, which is known to be expressed as early as E10.5 (Graus-Porta et al., 
2001). Consistent with the concept that mTORC1 controls organismal size as shown in other species 
(Long et al., 2002; Oldham et al., 2000), RAbKO mice show microcephaly and die shortly after birth 
with signs of cyanosis. In agreement, rapamycin treatment of developing embryos revealed that 
mTOR is essential for the development of the telencephalon and the survival after midgestation 
(Hentges et al., 2001). Thus, the prolonged survival of RAbKO mice compared to rapamycin-treated 
embryos suggests that rapamycin-treated embryos may die due to mTORC1 inhibition in non-CNS 
cells and /or to loss of activity of both mTOR complexes. 
 
Raptor regulates progenitor cell proliferation in the telencephalon and affects survival 
Inactivating rptor in neural progenitors caused aberrations in the cell cycle and in cell differentiation 
that resulted in the thinning of the telencephalic cortex and in a reduced brain size. Although 
differences in brain size and cellularity of the cortex were not obvious before peak neurogenesis at 
E15.5, during late embryonic and early postnatal stages the number of progenitors and differentiated 
cells was strongly reduced in RAbKO mice. These data are in agreement with slice culture studies 
where rapamycin had no effect on preplate splitting and the layering of the early cortical plate (Jossin 
and Goffinet, 2007). The RAbKO phenotype corresponded with a slowing of the cell cycle, supporting 
the described role for mTORC1 in cell cycle regulation (Ramirez-Valle et al., 2010). We also provide 
evidence for a cell autonomous effect of raptor on proliferation by showing that raptor-deficient 
stem/progenitor cells in neuroshpere cultures are able to be maintained but generate smaller clones. 
This reduction in neurosphere size but not number is probably a reflection of mitotic expansion within 
the cultures. Hence, we propose that raptor controls neural progenitor proliferation and loss of raptor 
results in an extended cell cycle. Our cumulative BrdU labeling experiments also indicate a trend 
towards a lengthening of the cell cycle. We think that small differences in cell cycle length might not be 
detectable by cumulative BrdU labeling because small aberrations in proliferative cell number might 
have to add up to a cumulative effect that becomes only significant when a higher proportion of cells is 
lost. This might only be the case after more than one cell cycle which is also supported by our data. 
Progenitor cell cycle and differentiation are interconnected in the developing nervous system (Calegari 
and Huttner, 2003). Interestingly, extension of the cell cycle, particularly G1 is often associated with 
differentiation. Recent evidence suggests that proliferation depends on mTORC1-mediated activation 
of 4E-BP proteins (Dowling et al., 2010). However, raptor-deficient neural progenitors show not only a 
longer cell cycle time but also reduced differentiation. The effect of raptor on differentiation of 
neurosphere cells into neurons in vitro was less apparent and rather the formation of astroglia was 
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affected. It will be interesting to establish the exact mechanism of raptor function in cell cycle 
progression and to determine whether raptor and mTORC1 are required in a separate differentiation 
mechanism in vivo. 
 Our work also provides evidence that mTORC1 function is important to warrant survival of cells at 
late stages of embryonic development as we observed a substantial extent of apoptosis at E19.5. 
These apoptotic events may also contribute to the small size of the brains in RAbKO mice at birth. The 
apoptotic cells were positive for the neuronal marker NeuN but not for GFAP, indicating that this 
process affects mostly neuronal cells and not glia. However, we do not know if prevention of apoptosis 
is a cell autonomous function of mTORC1 or a consequence of a failure of neurons to connect to their 
targets. Indeed, cultured neurons that lack raptor show deficits in neurite outgrowth.  
  
Raptor promotes gliogenesis by regulating the Jak-Stat signaling pathway 
It is possible that raptor is responsible for maintaining neural progenitors in a multipotent state through 
regulation of the Jak/Stat pathway. We found a reduction in early populations of GFAP-positive cells in 
RAbKO brains suggesting that glial differentiation was affected in vivo. The Jak-Stat pathway controls 
astrocytic differentiation (Bonni et al., 1997; Johe et al., 1996) and mTORC1 has been implicated in 
this Stat3-dependent function (Rajan et al., 2003; Wang et al., 2008). Phosphorylation of Stat3 at 
Ser727 is rapamycin-sensitive and phosphorylation of Stat3 at Tyr705 and Ser727 is essential for 
maximal activation (Wen et al., 1995; Yokogami et al., 2000). We show that Stat3 phosphorylation is 
strongly reduced in the brains of RAbKO mice. The reduced phosphorylation likely results in the 
reduced amounts of Stat3 protein that we also observed (He et al., 2005). Interestingly, deletion of the 
mTORC1 inhibitor TSC, a model for the genetic disease tuberous sclerosis in humans, increased 
Stat3 phosphorylation and GFAP expression (Onda et al., 2002). 
 
mTORC1 pathway is a key controller of neural development and brain size  
mTORC1 can be activated by Akt3/PKBγ. The role of raptor in controlling brain size was similar to the 
function described for the mTORC1-upstream molecule Akt3/PKBγ (Easton et al., 2005; Tschopp et 
al., 2005). As in RAbKO mice, cell number was reduced in the brains of Akt3/PKBγ -deficient mice 
(Tschopp et al., 2005). Together, these findings suggest that Akt3/PKBγ acts through mTORC1 during 
brain development. On the other hand S6K, one of the main targets of mTORC1 has been shown to 
affect cell size when deleted in vivo (Montagne et al., 1999; Shima et al., 1998). The lack of 
phosphorylation of S6K in the RAbKO brains likely affects cell size resulting in an increase in cell 
density and reduced complexity of the raptor-deficient neurons.  
 Deletion of mTORC1 causes a more severe phenotype than deletion of its upstream activator 
Rheb1. Rheb1 and not Rheb2 is the upstream GTPase responsible for the activation of mTORC1 (Zou 
et al., 2011). Mice in which Rheb1 was ablated from neural progenitors (using the same nestin-Cre 
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driver that we used to delete rptor) did not die and their brains were not smaller than controls at birth. 
However, postnatal brain size and myelination was strongly affected later and the mice died at 5 to 6 
weeks of age. Hence, deletion of rptor and inactivation of mTORC1 causes a more severe phenotype 
than deletion of Rheb1 suggesting the existence of either a functional redundancy in the GTPases that 
activate mTORC1 during brain development, or of alternative pathways that can activate mTORC1 in 
neural progenitors independent of Rheb1. In this context it is interesting that phosphorylation of Akt at 
serine 473 was increased in Rheb1-deficient mice as it is in RAbKO mice. These data show that in 
both mice mTORC1 activity is diminished and that the absence of the S6K-mediated feedback 
inhibition and/or an increase in mTORC2 activity is responsible for the increased phosphorylation of 
Akt at serine 473. Consistent with the notion that mTORC2 activity is increased, we also observed 
increased phosphorylation of mTOR at the mTORC2-specific site serine 2481. 
 
Role of mTORC1 in hippocampal layering 
Ablation of mTORC1 may affect granule cell migration in the dentate gyrus by affecting glial 
differentiation. In our mouse model, the malformation of the granule cell layer coincides with a 
generally decreased GFAP signal in the dentate gyrus. The glial scaffold in the dentate gyrus starts to 
express GFAP during late embryonic development (Forster et al., 2002; Rickmann et al., 1987). 
Granule cell migration originates from the hilus of the dentate gyrus and involves a highly organized 
glial network. A decrease in the organization of this scaffold causes malformations of the granule cell 
layer (Zhao et al., 2004). In addition, elongation and organization of glia in the dentate gyrus was 
reported to depend on reelin and some of its functions are rapamycin sensitive (Jossin and Goffinet, 
2007). In raptor-deficient hippocampi, both, the developing granule cell layer of the dentate gyrus and 
the pyramidal cell layer of the CA regions were perturbed, which also correlated with an impaired, 
Stat3-dependent glial differentiation.  
 
Concluding remarks 
Our data show that mTORC1 is crucial for normal brain growth and postnatal survival. Several aspects 
of brain development are affected by ablation of mTORC1 function and may in sum be responsible for 
the death of the newborn mice. Regulation of cell morphology (size) and division, which are both 
affected in RAbKO mice, are processes that are well known to be associated with mTORC1 signaling. 
Our data also strongly indicate that Stat3 is an important downstream target of mTORC1 that is 
required for normal differentiation of precursor cells into GFAP-positive glia. In summary, the multiple 
phenotypes of RAbKO mice described here show that mTORC1 has a central role in the integration of 
the inputs from several signaling pathways and that it activates various downstream effectors. 
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Figure 1 
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Fig. 1. Nestin-Cre-mediated deletion of rptor causes microcephaly and perinatal death. 
(A) Western blot analysis for the indicated proteins with whole brain lysates of E19.5 control and 
RAbKO mice. The presence of remaining raptor protein is probably due to meninges and blood 
vessels, which both do not express Cre in our mouse model (see Graus-Porta et al., 2001). 
(B) Photographs of newborn control and RAbKO mice (top) and body weight of E19.5 mice (bottom). 
(C) The brain from E19.5 RAbKO mice is considerably smaller (top) and weighs less (bottom). 
(D) Relative DNA amount per brain (top) and relative DNA amount per gram wet weight (bottom). Note 
that the DNA amount per brain in RAbKO mice is lower, indicative of lower number of cells whereas 
the DNA/g weight is increased indicative of a higher cell density. 
(E) Cresyl violet-stained sections of E19.5 control and RAbKO brains at different levels in the rostro-
caudal axis. 
(F) Cresyl violet-stained sections at E15.5 (top) and E17.5 (bottom). Note, that the brain of RAbKO 
mice is smaller at E17.5. 
(G) Quantification of the cell number in the cortex of control and RAbKO mice as measured in Hoechst 
staining. 
Bars in B, C, D represent means ± standard deviation; bar in G represents ± sem; number in the bars 
are the number of animals measured. Black bars: control; grey bars: heterozygous RAbKO; open 
bars: RAbKO mice. p-values (two-tailed t-Test) are: *** p < 0.001; * p < 0.05; ns p > 0.05. Scale bars: 
(E) and (F) = 1 mm. 
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Figure 2 
 
 
Fig. 2.  Loss of raptor leads to increased cell death during late brain development. 
(A) Examination of apoptosis at different developmental time points by staining for cleaved Caspase3 
(red) in conjunction with antibodies to β-tubulin III (Tuj1; green) and DAPI (blue). While no or only little 
apoptotic nuclei were detected at E15.5 and E17.5, RAbKO mice show a strong increase of apoptosis 
at E19.5 (white arrows). Yellow arrows indicate background staining in blood vessels. 
(B) Most of those apoptotic nuclei at E19.5 are also positive for the neuronal maker NeuN (arrows). 
(C) Histograms represent mean ± standard deviation using at least 3 animals for each genotype. p-
values (from two-tailed t-Test); * p < 0.05. Scale bars = 50 µm. 
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Figure 3 
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Fig. 3. Depletion of raptor alters location and number of proliferating precursor cells. 
Regions used for counting proliferating cells are indicated in the picture as R1 to R3 and are explained 
in Fig.S3. Sections were stained for BrdU (green in A,C; red in E, G) and DAPI (blue). Developmental 
time points are indicated in the picture. 
(A, B) Mice were sacrificed three hours after BrdU injection. There is no significant difference in the 
number of BrdU+ cells in R1 to R3. 
(C, D) Mice were sacrificed twelve hours after BrdU injection. The number of BrdU+ cells in the 
RAbKO mice is increased in R1 but decreased in R2. 
(E, F) Mice were sacrificed 24 hours after BrdU injection.  RAbKO mice had almost no BrdU+ cells in 
R1 (asterisk) but most in R2. 
(G) Injection of BrdU at E16.5 and analysis at E17.5. Note that RAbKO mice do not have many BrdU+ 
cells in the deepest layer, corresponding to R1 (asterisk). 
(H) Quantification of BrdU+ cells in comparable cortex regions normalized to ventricular surface 
length. 
(I) Percentage of BrdU+ cells per total cell number in comparable cortex sections. Mice were sacrificed 
after 8 hours of cumulative BrdU injections that were given every 2 hours. 
(J) Micrographs of secondary neurospheres derived from E19.5 brains. Note the pronounced 
difference in size. 
(K) Distribution of the diameters of secondary neurospheres derived from control (black) or RAbKO 
(white) brain. Size distribution of RAbKO neurospheres is shifted to the left. Inset: box plot of the 
median size of the neurospheres. N = 100 (control) or 91 (RAbKO) Neurospheres. 
Bars in B, D, F, H, I represent means ± standard deviation. For each experiment, at least 3 mice per 
genotype were analyzed. p-values (from two-tailed t-Test) are: n.s. p > 0.05*; p < 0.05, ** p < 0.01. 
Scale bars = 100 μm. Black bars: control; open bars: RAbKO mice. 
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Figure 4 
 
 
Fig. 4. Deficiency for raptor in the brain causes aberrant cell cycle exit and leads to decreased 
progenitor cell number. 
(A) Staining of brain sections for BrdU and Ki67 at indicated time points. 
(B) Quantification of BrdU+/Ki67- as percentage of all BrdU+ cells (cell cycle exit index). Note that at 
E17.5 viewer cells leave the cell cycle. 
(C) Analysis of mitosis at E17.5 by staining for PH3 and 
(D) corresponding quantification of mitotic nuclei at E15.5 and E17.5. 
(E) Staining of E17.5 brain sections with antibodies to Sox2 or (F) Tbr2. 
(G) Quantification of the number of Sox2+ and Tbr2+ cells per ventricular surface length at E17.5. 
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(H) Quantification of the number of Sox2+ and Tbr2+ cells per total cell number. (I) Staining for β-
catenin in the ventricular zone of cortical sections from E15.5 and E17.5 control and RAbKO mice. 
Error bars in B and H represent means ± STDV, bars in D and G represents ± sem. For each 
experiment, at least 3 mice per genotype were analyzed. p-values (from two-tailed t-Test) are: * p < 
0.05, ** p < 0.01. Scale bars in A, C and E = 100 μm. Scale bar in H = 20 μm. Black bars: control; 
open bars: RAbKO mice. 
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Figure 5 
 
 
Fig. 5. RAbKO mice show changes in the localization of late generated neurons without 
affecting overall cortical layering. 
(A, B) BrdU was injected into pregnant dams at E12.5 (A) or at E14.5 (B) of embryonic development 
and brain sections were prepared from E19.5 embryos. BrdU (red)/DAPI (blue) staining shows a 
difference in the distribution of BrdU-labeled cells when labeled at E14.5 but not at E12.5. Note, that 
viewer cells reach the CP. 
(C) Quantification of the distribution of BrdU-labeled cells in the cortex of mice in which BrdU was 
administered at E14.5. Results are presented as the ratio between the number of BrdU+ cells 
localized to the CP and those remaining in the VZ/SVZ/IZ. 
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(D) Cortical sections of E19.5 control and RAbKO mice stained with cresyl violet. Abbreviations: MZ: 
marginal zone; CP: cortical plate; SP: subplate; IZ: intermediate zone; SVZ: subventricular zone; VZ: 
ventricular zone. 
(E) Cortical sections of E19.5 control and RAbKO mice stained with antibodies to NeuN (red) and (F) 
Map2 (green) and Hoechst (blue). 
(G) Confocal picture of cultured hippocampal neurons isolated from rptorfl/fl mice that were transfected 
with control plasmid (control) or a Cre-expressing construct (Cre). To visualize the transfected 
neurons, cells were co-transfected with a GFP-expression plasmid. Neurons were transfected at DIV 4 
and analyzed at DIV 14. 
(H) Sholl analysis of Cre-expressing and control neurons. 
Sample number N in (C) is 5 mice per genotype. Number of samples in (H) is 5 control mice and 4 
RAbKO mice. p-values (from two-tailed t-Test): * p < 0.05. Error bar in C represents mean ± STDV, 
error bar in H represents confidence intervals. Scale bar in (A, B, D-F) = 100 µm. Scale bar in (G) = 50 
μm. 
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Figure 6 
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Fig. 6. RAbKO mice display defects in hippocampal layering. 
(A) Sections from E19.5 hippocampi with indicated stainings. RAbKO mice show a deficit in the CA 
region and the dentate gyrus (DG). Map2 (green) and DAPI (blue) stainings reveal changes in 
hippocampus and cortical plate (CP). NeuN+ neurons (red) accumulate in the hilus (asterisk) and do 
not form a distinct granular cell layer (arrow) in RAbKO mice. Note that staining for NeuN in the 
pyramidal layer (open arrowhead) is also missing in RAbKO mice. 
(B) Hippocampal sections of E15.5 embryos. There is no large difference in cresyl violet-stained 
sections between genotypes. The subplate neuron-specific staining visualized with antibodies to Map2 
(green) fades off before it reaches the hippocampus (arrowhead). Neuron specific staining (visualized 
by NeuN) is normal in the dentate gyrus of E15.5 RAbKO brains. 
(C) Hippocampal sections from E19.5 embryos that were labeled at E14.5 with BrdU (red). BrdU-
labeled cells are more broadly distributed in RAbKO mice (arrow). Scale bars = 200 µm.  
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Figure 7 
 
 
Fig. 7. Astrocytic differentiation is impaired in RAbKO brains. 
(A) Western blot analysis of E19.5 brain lysates probed for indicated markers of neural development. 
(B) Upper part: Cresyl violet stainings of brain sections from E19.5 mice. Red boxes represent regions 
shown below: Sections of dentate gyrus and midline glial structure regions stained with antibody to 
GFAP (red) and DAPI (blue). 
IGG: indusium griseum glia; MZG: midline zipper glia; GW: glial wedge. 
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(C) Analysis of apoptotic cells in E19.5 hippocampus of RAbKO mice stained for GFAP (red) and 
Caspase 3 (green). Note that the apoptotic cells are not GFAP+. The white frame indicates the 
magnified inset. 
(D) Western blot analysis of E19.5 brain lysates probed for Stat3 and its phosphorylated forms. 
(E) Cells from dissociated neurospheres that have differentiated for 5 days. Cells were stained with 
antibodies against β-tubulin III (red), GFAP (green) and with DAPI (blue). There are fewer GFAP+ 
cells in RAbKO cultures whereas the number of β-tubulin III+ cells is the same. 
(F) Relative number of neurons (left) and astrocytes (right) derived from neurospheres from control or 
RAbKO mice. Bars represent mean ± standard deviation. N = 3 independent experiments. 
(G) Western blot analysis of lysates from cultures grown under the same conditions as in (E) probed 
with antibodies against the proteins indicated. 
Bars represent means ± standard deviation. p-values (from t-Test): * p < 0.05. Scale bars: (B, C) = 
200 µm, (E) = 100 µm.  
 
 
 
 
 
 
 
 
Table 1 
 
Table 1. Number and percentage of E19.5 
embryos or newborns of indicated genotype.  
 rptorfll+ or 
rptorfl/fl  
rptorfll+; 
nestin-Cre 
rptorfl/fl; 
nestin-Cre 
Number per  
genotype 
56 27 24 
Percentage  
of total 
52.3 25.2 22.4 
Genotyping reveals that RAbKO mice are born with 
the expected Mendelian frequency. 
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Supplementary Figure S1 
 
 
Fig. S1. Generation of CNS-specific raptor knockout mice. 
(A) Schematic representation of the wild-type (rptor floxed) and after (rptor ko) recombination. Position 
of PCR primers P1, P2 and P3 used in (B) are indicated. 
(B) PCR analysis of genomic DNA isolated from brains or the tails of newborn control (rptorfl/fl) and 
RAbKO (rptorfl/fl;nestin-Cre) mice. PCR using primers within the rictor allele served as control. 
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Supplementary Figure S2 
 
 
Fig. S2. Neuromuscular junctions are properly formed in RAbKO mice. 
Micrographs of whole-mount preparations of diaphragms of E19.5 control (upper panels) and RAbKO 
(lower panels) mice stained with neurofilament antibody (green) and α-bungarotoxin (red). 
Scale bar = 50 µm. 
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Supplementary Figure S3 
 
 
Fig. S3. Staining of E15.5 cortical sections from control and RAbKO mice with antibodies to 
BrdU, Sox2 and Tbr2. 
Region R1 spanned the most apical part of the ventricular zone (VZ) and was defined by the exclusive 
presence of Sox2-positive (Sox+) but Tbr2-negative (Tbr2-) cells. Region R2 harbored the basal VZ 
and the sub-ventricular zone (SVZ) containing all Tbr2+ cells (but also Sox2+ cells). Finally, region R3 
covered the intermediate zone (IZ) and the cortical plate (CP) and was defined by the absence of both 
Sox2+ and Tbr2+ cells. 
Abbreviations are: VZ: ventricular zone; SVZ: subventricular zone; IZ: intermediate zone; CP: cortical 
plate. Scale bar = 100 mm. 
 
 
Supplementary Figure S4 
 
 
Fig. S4. Labeling index. 
Labeling index in E15.5 control and RAbKO embryos as defined by the number of BrdU positive cells 
per total cell number. BrdU was cummulatively injected for 3, 8 and 12 hours. After 8 hours 50 % of 
the cells are BrdU positive. There is no significant difference in the number of BrdU positive cells per 
total cell number. Data represent mean +- sem. p > 0.05, N = 3 mice per genotype and time point. 
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Supplementary Figure S5 
 
 
Fig. S5. Analysis of the morphology and attachment of radial glia in E15.5 RAbKO mice. 
(A) Staining for Nestin in cortical sections of E15.5 control and RAbKO mice. 
(B) Staining of actin filaments with Phalloidin in cortical sections of E15.5 control and RAbKO mice. 
 
 
 
 
 
Supplementary Figure S6 
 
 
Fig. S6. Determination of S100β-positive cells in E19.5 RAbKO cortex. 
(A) Cortical sections of E19.5 control and RAbKO  mice stained for S100β (green) and Hoechst (blue). 
White arrows indicate S100β-positive cells, yellow arrows indicate blood vessels. 
(B) Quantification of S100β-positive cells in the two genotypes. Although viewer S100β-positive cells 
were detected in RAbKO mice, the difference was not significant. p > 0.05, N = 3 mice. Scale bar  = 
100 µm. 
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Supplementary Figure S7 
 
 
Fig. S7. Analysis of differentiation in E19.5 rptorfl/+ and rptorfl/fl neurospheres transduced with 
Cre-expressing adenoviruses. 
(A) Micrographs of neurosphere-derived cells after differentiation. Dissociated cells from the spheres 
were transduced at a density of 106 cells/ml and at an MOI of 500 for 1 hour and then plated. After 5 
days, cultures were stained with anti-β-tubulin III antibody (red), anti-GFAP antibody (green) and DAPI 
(blue). 
(B) Quantification of the fraction of neurons (upper panel) and astrocytes (lower panel) in percent of 
control. Bars represent mean ± standard deviation. 
(C) Western blot analysis of lysates from cultures grown under the same conditions as in (A) probed 
for the indicated marker proteins. 
(D) Western blot analysis of lysates from RAbKO and control cultures with antibodies against the 
proteins indicated. 
Sample number in (B) are 4 (control) and 4 (RAbKO). p-values (from t-Test): * p < 0.05, ** p < 0.01. 
Scale bar = 100 µm. 
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MATERIALS AND METHODS 
Brain-specific rptor knockout mice 
Mice that lack mTORC1 in the brain were generated by crossing mice in which exon 6 of the gene 
encoding raptor (rptor) was flanked by loxP sites (Bentzinger et al., 2008)  with mice that express Cre 
under control of the central nervous system (CNS) stem cell-specific enhancer of the nestin promoter 
(Bentzinger et al., 2008; Graus-Porta et al., 2001; Tronche et al., 1999; Zimmerman et al., 1994). In 
the resulting rptorfl/fl; nestin-Cre (herein called RAbKO for raptor brain knockout) mice, Cre-mediated 
recombination induces a frame shift that causes a precocious stop of translation (Fig. S1A). Time 
matings were made and E15.5, E17.5 and E19.5 embryos or newborns were taken for analysis. 
Genotyping was performed on tail or brain lysates using primers depicted in Fig. S1A. P1: 5'-ATG GTA 
GCA GGC ACA CTC TTC ATG; P2: 5'-GCT AAA CAT TCA GTC CCT AAT C; P3: 5'-CAG ATT CAA 
GCA TGT CCT AAG C; Cre-forward: 5'-TGT GGC TGA TGA TCC GAA TA; Cre-backward: 5'-GCT 
TGC ATG ATC TCC GGT AT. Mice that were heterozygous or homozygous for the floxed rptor allele 
and were negative for Cre were used as control. 
 
Antibodies 
The following rabbit polyclonal antibodies were used: mTOR, S6 Ribosomal Protein, P-S6 Ribosomal 
Protein (Ser235/236), P-mTOR (Ser2448), P-mTOR (2481), Akt, P-Stat3 (Ser727), cleaved Caspase 
3, from Cell Signaling; BLBP and Map2 from Chemicon; GAD65/67 and neurofilament from Sigma; Ki-
67 from Novocastra; and Tbr2 from Abcam. Rabbit monoclonal antibodies were as follows: raptor, 
rictor, P-Akt (Ser473), P-Stat3 (Tyr705) and β-actin from Cell Signaling. Mouse monoclonal antibodies 
were as follows: Stat3 from Cell Signaling; NeuN and GFAP from Chemicon; β-Tubulin III (also called 
Tuj1) from Sigma. Goat polyclonal antibodies to Sox2 were from Santa Cruz. Rat monoclonal 
antibodies to BrdU were from AbD Serotec.  
 
Brain lysates for Western blots 
Brains were dissected, washed in ice-cold PBS and combined with 10x (volume/weight) lysis buffer 
(50 mM Tris at pH 8, 150 mM NaCl, 1 mM EDTA, 1% Triton-X100) supplemented with protease 
inhibitor cocktail tablets (Roche) and phosphatase inhibitor cocktail I and II (Sigma). Brains were 
passed several times through a 1 ml pipette tip and homogenized with a glass-teflon homogenizer by 
using 12 strokes at 800 rpm. After lysate clearing, protein levels were determined using the BCA 
protein assay (Pierce). Equal amounts of protein were loaded onto SDS gels, transferred to 
nitrocellulose membranes and probed for indicated antibodies. 
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Brain sections, histochemistry and immunohistochemistry 
For immunohistochemistry, the heads of the embryos were fixed in 4% PFA in PBS overnight and then 
cryoprotected in 30% sucrose in PBS. Brains were embedded in OCT reagent and frozen on dry ice. 
For fresh frozen sections (size comparison, cresyl violet), heads were directly frozen in OCT on dry 
ice. 10 or 12 μm-thick brain sections were prepared with a cryostat. Fresh frozen sections were post-
fixed for 20 min with 4% PFA. For paraffin sections, brains were fixed for at least two days in 4% PFA 
in PBS, then dehydrated in a graded alcohol series and paraffin embedded. 4 μm sections were 
prepared on a microtome. Mounted sections were deparaffinized by heating for 20 minutes at 65°C, 
immediately immersed twice in xylol for 5 min each. Sections were rehydrated and either directly 
subjected to cresyl violet staining or to antigen retrieval. For antigen retrieval, slides were boiled in 
sodium citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6) and allowed to cool slowly for 
another 20 minutes. For immunohistochemistry, sections were blocked for 30 minutes in PBS 
containing 5% BSA and 0.25% Triton-X100 or TSA Blocking reagent (Perkin Elmer lifescience) 
followed by washing in PBS. Slices were incubated overnight at 4°C in blocking buffer or in PBS (if 
TSA blocked) with following primary antibodies: GFAP (1:200), NeuN (1:200), Map2 (1:400), Sox2 
(1:100), Tbr2 (1:200), Ki67 (1:200) BrdU (1:500). Subsequently, slides were washed 3 x with PBS for 
5 min each and incubated with appropriate secondary antibodies and DAPI (0.2 μg/ml) for 1 hour at 
room temperature. After washing in PBS, coverslips were mounted with Kaiser’s glycerol gelatin. For 
birthdating analysis, 50 mg BrdU/kg was applied by intraperitoneal injection to pregnant mice. Brain 
sections were incubated in 2 M HCl for 1h at 37°C. Subsequently, sections were washed 3 x in PBS, 
incubated for 10 minutes in borate buffer (0.1 M, pH 8.5) and processed for immunohistochemistry as 
described. Separation of cortical regions in R1, R2 and R3 were defined in stainings to BrdU, Sox2 
and Tbr2 as described in Fig. S3. In this experiment BrdU injections were given 24 hours prior to 
analysis.  To measure the cell cycle time, we injected pregnant mice cumulatively every 2 hours with 
BrdU for a period of up to 12 hours (E15.5) and up to 8 hours (E17.5).  
 
Quantifications 
For all experiments at least three mice per genotype were examined. For the BrdU pulse chase 
experiments, BrdU was administered to a pregnant mouse by a single intraperitoneal injection and the 
brains of the embryos were harvested 3, 12 or 24 hours later. For the cumulative BrdU experiments, 
BrdU was injected every 2 hours for a maximum time period of 12 hours. The brains of the embryos 
were removed and the tissue was then processed for immunostaining as described above. 
Quantification of BrdU-labeled cells was done by determining the number of BrdU-positive cells that 
were localized above a specifically-defined ventricular surface length. This allowed the detection of all 
newly generated cells originating from a defined length of the apical membrane. Similar quantification 
was applied for PH3-positive cells. All quantifications were carried out in anatomically-matched 
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regions. The total number of cells was determined by counting the number of Hoechst-stained nuclei 
in at least 3 sections per animal in a defined area that spanned from the ventricle up to the pial 
surface. The paired t-test was used for statistical analysis. 
 
DNA quantification 
DNA was quantified in tissue homogenates (Labarca and Paigen, 1980) as already characterize for 
the quantification of brain size in Akt3/PKBγ knockout mice (Easton et al., 2005; Tschopp et al., 2005). 
Briefly, brains were homogenized by Polytron in detection buffer (0.05 M sodium phosphate, 2.0 M 
NaCl, 2 mM EDTA, 1 μg/ml Hoechst 33258 (Sigma), pH 7.4), followed by sonication for 20 seconds. 
Samples were excited at 356 nm and emission at 492 nm was determined. DNA concentration of 
homogenates was determined relative to a standard curve using calf thymus DNA (Sigma).  
 
Neurospheres 
Neurospheres were prepared from P0 telencephali (Giachino et al., 2009). Briefly, telencephali were 
dissected in HBSS, the meninges and the olfactory bulbs were removed. The tissue was triturated with 
a 1 ml pipette tip in neurosphere medium consisting of DMEM/F12 (1:1), 0.2 mg/ml L-glutamine, 1% 
penicillin/streptomycin, 2% B27, 2 μg/ml heparin, 20 ng/ml EGF and 10 ng/ml FGF2. The homogenate 
was diluted twice in the ratio 1:1 with fresh medium and each time triturated shortly. 5 x 104 cells were 
plated in a 5 cm dish. After 7 days, cultures were split. For determination of the capacity of secondary 
neurosphere formation and growth, cells were plated at a clonal density of 3000 cells/ml (Sirko et al., 
2007). Six representative images were taken for each well of a 6-well plate to determine neurosphere 
number and diameter. For differentiation, neurospheres were split after 5 to 6 days and plated on 
coverslips coated with 15 μg/ml Poly-L-ornithin and 40 μg/ml laminin (150,000 cells/cm²). The 
dispersed cultures were differentiated in neurosphere medium lacking FGF2, EGF and heparin and 
fixed after 5 days with 4% PFA (Giachino et al., 2009). For staining, cells were washed 3 x with PBS, 
incubated for 10 minutes in PBS containing 0.25% TritonX. Staining was performed with the same 
procedure as described above for the brain sections, β-tubulin III antibody was used 1:400 in 
stainings.  
 
Hippocampal cultures 
Hippocampi were dissected from E16.5 mice in HBSS and incubated for 10 minutes at 37°C in HBSS 
containing 0.05% Trypsin and 0.02% EDTA. Afterwards, hippocampi were gently washed twice with 
HBSS and then triturated in plating medium consisting of DMEM, 0.2 mg/ml L-glutamine, 1% 
penicillin/streptomycin and 10% FCS. Neurons were plated at a density of 100,000 cells/cm² on glass 
coverslips coated with 10 μg/ml Poly-D-Lysin. After 3 hours, this medium was replaced by growth 
medium consisting of Neurobasal medium (Invitrogen), 0.2 mg/ml L-glutamine, 1% 
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penicillin/streptomycin and 2% B27 (Invitrogen). After 4 days, the conditioned culture medium was 
decanted and kept and cells were cotransfected with a plasmid expressing GFP from the synapsin 
promoter and either a Cre- or a control plasmid which contain both the CMV promoter. Lipofectamine 
2000 (Invitrogen) was used as transfection reagent according to the user manual. 0.5 μg total DNA 
and 1 μl Lipofectamine 2000 was used for transfection of 100,000 cells. After 3 hours, the transfection 
mix was exchanged for the conditioned medium. Cells were fixed after 14 days in culture and imaged 
by confocal microscopy. 
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4.3 Additional findings 
Besides the conventional approach of a conditional knockout mouse model in which the Cre 
recombinase is under the control of a tissue-specific promoter (thus with a given expression pattern 
within a given timeframe), there exists a refined method that allows the temporal control for the onset 
of the recombination to take place. The time-specific induction of recombination can be achieved by 
the fusion of the Cre recombinase with a mutated ligand binding domain of the human estrogen 
receptor (ERT2) (Baumgartel et al., 2007). The ERT2 does not bind to endogenous estradiol, whereas 
it binds specifically to the synthetic estrogen receptor antagonist Tamoxifen. The inducible Cre-LoxP 
system is based on the fact that the chimeric recombinase CreERT2 is kept in the cytoplasm by heat-
shock proteins (e.g. Hsp90) that interact with the ERT2 domain. Only upon Tamoxifen application the 
CreERT2 dissociates from Hsp90 and is able to enter the nucleus where it can combine with the DNA 
and exert its recombination-activity (Feil et al., 1997). 
 
4.3.1 Results from α-CamKII-CreERT2 mediated rptor knockout 
In order to more specifically control the recombination-pattern of the rptor knockout we originally 
intended to make use of an inducible Cre-LoxP system. The mice expressing CreERT2 under the 
control of the αCamKII-promoter were kindly provided by Isabelle Mansuy, Brain Research Institute, 
University of Zurich. A schematic illustration of the CreERT2-system is depicted in Supplementary 
Figure 1S, A and B. For the analysis of the recombination pattern we used a GFP-reporter mouse line 
that was provided by Matthias Müller, Novartis AG, Basel. In a first attempt, we injected Tamoxifen (1 
mg) into a lactating mouse for 10 days (during the age P5 – P15 of the pups). The recombination 
efficiency of such an early induced Cre-activity was very low and only some single cells in the 
hippocampus and the hypothalamus showed recombination (data not shown). Also Western blot 
analysis of different tissue-fractions from homozygously floxed rptor mice that additionally were 
positive for CreERT2 revealed no substantial recombination upon Tamoxifen injections into the 
lactating mother. No detectable difference in raptor protein or phosphorylated S6 levels could be 
observed (Figure S1, E). Due to the failure of early recombination induction by Tamoxifen application 
via the lactation-path, we injected Tamoxifen (1 mg) into adult mice and analyzed the recombination 
pattern 3 month post induction. Main sites of recombination were found in the olfactory bulb, 
hippocampus and hypothalamus in the GFP-reporter mouse line (Figure S1, C). The same Tamoxifen 
administration was performed in mice carrying the GFP-reporter allele in addition to the floxed rptor 
alleles and the CreERT2 transgene. GFP-positive cells were considered as cells where recombination 
took place. However, immunohistochemical analysis of hippocampal CA1 neurons from such mice 
revealed no distinct difference in pS6 staining between GFP-positive and GFP-negative cells (Figure 
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S1, D). Furthermore, Western blot analysis of lysates from the olfactory bulbs, hippocampus and 
hypothalamus did not show reduced protein levels of raptor or phosphorylation level of S6 (Figure S1, 
F). Together, these results indicate that the used mouse model leads to minor recombination 
efficiency upon Tamoxifen injections in both young and adult mice. Therefore, it was not suitable for 
further experiments such as behavioral studies, field recordings or biochemical analysis. 
 
4.3.2 Material and methods of α-CamKII-CreERT2 experiments 
Tamoxifen (Sigma-Aldrich) was dissolved in 90% corn oil (Sigma-Aldrich), 10% EtOH (Sigma-Aldrich) 
to a final concentration of 10 mg/ml, and sonicated in a water bath during 5 min. Mice received 
intraperitoneal injections (1 mg) of freshly prepared Tamoxifen-solution. Injection-regimes were as 
follows: a) One Tamoxifen injection per day over 10 consecutive days into lactating mothers from P5 – 
P15 old pups. b) Two Tamoxifen injections per day over 5 consecutive days into adult mice. For 
immunohistochemical analysis, the procedures for perfusion, tissue processing and staining were as 
described in the chapter 4.1. Following antibodies were used: chicken anti-GFP (Invitrogen, 1:200), 
rabbit anti pS6 (Cell Signaling, 1:200), DAPI (1:1000), goat anti rabbit Cy3 (Jackson Immunoresearch, 
1:500), goat anti chicken Alexa488 (Jackson Immunoresearch, 1:500). The procedure for Western blot 
analysis was as described in the chapter 4.1. Genotyping for floxed rptor alleles and Cre was 
performed as described in chapter 4.1. For detection of the LoxPstopLoxPGFP allele in the GFP-
reporter mice the following primers were used: GFP for: TGA TAT TGC TGA AGA GCT TGG CGG C; 
GFP rev: TGT GTG TAT TCC TGG CTA TCC.  
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Additional findings. Analysis of αCamKII-CreERT2 mediated knockout. A Breeding scheme of inducible 
knockout mice. B Mechanism of Tamoxifen induced recombination. C Tissue analysis of GFP-reporter mice 
injected with Tamoxifen (1 mg, twice per day over 5 days) shows recombination in the olfactory bulb, 
hippocampus and hypothalamus (upper panel). Lower panel shows the according brain structure from Allen Brain 
Atlas. D Mice homozygous for the floxed rptor allele and the reporter allele and carrying the CreERT2-transgene 
were treated with the Tamoxifen-regime as in C. No distinct reduction of pS6 staining is observable in cells 
positive for the GFP-reporter (yellow arrows). E and F show representative Western blots of indicated tissue 
lysates probed for raptor, pS6 and β-actin. Lysates of mice with Tamoxifen application at P5 - P15 are depicted in 
E. Lysates of Tamoxifen application at adult stages are depicted in F. Abbreviations: Ctr, control; KO, knockout; 
Het, heterozygous; Hsp90, heat-shock protein 90. Scale bars: 200 µm (C); 50 µm (D). 
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5 CONCLUDING REMARKS 
In this study, we report on two knockout mouse models and provide new insights into the function and 
importance of mTORC1 signaling in the developing and adult central nervous system. The conditional 
knockout of rptor at an early embryonic stage in all neuronal cells and in adult forebrain neurons, 
respectively, allowed us to specifically analyze the function of mTORC1 with regard to very distinct 
phases of a brain’s or neuron’s life. 
 
The characterization of the RAbKO mice revealed a crucial role of mTORC1 for embryonic brain 
development, brain growth and ultimately for postnatal survival. As summarized in chapter 3.2.1, 
based on cell culture experiments the importance of mTORC1 signaling for axonal outgrowth and 
path-finding, dendritic arborization as well as for cell differentiation was suggested. Our data now 
provide first in vivo evidence that several of these aspects that are important during brain development 
are affected by ablation of mTORC1 activity. The most striking phenotypes observed in RAbKO mice 
are: hindered differentiation towards the glial lineage likely due to reduction of Stat3 signaling, deficits 
in cell proliferation and defective cortical as well as hippocampal layering. The molecular mechanisms 
behind these observations are – except for the Stat3-mediated triggering of glial differentiation – not 
clear yet. However, there are up- and downstream targets of mTORC1, which could serve as good 
candidates in regard to the mechanisms responsible for the observed phenotypes. The irregular 
cortical layering could be mediated via a disturbed nerve growth factor signaling or via a potential 
irresponsiveness to REDD1 signaling in the RAbKO mice. Furthermore, with reference to the overall 
reduced brain size the proteins Reelin and Ulk-1 were both associated with mTORC1 signaling and 
described as regulators of dendritic- and axonal outgrowth, respectively (Jossin and Goffinet, 2007; 
Zhou et al., 2007). Additionally, the alterations in proliferation and cell cycle length can largely (in 
addition to apoptosis) explain the reduction in brain size and besides possible intrinsic factors this may 
be due to a lack of response to EGF and BDNF signaling. 
 
The examination of RcKO mice is the first study that investigated the direct role of mTORC1 in the 
adult brain by a genetic approach. In this work, we provide evidence that mTORC1 signaling in the 
adult brain is critical for postmitotic neuron cell size maintenance, synaptic efficiency and plasticity as 
well as specific forms of learning and memory. So far, only the consequences of enhanced mTORC1 
activity have been discussed in quite some detail in literature but to date low focus – mainly by the use 
of rapamycin – was paid on hindered mTORC1 signaling. 
 Our data now suggest that well balanced mTORC1 signaling is crucial for basal synaptic 
efficiency. Besides the involvement of mTORC1 in basal synaptic functions, mTORC1 activity likely is 
further modulated in response to enhanced neuronal activity in order to trigger local protein synthesis 
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that is believed to be essential for L-LTP and long term memory. We found that both 
electrophysiological correlates to learning and short- and long-term memory, namely E-LTP and L-
LTP, are altered in RcKO mice. This observation was accompanied by the finding that both the 
learning and the memory performance in the Morris water maze are markedly reduced in RcKO mice 
compared to control littermates. Interestingly, we found that in the same paradigm the learning and 
memory deficits can be bypassed upon a training scheme that is characterized by short inter-training-
intervals. This observation indicates that several signaling pathways run in parallel to assemble in a 
complex network that finally accounts for the molecular requisite for synaptic plasticity. mTORC1 
seems to be critical within this network, especially for tasks that include long time-intervals between 
individual trainings and thereby consolidation phases that are within a time frame where protein 
synthesis is crucial. Notably, upon intensive training in a time-setting that is characterized by short 
consolidation phases between individual trainings, the lack of mTORC1 signaling does not lead to 
learning or memory deficits. 
 Furthermore, we observed a specific deficit in the extinction test of the fear conditioning in RcKO 
mice whereas the learning and memory in the cue- and context test were not altered compared to 
control mice. It is well known that the mechanisms of the extinction learning do represent a distinct 
form of learning from the initial fear acquisition. Thus, our finding that mTORC1 deficiency specifically 
leads to an impairment of processes involved in extinction but not in the initial fear conditioning is very 
interesting. In summary, our observations on the learning and memory performance of RcKO mice in 
different behavioral paradigms suggest that mTORC1 is contributing to the complex molecular 
mechanisms that account for at least two distinct forms of learning and memory, namely spatial 
learning and memory and extinction learning, respectively. Other forms of plasticity-related learning 
and memory tests, such as fear conditioning and cue- and context-memory, are not dependent on 
mTORC1 activity.  
 Finally, we observed a striking reduction in neuronal cell size in the hippocampus as well as an 
overall reduced brain weight in RcKO mice compared to control mice. These data suggest that 
mTORC1 is critical for cell growth and proliferation and additionally plays an important role in cell size 
maintenance of postmitotic neurons. 
 As rapamycin is used in several indications, e.g. metabolic diseases, cancer, neurodegenerative 
diseases and mental disorders, our data are of general importance in respect to possible brain-specific 
side effects of prolonged mTORC1 inhibition. 
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6 OUTLOOK 
The data presented here represent the first initial characterization of the RAbKO mice and RcKO mice, 
respectively. The reported phenotypes are of very interesting nature but the detailed mechanisms 
responsible for several findings are not understood in detail yet. Therefore, it will be important to 
further analyze the initially described phenotypes into depth with focus on the molecular mechanisms 
underlying the particular observations. 
 
More precisely, the underlying mechanism for the disturbed cortical and hippocampal layering in 
RAbKO mice should be carefully analyzed. Birth-dating experiments in combination with 
immunohistochemistry as well as in vitro migrationassays could be performed. Furthermore, the 
proliferation capacity of the precursor cell pool at different embryonic stages as well as the features of 
axonal and dendritic outgrowth of newborn neurons are aspects for potential further investigations. It 
will be important to look for and identify signaling components which trigger axonal and dendritic 
outgrowth via mTORC1. One possible tool to achieve those goals would be the generation of an 
inducible knockout system with the additional possibility to track individual cells by a GFP-reporter. 
Such a mouse model would allow to differentiate between intrinsic mechanisms and environmental 
factors that possibly lead to the observed phenotypes. Furthermore, it could enable to more 
specifically define time-point specific effects of the mTORC1 inactivation. 
 
With regard to RcKO mice, it will be interesting – although technically challenging – to examine the 
basal protein synthesis level and the protein synthesis level after LTP induction in the dendritic 
compartments as well as in the soma of CA1 neurons. Such investigations would provide more insight 
into the class of mRNA that is transcriptionally controlled by mTORC1 under basal and plasticity-
related conditions. With regard to the L-LTP phenotype that was observed in RcKO mice it still 
remains unclear to what extent the decreased synaptic efficiency may also account for the L-LTP 
maintenance deficit. In order to more clearly separate the phenotype of synaptic efficiency and the 
phenotype of protein synthesis-dependent L-LTP progression, an excessive HFS paradigm could be 
applied to acute hippocampal slices. Assuming that such an LTP-induction protocol does obscure the 
differences in basal synaptic efficiency, the subsequent analysis of L-LTP progression would allow to 
make a more profound statement on the mTORC1 contribution to the protein synthesis-dependent 
phase of LTP. 
 In a broader point of view, the RcKO mice could serve as a useful model to study the contribution 
of mTORC1 signaling in various kinds of neurodegenerative diseases and mental disorders. The 
combination of different disease-related mouse models with RcKO mice could provide insight into the 
still open question about the cause or consequence of altered mTORC1 signaling in those diseases. 
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Such studies would improve the knowledge about brain specific mTOR signaling in general and the 
perception of disease-origins and progression in particular. 
 Furthermore, a very interesting topic that so far has not at all been approached is the 
phenomenon of long-term depression (LTD). In some aspects, such as kinase activation and protein 
synthesis dependence, L-LTD shares certain similarities with L-LTP. However, the molecular 
mechanisms that underlie the induction of LTD are regulated differently. Both, the induction phase and 
the maintenance phase are potentially dependent on mTORC1 signaling. E.g. GSK3α and GSK3β are 
well known components for LTD and at least GSK3α seems to be altered in RcKO mice (preliminary 
data, not shown). In respect of LTD, of course also mTORC2 should be taken into account. Based on 
the observation that several PKC isoforms are completely missing in rictor-deficient brains and in 
consideration of the well-known function of PKC in LTD and LTP, respectively, a detailed 
electrophysiological analysis of α-CamK2-Cre mediated rictor knockout would be worth to be carried 
out. The characterization of such a mouse model on the level of synaptic plasticity and learning and 
memory would further shed light of whether the synaptic plasticity-related effects that have been 
attributed to rapamycin are mTORC1 specific or involve further contributions by mTORC2.  
 
 
 
References  Regula M. Lustenberger 
 
 
Page | 118  
7 REFERENCES 
Abraham, W.C., and Williams, J.M. (2008). LTP maintenance and its protein synthesis-dependence. 
Neurobiol Learn Mem 89, 260-268. 
Altmann, M., Muller, P.P., Pelletier, J., Sonenberg, N., and Trachsel, H. (1989). A mammalian 
translation initiation factor can substitute for its yeast homologue in vivo. J Biol Chem 264, 12145-
12147. 
An, W.L., Cowburn, R.F., Li, L., Braak, H., Alafuzoff, I., Iqbal, K., Iqbal, I.G., Winblad, B., and Pei, J.J. 
(2003). Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary 
pathology in Alzheimer's disease. Am J Pathol 163, 591-607. 
Andrade, M.A., and Bork, P. (1995). HEAT repeats in the Huntington's disease protein. Nat Genet 11, 
115-116. 
Antion, M.D., Merhav, M., Hoeffer, C.A., Reis, G., Kozma, S.C., Thomas, G., Schuman, E.M., 
Rosenblum, K., and Klann, E. (2008). Removal of S6K1 and S6K2 leads to divergent alterations in 
learning, memory, and synaptic plasticity. Learn Mem 15, 29-38. 
Asaki, C., Usuda, N., Nakazawa, A., Kametani, K., and Suzuki, T. (2003). Localization of translational 
components at the ultramicroscopic level at postsynaptic sites of the rat brain. Brain Res 972, 168-
176. 
Auerbach, B.D., Osterweil, E.K., and Bear, M.F. (2011). Mutations causing syndromic autism define 
an axis of synaptic pathophysiology. Nature 480, 63-68. 
Banko, J.L., Poulin, F., Hou, L., DeMaria, C.T., Sonenberg, N., and Klann, E. (2005). The translation 
repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the 
hippocampus. J Neurosci 25, 9581-9590. 
Bartsch, D., Casadio, A., Karl, K.A., Serodio, P., and Kandel, E.R. (1998). CREB1 encodes a nuclear 
activator, a repressor, and a cytoplasmic modulator that form a regulatory unit critical for long-term 
facilitation. Cell 95, 211-223. 
Baumgartel, K., Fernandez, C., Johansson, T., and Mansuy, I.M. (2007). Conditional transgenesis and 
recombination to study the molecular mechanisms of brain plasticity and memory. Handb Exp 
Pharmacol, 315-345. 
Bentzinger, C.F., Romanino, K., Cloetta, D., Lin, S., Mascarenhas, J.B., Oliveri, F., Xia, J., Casanova, 
E., Costa, C.F., Brink, M., et al. (2008). Skeletal muscle-specific ablation of raptor, but not of rictor, 
causes metabolic changes and results in muscle dystrophy. Cell Metab 8, 411-424. 
Berger, Z., Ravikumar, B., Menzies, F.M., Oroz, L.G., Underwood, B.R., Pangalos, M.N., Schmitt, I., 
Wullner, U., Evert, B.O., O'Kane, C.J., et al. (2006). Rapamycin alleviates toxicity of different 
aggregate-prone proteins. Hum Mol Genet 15, 433-442. 
Berry-Kravis, E., Knox, A., and Hervey, C. (2011). Targeted treatments for fragile X syndrome. J 
Neurodev Disord 3, 193-210. 
Bidinosti, M., Ran, I., Sanchez-Carbente, M.R., Martineau, Y., Gingras, A.C., Gkogkas, C., Raught, B., 
Bramham, C.R., Sossin, W.S., Costa-Mattioli, M., et al. (2010). Postnatal deamidation of 4E-BP2 in 
References  Regula M. Lustenberger 
 
 
Page | 119  
brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Mol 
Cell 37, 797-808. 
Bliss, T.V., and Lomo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area 
of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232, 331-356. 
Bourne, J.N., Sorra, K.E., Hurlburt, J., and Harris, K.M. (2007). Polyribosomes are increased in spines 
of CA1 dendrites 2 h after the induction of LTP in mature rat hippocampal slices. Hippocampus 17, 1-
4. 
Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S., and Schreiber, S.L. 
(1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-
758. 
Brown, N.F., Stefanovic-Racic, M., Sipula, I.J., and Perdomo, G. (2007). The mammalian target of 
rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes. Metabolism 56, 1500-
1507. 
Brown, R.E. (2006). The life and work of Donald Olding Hebb. Acta Neurol Taiwan 15, 127-142. 
Brugarolas, J., Lei, K., Hurley, R.L., Manning, B.D., Reiling, J.H., Hafen, E., Witters, L.A., Ellisen, 
L.W., and Kaelin, W.G., Jr. (2004). Regulation of mTOR function in response to hypoxia by REDD1 
and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18, 2893-2904. 
Cammalleri, M., Lutjens, R., Berton, F., King, A.R., Simpson, C., Francesconi, W., and Sanna, P.P. 
(2003). Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of 
late-phase long-term potentiation in the CA1. Proc Natl Acad Sci U S A 100, 14368-14373. 
Campbell, D.S., and Holt, C.E. (2001). Chemotropic responses of retinal growth cones mediated by 
rapid local protein synthesis and degradation. Neuron 32, 1013-1026. 
Chen, X.G., Liu, F., Song, X.F., Wang, Z.H., Dong, Z.Q., Hu, Z.Q., Lan, R.Z., Guan, W., Zhou, T.G., 
Xu, X.M., et al. (2010). Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and 
mTORC2 signaling pathways. Mol Carcinog 49, 603-610. 
Chong, Z.Z., Shang, Y.C., Zhang, L., Wang, S., and Maiese, K. (2010). Mammalian target of 
rapamycin: hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev 3, 374-391. 
Corradetti, M.N., Inoki, K., and Guan, K.L. (2005). The stress-inducted proteins RTP801 and RTP801L 
are negative regulators of the mammalian target of rapamycin pathway. J Biol Chem 280, 9769-9772. 
Crespo, J.L., and Hall, M.N. (2002). Elucidating TOR signaling and rapamycin action: lessons from 
Saccharomyces cerevisiae. Microbiol Mol Biol Rev 66, 579-591, table of contents. 
Cunningham, J.T., Rodgers, J.T., Arlow, D.H., Vazquez, F., Mootha, V.K., and Puigserver, P. (2007). 
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. 
Nature 450, 736-740. 
Cybulski, N., and Hall, M.N. (2009). TOR complex 2: a signaling pathway of its own. Trends Biochem 
Sci 34, 620-627. 
Davis, M. (2011). NMDA receptors and fear extinction: implications for cognitive behavioral therapy. 
Dialogues Clin Neurosci 13, 463-474. 
References  Regula M. Lustenberger 
 
 
Page | 120  
Davis, S., Bozon, B., and Laroche, S. (2003). How necessary is the activation of the immediate early 
gene zif268 in synaptic plasticity and learning? Behav Brain Res 142, 17-30. 
Di Nardo, A.A., Nedelec, S., Trembleau, A., Volovitch, M., Prochiantz, A., and Montesinos, M.L. 
(2007). Dendritic localization and activity-dependent translation of Engrailed1 transcription factor. Mol 
Cell Neurosci 35, 230-236. 
Duvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., 
Gorski, R., Cleaver, S., et al. (2010). Activation of a metabolic gene regulatory network downstream of 
mTOR complex 1. Mol Cell 39, 171-183. 
Ehninger, D., Li, W., Fox, K., Stryker, M.P., and Silva, A.J. (2008). Reversing neurodevelopmental 
disorders in adults. Neuron 60, 950-960. 
El-Chaar, D., Gagnon, A., and Sorisky, A. (2004). Inhibition of insulin signaling and adipogenesis by 
rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. Int J Obes Relat Metab Disord 
28, 191-198. 
Facchinetti, V., Ouyang, W., Wei, H., Soto, N., Lazorchak, A., Gould, C., Lowry, C., Newton, A.C., 
Mao, Y., Miao, R.Q., et al. (2008). The mammalian target of rapamycin complex 2 controls folding and 
stability of Akt and protein kinase C. Embo J 27, 1932-1943. 
Feil, R., Wagner, J., Metzger, D., and Chambon, P. (1997). Regulation of Cre recombinase activity by 
mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237, 752-757. 
Feng, Z., Zhang, H., Levine, A.J., and Jin, S. (2005). The coordinate regulation of the p53 and mTOR 
pathways in cells. Proc Natl Acad Sci U S A 102, 8204-8209. 
Fingar, D.C., and Blenis, J. (2004). Target of rapamycin (TOR): an integrator of nutrient and growth 
factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23, 3151-3171. 
Fitzjohn, S.M., Irving, A.J., Palmer, M.J., Harvey, J., Lodge, D., and Collingridge, G.L. (1996). 
Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neurosci Lett 
203, 211-213. 
Foretz, M., Guichard, C., Ferre, P., and Foufelle, F. (1999). Sterol regulatory element binding protein-
1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-
related genes. Proc Natl Acad Sci U S A 96, 12737-12742. 
Frey, U., Krug, M., Reymann, K.G., and Matthies, H. (1988). Anisomycin, an inhibitor of protein 
synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res 
452, 57-65. 
Frey, U., and Morris, R.G. (1997). Synaptic tagging and long-term potentiation. Nature 385, 533-536. 
Fukunaga, K., Stoppini, L., Miyamoto, E., and Muller, D. (1993). Long-term potentiation is associated 
with an increased activity of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 268, 7863-
7867. 
Gafford, G.M., Parsons, R.G., and Helmstetter, F.J. (2011). Consolidation and reconsolidation of 
contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal 
hippocampus. Neuroscience 182, 98-104. 
References  Regula M. Lustenberger 
 
 
Page | 121  
Gangloff, Y.G., Mueller, M., Dann, S.G., Svoboda, P., Sticker, M., Spetz, J.F., Um, S.H., Brown, E.J., 
Cereghini, S., Thomas, G., et al. (2004). Disruption of the mouse mTOR gene leads to early 
postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24, 9508-9516. 
Ganley, I.G., Lam du, H., Wang, J., Ding, X., Chen, S., and Jiang, X. (2009). ULK1.ATG13.FIP200 
complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 284, 12297-12305. 
Garami, A., Zwartkruis, F.J., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S.C., Hafen, 
E., Bos, J.L., and Thomas, G. (2003). Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP 
signaling, is inhibited by TSC1 and 2. Mol Cell 11, 1457-1466. 
Garcia-Martinez, J.M., and Alessi, D.R. (2008). mTOR complex 2 (mTORC2) controls hydrophobic 
motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). 
Biochem J 416, 375-385. 
Garelick, M.G., and Kennedy, B.K. (2011). TOR on the brain. Exp Gerontol 46, 155-163. 
Gelinas, J.N., Banko, J.L., Hou, L., Sonenberg, N., Weeber, E.J., Klann, E., and Nguyen, P.V. (2007). 
ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate 
induction of protein synthesis-dependent long-term potentiation. J Biol Chem 282, 27527-27535. 
Gingras, A.C., Raught, B., and Sonenberg, N. (1999). eIF4 initiation factors: effectors of mRNA 
recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68, 913-963. 
Goorden, S.M., van Woerden, G.M., van der Weerd, L., Cheadle, J.P., and Elgersma, Y. (2007). 
Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol 62, 648-
655. 
Griffin, R.J., Moloney, A., Kelliher, M., Johnston, J.A., Ravid, R., Dockery, P., O'Connor, R., and 
O'Neill, C. (2005). Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and 
altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 93, 
105-117. 
Guertin, D.A., Stevens, D.M., Thoreen, C.C., Burds, A.A., Kalaany, N.Y., Moffat, J., Brown, M., 
Fitzgerald, K.J., and Sabatini, D.M. (2006). Ablation in mice of the mTORC components raptor, rictor, 
or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. 
Dev Cell 11, 859-871. 
Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., Turk, B.E., 
and Shaw, R.J. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30, 
214-226. 
Han, J., Wang, B., Xiao, Z., Gao, Y., Zhao, Y., Zhang, J., Chen, B., Wang, X., and Dai, J. (2008). 
Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural 
progenitors induced by insulin. Mol Cell Neurosci 39, 118-124. 
Hannan, K.M., Brandenburger, Y., Jenkins, A., Sharkey, K., Cavanaugh, A., Rothblum, L., Moss, T., 
Poortinga, G., McArthur, G.A., Pearson, R.B., et al. (2003). mTOR-dependent regulation of ribosomal 
gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal 
activation domain of the nucleolar transcription factor UBF. Mol Cell Biol 23, 8862-8877. 
Hara, K., Yonezawa, K., Weng, Q.P., Kozlowski, M.T., Belham, C., and Avruch, J. (1998). Amino acid 
sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector 
mechanism. J Biol Chem 273, 14484-14494. 
References  Regula M. Lustenberger 
 
 
Page | 122  
Hardie, D.G., Carling, D., and Carlson, M. (1998). The AMP-activated/SNF1 protein kinase subfamily: 
metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67, 821-855. 
Harrington, L.S., Findlay, G.M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, 
N.R., Cheng, S., Shepherd, P.R., et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K 
signaling via regulation of IRS proteins. J Cell Biol 166, 213-223. 
Hay, N., and Sonenberg, N. (2004). Upstream and downstream of mTOR. Genes Dev 18, 1926-1945. 
Heesom, K.J., and Denton, R.M. (1999). Dissociation of the eukaryotic initiation factor-4E/4E-BP1 
complex involves phosphorylation of 4E-BP1 by an mTOR-associated kinase. FEBS Lett 457, 489-
493. 
Heitman, J., Movva, N.R., and Hall, M.N. (1991). Targets for cell cycle arrest by the 
immunosuppressant rapamycin in yeast. Science 253, 905-909. 
Herron, C.E., Lester, R.A., Coan, E.J., and Collingridge, G.L. (1986). Frequency-dependent 
involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature 322, 265-
268. 
Hershey, J.W. (1991). Translational control in mammalian cells. Annu Rev Biochem 60, 717-755. 
Hoeffer, C.A., Tang, W., Wong, H., Santillan, A., Patterson, R.J., Martinez, L.A., Tejada-Simon, M.V., 
Paylor, R., Hamilton, S.L., and Klann, E. (2008). Removal of FKBP12 enhances mTOR-Raptor 
interactions, LTP, memory, and perseverative/repetitive behavior. Neuron 60, 832-845. 
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S., Natsume, T., 
Takehana, K., Yamada, N., et al. (2009). Nutrient-dependent mTORC1 association with the ULK1-
Atg13-FIP200 complex required for autophagy. Mol Biol Cell 20, 1981-1991. 
Hsu, P.P., Kang, S.A., Rameseder, J., Zhang, Y., Ottina, K.A., Lim, D., Peterson, T.R., Choi, Y., Gray, 
N.S., Yaffe, M.B., et al. (2011). The mTOR-regulated phosphoproteome reveals a mechanism of 
mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322. 
Huang, Y.S., Jung, M.Y., Sarkissian, M., and Richter, J.D. (2002). N-methyl-D-aspartate receptor 
signaling results in Aurora kinase-catalyzed CPEB phosphorylation and alpha CaMKII mRNA 
polyadenylation at synapses. Embo J 21, 2139-2148. 
Inoki, K., Li, Y., Xu, T., and Guan, K.L. (2003a). Rheb GTPase is a direct target of TSC2 GAP activity 
and regulates mTOR signaling. Genes Dev 17, 1829-1834. 
Inoki, K., Zhu, T., and Guan, K.L. (2003b). TSC2 mediates cellular energy response to control cell 
growth and survival. Cell 115, 577-590. 
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M.A., Hall, A., and Hall, M.N. (2004). Mammalian 
TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6, 1122-
1128. 
Jaworski, J., Spangler, S., Seeburg, D.P., Hoogenraad, C.C., and Sheng, M. (2005). Control of 
dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. 
J Neurosci 25, 11300-11312. 
Jefferies, H.B., Reinhard, C., Kozma, S.C., and Thomas, G. (1994). Rapamycin selectively represses 
translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci U S A 91, 4441-4445. 
References  Regula M. Lustenberger 
 
 
Page | 123  
Jossin, Y., and Goffinet, A.M. (2007). Reelin signals through phosphatidylinositol 3-kinase and Akt to 
control cortical development and through mTor to regulate dendritic growth. Mol Cell Biol 27, 7113-
7124. 
Jurado, S., Benoist, M., Lario, A., Knafo, S., Petrok, C.N., and Esteban, J.A. (2010). PTEN is recruited 
to the postsynaptic terminal for NMDA receptor-dependent long-term depression. Embo J 29, 2827-
2840. 
Kalkman, H.O. (2006). The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in 
schizophrenia. Pharmacol Ther 110, 117-134. 
Kang, H., and Schuman, E.M. (1996). A requirement for local protein synthesis in neurotrophin-
induced hippocampal synaptic plasticity. Science 273, 1402-1406. 
Kelleher, R.J., 3rd, Govindarajan, A., Jung, H.Y., Kang, H., and Tonegawa, S. (2004). Translational 
control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467-479. 
Kersten, S. (2001). Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2, 
282-286. 
Khurana, V., Lu, Y., Steinhilb, M.L., Oldham, S., Shulman, J.M., and Feany, M.B. (2006). TOR-
mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol 
16, 230-241. 
Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., Tempst, P., 
and Sabatini, D.M. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals 
to the cell growth machinery. Cell 110, 163-175. 
Kim, D.H., Sarbassov, D.D., Ali, S.M., Latek, R.R., Guntur, K.V., Erdjument-Bromage, H., Tempst, P., 
and Sabatini, D.M. (2003). GbetaL, a positive regulator of the rapamycin-sensitive pathway required 
for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11, 895-904. 
Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T.P., and Guan, K.L. (2008). Regulation of TORC1 by 
Rag GTPases in nutrient response. Nat Cell Biol 10, 935-945. 
Kim, J.E., and Chen, J. (2004). regulation of peroxisome proliferator-activated receptor-gamma activity 
by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53, 2748-2756. 
Kimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K., Kemp, B.E., Witters, L.A., 
Mimura, O., and Yonezawa, K. (2003). A possible linkage between AMP-activated protein kinase 
(AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 8, 65-79. 
Klann, E., Chen, S.J., and Sweatt, J.D. (1991). Persistent protein kinase activation in the maintenance 
phase of long-term potentiation. J Biol Chem 266, 24253-24256. 
Klann, E., Chen, S.J., and Sweatt, J.D. (1993). Mechanism of protein kinase C activation during the 
induction and maintenance of long-term potentiation probed using a selective peptide substrate. Proc 
Natl Acad Sci U S A 90, 8337-8341. 
Koren, I., Reem, E., and Kimchi, A. (2010). DAP1, a novel substrate of mTOR, negatively regulates 
autophagy. Curr Biol 20, 1093-1098. 
Kremer, E.J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S.T., Schlessinger, D., 
Sutherland, G.R., and Richards, R.I. (1991). Mapping of DNA instability at the fragile X to a 
trinucleotide repeat sequence p(CCG)n. Science 252, 1711-1714. 
References  Regula M. Lustenberger 
 
 
Page | 124  
Kumar, V., Zhang, M.X., Swank, M.W., Kunz, J., and Wu, G.Y. (2005). Regulation of dendritic 
morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 25, 11288-
11299. 
Lafay-Chebassier, C., Paccalin, M., Page, G., Barc-Pain, S., Perault-Pochat, M.C., Gil, R., Pradier, L., 
and Hugon, J. (2005). mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 
transgenic models and in patients with Alzheimer's disease. J Neurochem 94, 215-225. 
Lang, U.E., Heger, J., Willbring, M., Domula, M., Matschke, K., and Tugtekin, S.M. (2009). 
Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot 
study shows significant cognitive and affective improvement. Transplant Proc 41, 4285-4288. 
Langstrom, N.S., Anderson, J.P., Lindroos, H.G., Winblad, B., and Wallace, W.C. (1989). Alzheimer's 
disease-associated reduction of polysomal mRNA translation. Brain Res Mol Brain Res 5, 259-269. 
Laplante, M., and Sabatini, D.M. (2012). mTOR Signaling in Growth Control and Disease. Cell 149, 
274-293. 
Lee, D.F., Kuo, H.P., Chen, C.T., Hsu, J.M., Chou, C.K., Wei, Y., Sun, H.L., Li, L.Y., Ping, B., Huang, 
W.C., et al. (2007). IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the 
mTOR pathway. Cell 130, 440-455. 
Ling, D.S., Benardo, L.S., and Sacktor, T.C. (2006). Protein kinase Mzeta enhances excitatory 
synaptic transmission by increasing the number of active postsynaptic AMPA receptors. Hippocampus 
16, 443-452. 
Lisman, J., Schulman, H., and Cline, H. (2002). The molecular basis of CaMKII function in synaptic 
and behavioural memory. Nat Rev Neurosci 3, 175-190. 
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D., Oppliger, W., 
Jenoe, P., and Hall, M.N. (2002). Two TOR complexes, only one of which is rapamycin sensitive, have 
distinct roles in cell growth control. Mol Cell 10, 457-468. 
Low, P. (2011). The role of ubiquitin-proteasome system in ageing. Gen Comp Endocrinol 172, 39-43. 
Ma, T., Hoeffer, C.A., Capetillo-Zarate, E., Yu, F., Wong, H., Lin, M.T., Tampellini, D., Klann, E., 
Blitzer, R.D., and Gouras, G.K. (2010). Dysregulation of the mTOR pathway mediates impairment of 
synaptic plasticity in a mouse model of Alzheimer's disease. PLoS One 5. 
Ma, X.M., and Blenis, J. (2009). Molecular mechanisms of mTOR-mediated translational control. Nat 
Rev Mol Cell Biol 10, 307-318. 
Mader, S., Lee, H., Pause, A., and Sonenberg, N. (1995). The translation initiation factor eIF-4E binds 
to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-
binding proteins. Mol Cell Biol 15, 4990-4997. 
Malagelada, C., Jin, Z.H., Jackson-Lewis, V., Przedborski, S., and Greene, L.A. (2010). Rapamycin 
protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci 30, 
1166-1175. 
Malinow, R., Schulman, H., and Tsien, R.W. (1989). Inhibition of postsynaptic PKC or CaMKII blocks 
induction but not expression of LTP. Science 245, 862-866. 
Manning, B.D. (2004). Balancing Akt with S6K: implications for both metabolic diseases and 
tumorigenesis. J Cell Biol 167, 399-403. 
References  Regula M. Lustenberger 
 
 
Page | 125  
Manning, B.D., and Cantley, L.C. (2003). United at last: the tuberous sclerosis complex gene products 
connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) 
signalling. Biochem Soc Trans 31, 573-578. 
Mendez, R., Hake, L.E., Andresson, T., Littlepage, L.E., Ruderman, J.V., and Richter, J.D. (2000). 
Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA. Nature 404, 302-
307. 
Mendez, R., and Richter, J.D. (2001). Translational control by CPEB: a means to the end. Nat Rev 
Mol Cell Biol 2, 521-529. 
Mercaldo, V., Descalzi, G., and Zhuo, M. (2009). Fragile X mental retardation protein in learning-
related synaptic plasticity. Mol Cells 28, 501-507. 
Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J 
Neurosci Methods 11, 47-60. 
Noda, T., and Ohsumi, Y. (1998). Tor, a phosphatidylinositol kinase homologue, controls autophagy in 
yeast. J Biol Chem 273, 3963-3966. 
Panja, D., Dagyte, G., Bidinosti, M., Wibrand, K., Kristiansen, A.M., Sonenberg, N., and Bramham, 
C.R. (2009). Novel translational control in Arc-dependent long term potentiation consolidation in vivo. J 
Biol Chem 284, 31498-31511. 
Parkinson, J. (2002). An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 14, 223-
236; discussion 222. 
Pearce, L.R., Komander, D., and Alessi, D.R. (2010). The nuts and bolts of AGC protein kinases. Nat 
Rev Mol Cell Biol 11, 9-22. 
Pei, J.J., Bjorkdahl, C., Zhang, H., Zhou, X., and Winblad, B. (2008). p70 S6 kinase and tau in 
Alzheimer's disease. J Alzheimers Dis 14, 385-392. 
Pei, J.J., and Hugon, J. (2008). mTOR-dependent signalling in Alzheimer's disease. J Cell Mol Med 
12, 2525-2532. 
Phillips, R.G., and LeDoux, J.E. (1992). Differential contribution of amygdala and hippocampus to 
cued and contextual fear conditioning. Behav Neurosci 106, 274-285. 
Piper, M., Anderson, R., Dwivedy, A., Weinl, C., van Horck, F., Leung, K.M., Cogill, E., and Holt, C. 
(2006). Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal growth cones. 
Neuron 49, 215-228. 
Porstmann, T., Santos, C.R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J.R., Chung, Y.L., 
and Schulze, A. (2008). SREBP activity is regulated by mTORC1 and contributes to Akt-dependent 
cell growth. Cell Metab 8, 224-236. 
Raught, B., Peiretti, F., Gingras, A.C., Livingstone, M., Shahbazian, D., Mayeur, G.L., Polakiewicz, 
R.D., Sonenberg, N., and Hershey, J.W. (2004). Phosphorylation of eucaryotic translation initiation 
factor 4B Ser422 is modulated by S6 kinases. Embo J 23, 1761-1769. 
Raymond, C.R. (2007). LTP forms 1, 2 and 3: different mechanisms for the "long" in long-term 
potentiation. Trends Neurosci 30, 167-175. 
References  Regula M. Lustenberger 
 
 
Page | 126  
Reymann, K.G., and Frey, J.U. (2007). The late maintenance of hippocampal LTP: requirements, 
phases, 'synaptic tagging', 'late-associativity' and implications. Neuropharmacology 52, 24-40. 
Reymann, K.G., Matthies, H.K., Schulzeck, K., and Matthies, H. (1989). N-methyl-D-aspartate 
receptor activation is required for the induction of both early and late phases of long-term potentiation 
in rat hippocampal slices. Neurosci Lett 96, 96-101. 
Roberson, E.D., English, J.D., and Sweatt, J.D. (1996). A biochemist's view of long-term potentiation. 
Learn Mem 3, 1-24. 
Roberson, E.D., and Sweatt, J.D. (1996). Transient activation of cyclic AMP-dependent protein kinase 
during hippocampal long-term potentiation. J Biol Chem 271, 30436-30441. 
Rosen, E.D., and MacDougald, O.A. (2006). Adipocyte differentiation from the inside out. Nat Rev Mol 
Cell Biol 7, 885-896. 
Roux, P.P., Ballif, B.A., Anjum, R., Gygi, S.P., and Blenis, J. (2004). Tumor-promoting phorbol esters 
and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 
kinase. Proc Natl Acad Sci U S A 101, 13489-13494. 
Rubinsztein, D.C. (2002). Lessons from animal models of Huntington's disease. Trends Genet 18, 
202-209. 
Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P., and Snyder, S.H. (1994). RAFT1: a 
mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to 
yeast TORs. Cell 78, 35-43. 
Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L., and Sabatini, 
D.M. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 
320, 1496-1501. 
Santini, E., and Klann, E. (2011). Dysregulated mTORC1-Dependent Translational Control: From 
Brain Disorders to Psychoactive Drugs. Front Behav Neurosci 5, 76. 
Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P., 
and Sabatini, D.M. (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive 
and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14, 1296-1302. 
Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., Markhard, A.L., and 
Sabatini, D.M. (2006). Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol 
Cell 22, 159-168. 
Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M. (2005). Phosphorylation and regulation of 
Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101. 
Schieke, S.M., Phillips, D., McCoy, J.P., Jr., Aponte, A.M., Shen, R.F., Balaban, R.S., and Finkel, T. 
(2006). The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen 
consumption and oxidative capacity. J Biol Chem 281, 27643-27652. 
Schmitt, J.M., Guire, E.S., Saneyoshi, T., and Soderling, T.R. (2005). Calmodulin-dependent kinase 
kinase/calmodulin kinase I activity gates extracellular-regulated kinase-dependent long-term 
potentiation. J Neurosci 25, 1281-1290. 
Sehgal, S.N., Baker, H., and Vezina, C. (1975). Rapamycin (AY-22,989), a new antifungal antibiotic. II. 
Fermentation, isolation and characterization. J Antibiot (Tokyo) 28, 727-732. 
References  Regula M. Lustenberger 
 
 
Page | 127  
Shah, O.J., Wang, Z., and Hunter, T. (2004). Inappropriate activation of the TSC/Rheb/mTOR/S6K 
cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14, 
1650-1656. 
Sharma, A., Hoeffer, C.A., Takayasu, Y., Miyawaki, T., McBride, S.M., Klann, E., and Zukin, R.S. 
(2010). Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30, 694-702. 
Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.H., Bardeesy, N., Depinho, R.A., Montminy, M., and 
Cantley, L.C. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects 
of metformin. Science 310, 1642-1646. 
Shima, H., Pende, M., Chen, Y., Fumagalli, S., Thomas, G., and Kozma, S.C. (1998). Disruption of the 
p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. Embo J 
17, 6649-6659. 
Siuta, M.A., Robertson, S.D., Kocalis, H., Saunders, C., Gresch, P.J., Khatri, V., Shiota, C., Kennedy, 
J.P., Lindsley, C.W., Daws, L.C., et al. (2010). Dysregulation of the norepinephrine transporter 
sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. 
PLoS Biol 8, e1000393. 
Soderling, T.R., and Derkach, V.A. (2000). Postsynaptic protein phosphorylation and LTP. Trends 
Neurosci 23, 75-80. 
Sperow, M., Berry, R.B., Bayazitov, I.T., Zhu, G., Baker, S.J., and Zakharenko, S.S. (2012). 
Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on 
neuronal morphology and migration. J Physiol 590, 777-792. 
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., and Mak, T.W. 
(2001). Regulation of PTEN transcription by p53. Mol Cell 8, 317-325. 
Steward, O., and Schuman, E.M. (2003). Compartmentalized synthesis and degradation of proteins in 
neurons. Neuron 40, 347-359. 
Stoica, L., Zhu, P.J., Huang, W., Zhou, H., Kozma, S.C., and Costa-Mattioli, M. (2011). Selective 
pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term 
synaptic plasticity and memory storage. Proc Natl Acad Sci U S A 108, 3791-3796. 
Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S.S., Birnbaum, M.J., and Meyuhas, 
O. (2002). Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is 
fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 
phosphorylation. Mol Cell Biol 22, 8101-8113. 
Sutton, M.A., and Schuman, E.M. (2005). Local translational control in dendrites and its role in long-
term synaptic plasticity. J Neurobiol 64, 116-131. 
Swiech, L., Perycz, M., Malik, A., and Jaworski, J. (2008). Role of mTOR in physiology and pathology 
of the nervous system. Biochim Biophys Acta 1784, 116-132. 
Tang, S.J., Reis, G., Kang, H., Gingras, A.C., Sonenberg, N., and Schuman, E.M. (2002). A 
rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. 
Proc Natl Acad Sci U S A 99, 467-472. 
Tavazoie, S.F., Alvarez, V.A., Ridenour, D.A., Kwiatkowski, D.J., and Sabatini, B.L. (2005). Regulation 
of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8, 1727-
1734. 
References  Regula M. Lustenberger 
 
 
Page | 128  
Thomas, G. (2002). The S6 kinase signaling pathway in the control of development and growth. Biol 
Res 35, 305-313. 
Tokuda, S., Mahaffey, C.L., Monks, B., Faulkner, C.R., Birnbaum, M.J., Danzer, S.C., and Frankel, 
W.N. (2011). A novel Akt3 mutation associated with enhanced kinase activity and seizure 
susceptibility in mice. Hum Mol Genet 20, 988-999. 
Tomasoni, R., and Mondino, A. (2011). The tuberous sclerosis complex: balancing proliferation and 
survival. Biochem Soc Trans 39, 466-471. 
Tsien, J.Z., Chen, D.F., Gerber, D., Tom, C., Mercer, E.H., Anderson, D.J., Mayford, M., Kandel, E.R., 
and Tonegawa, S. (1996). Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87, 
1317-1326. 
Tsokas, P., Grace, E.A., Chan, P., Ma, T., Sealfon, S.C., Iyengar, R., Landau, E.M., and Blitzer, R.D. 
(2005). Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after 
induction of late long-term potentiation. J Neurosci 25, 5833-5843. 
Tsokas, P., Ma, T., Iyengar, R., Landau, E.M., and Blitzer, R.D. (2007). Mitogen-activated protein 
kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the 
mammalian target of rapamycin pathway. J Neurosci 27, 5885-5894. 
Uhlmann, E.J., Apicelli, A.J., Baldwin, R.L., Burke, S.P., Bajenaru, M.L., Onda, H., Kwiatkowski, D., 
and Gutmann, D.H. (2002). Heterozygosity for the tuberous sclerosis complex (TSC) gene products 
results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells. 
Oncogene 21, 4050-4059. 
Um, S.H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, 
P.R., Kozma, S.C., Auwerx, J., et al. (2004). Absence of S6K1 protects against age- and diet-induced 
obesity while enhancing insulin sensitivity. Nature 431, 200-205. 
Vivanco, I., and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human 
cancer. Nat Rev Cancer 2, 489-501. 
von der Brelie, C., Waltereit, R., Zhang, L., Beck, H., and Kirschstein, T. (2006). Impaired synaptic 
plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23, 686-692. 
Walton, M., Henderson, C., Mason-Parker, S., Lawlor, P., Abraham, W.C., Bilkey, D., and Dragunow, 
M. (1999). Immediate early gene transcription and synaptic modulation. J Neurosci Res 58, 96-106. 
Wang, X., and Proud, C.G. (2011). mTORC1 signaling: what we still don't know. J Mol Cell Biol 3, 206-
220. 
Weiler, I.J., Irwin, S.A., Klintsova, A.Y., Spencer, C.M., Brazelton, A.D., Miyashiro, K., Comery, T.A., 
Patel, B., Eberwine, J., and Greenough, W.T. (1997). Fragile X mental retardation protein is translated 
near synapses in response to neurotransmitter activation. Proc Natl Acad Sci U S A 94, 5395-5400. 
Wiegert, J.S., and Bading, H. (2011). Activity-dependent calcium signaling and ERK-MAP kinases in 
neurons: a link to structural plasticity of the nucleus and gene transcription regulation. Cell Calcium 49, 
296-305. 
Woods, A., Johnstone, S.R., Dickerson, K., Leiper, F.C., Fryer, L.G., Neumann, D., Schlattner, U., 
Wallimann, T., Carlson, M., and Carling, D. (2003). LKB1 is the upstream kinase in the AMP-activated 
protein kinase cascade. Curr Biol 13, 2004-2008. 
References  Regula M. Lustenberger 
 
 
Page | 129  
Wu, Z., and Boss, O. (2007). Targeting PGC-1 alpha to control energy homeostasis. Expert Opin Ther 
Targets 11, 1329-1338. 
Wullschleger, S., Loewith, R., and Hall, M.N. (2006). TOR signaling in growth and metabolism. Cell 
124, 471-484. 
Yao, Y., Kelly, M.T., Sajikumar, S., Serrano, P., Tian, D., Bergold, P.J., Frey, J.U., and Sacktor, T.C. 
(2008). PKM zeta maintains late long-term potentiation by N-ethylmaleimide-sensitive factor/GluR2-
dependent trafficking of postsynaptic AMPA receptors. J Neurosci 28, 7820-7827. 
Zearfoss, N.R., Alarcon, J.M., Trifilieff, P., Kandel, E., and Richter, J.D. (2008). A molecular circuit 
composed of CPEB-1 and c-Jun controls growth hormone-mediated synaptic plasticity in the mouse 
hippocampus. J Neurosci 28, 8502-8509. 
Zhang, H., Cicchetti, G., Onda, H., Koon, H.B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, 
C.L., and Kwiatkowski, D.J. (2003). Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt 
signaling through downregulation of PDGFR. J Clin Invest 112, 1223-1233. 
Zhou, X., Babu, J.R., da Silva, S., Shu, Q., Graef, I.A., Oliver, T., Tomoda, T., Tani, T., Wooten, M.W., 
and Wang, F. (2007). Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia 
extension and branching of sensory axons. Proc Natl Acad Sci U S A 104, 5842-5847. 
Zinzalla, V., Stracka, D., Oppliger, W., and Hall, M.N. (2011). Activation of mTORC2 by association 
with the ribosome. Cell 144, 757-768. 
 
 
 
 
 
 
 
 
 
Acknowledgment  Regula M. Lustenberger 
 
 
Page | 130  
ACKNOWLEDGMENT 
In the first place I would like to express my deepest gratefulness to my parents! Without any 
reservation they granted relief to me during all the years of my personal and professional 
development. They thoroughly supported me in all my steps and decisions and always provided a site 
of recreation in a way only Family can do. 
 
I would like to thank Prof. Markus A. Rüegg for giving me the opportunity to do my PhD in his lab. 
Thanks to his way of supervision, I acquired not only scientific qualities but also learned many things 
that go beyond. He placed the responsibility for organizational functions and methodological 
developments on me and was confident that I would manage. It definitely took a while until the first 
fruits could be harvested, but thanks to his patience it turned out to be worthwhile. 
 
I could count on a great assistance and unlimited support by Prof. Kaspar E. Vogt. Without his 
enormous expertise in electrophysiology and his goodwill to help a complete greenhorn such as me, I 
would never have been able to set up the two Rigs and to learn the technique of patch clamp and field 
recording, respectively. I highly appreciate Kaspar’s scientific and technical support and would like to 
express my gratitude! 
 
A warm thank goes to all the present and former Rüegg-Lab members! It was a pleasure to work with 
you – in good times and bad times. Especially the bad times were much more bearable in the 
presence of good colleagues that knew how to cheer me up. 
 
I would like to thank Prof. David P. Wolfer and his team from the Institute of Anatomy, University of 
Zurich, for providing the facility and support for the behavioral experiments. 
 
Thanks to Novartis Stiftung für medizinisch biologische Forschung and the SGV for funding. 
 
I would like to thank Riad Seddik, Mathieu Rajalu, Audrée Pinard, Enrique Perez Garci, Julien 
Gaudias and Silvia Willadt for assistance in electrophysiological questions. 
 
Several people at the Biozentrum contributed to my work in one or the other way: the staff of the 
animal facility; the team of the mechanic and electric workshop; the members of the Handschin-Lab, 
the Barde-Lab, and the Bettler-Lab. Thank you to all of them. 
 
A special thank goes to my sisters, my brother, the “Bios” – especially Anna for proofreading, danke 
1000! – and all my other close friends. They had to accept that I usually came “1-2 hours later” and 
that I often had my mind absorbed with PhD-related issues. Merci for your understanding and mental 
support! You were a backup of unestimable value to me. 
 
Last but in no case at least, with all my heart I would like to dearly thank Ruedi who went with me 
through my PhD probably as intensively as I did. To know you being at my side means extremely 
much to me! SoB! 
 
